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Summary
Introduction: 0PA3  is the causative gene of the autosomal recessive, multi-systemic neuro- 
ophthalmological syndrome, 3-methylglutaconic aciduria Type III (MGA-III) and Autosomal 
Dominant Optic Atrophy and Cataract (ADOAC). Early onset bilateral optic atrophy is a 
common characteristic of both disorders where retinal ganglion cells (RGCs) are lost.
Purpose: To investigate the pathophysiology of the disease and function of the OP A3 protein 
we generated a novel ENU-induced mutant mouse carrying the missense mutation p.L122P in 
exon 2 of Opa3 which is predicted to alter tertiary protein structure.
Methods: Visual function was assessed using optokinetic nystagmus and pupillary light 
reflex. Histology explored retinal degeneration and metabolic dysfunction. Rotarod, wirehang 
and open field analysed neurological, neuromuscular and behavioural aspects of the disease. 
Genomic structure of Opa3 was re-examined using RT-PCR and bio-informatic programs 
characterized possible upstream transcription factor binding sites (TFBS).
Results: Opa3~l~ mice displayed a multi-systemic disease, including decreased life span and 
weight, extra-pyramidal dysfunction, neuro-muscular defect, craniofacial defects, reduction in 
intra-abdominal white adipose tissue, elevated marrow adiposity and severe hepatic steatosis. 
Opa3~/~ are functionally blind but pupillary function was essentially intact. Histology showed 
loss of RGCs and other cell types through postnatal development onwards. RT-PCR identified 
a third exon and analysis of 53 TFBS identified suggests a role for Opa3 in retinal and 
craniofacial development, cellular stress response/apoptosis and adipogenesis.
Conclusions: Opa3~'~ display many aspects of human MGA-III syndrome and phenotypes not 
observed such as craniofacial defects and a profound disturbance in lipid metabolism. Opa3 is 
thought to be involved in the mevalonate shunt and leucine degradation metabolic pathways. 
Defects in these pathways can cause a build up of 3-methylglutaconic acid and 3- 
methylglyaric acid in the inner mitochondrial membrane which may have a profound affect on 
mitochondrial metabolism particularly in high energy demand tissues such as retina, heart and 
neurons.
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IPL- Inner plexiform layer
ipRGCs- Intrinsically photoreceptive retinal ganglion cells 
kb- kilobase 
kD- kilodalton
LGN- Lateral genticulate nucleus
LHON- Leber’s hereditary optic neuropathy
LPL- Lipoprotein lipase
MGA - Methylglutaconic aciduria
MGA III- Methylglutaconic aciduria Type III
mins- Minutes
mm- Millimetres
MNDA- N-methyl D-aspartate
MRC- Medical research council
MRI- Magnetic resonance imaging
mRNA- Messenger RNA
mtDNA- Mitochondrial DNA
mtPTP- Mitochondrial permeability transition pore
MULAN- Multiple sequence Local AligNment and conservation visualization tool
m/z- Mass to charge ratio
NADH- Nicotinamide adenine dinucleotide
NBF- Neutral buffered formalin
NBL- Neuroblastic layer
NCBI- National Center for Biotechnology Information
nDNA- nuclear DNA
NFL- Nerve fibre layer
NIF- Non-image forming pathway
Nnt- Nicotinamide nucleotide transhydrogenase
NO- Nitric oxide
OCT- Optimal Cutting Temperature compound
OKN- Optokinetic nystagmus
OMIM- Online Mendelian Inheritance in Man
OMM- Outer mitochondrial membrane
ONbL- Outer neuroblastic layer
ONL- Outer nuclear layer
OPL- Outer plexiform layer
ORF- Open reading frame
OXPHOS- Oxidative phosphorylation
P- Postnatal day
PBDs- Peroxisome biogenesis disorders
PBS- Phosphate buffered solution
PCR- Polymerase chain reaction
PFA- Paraformaldehyde
PLR- Pupil light reflex
PMB- Papillomacular bundle
PPAR- Peroxisome proliferator activated receptor
psi- Pounds per square inch
PWM- Position weight matrix
Rdl - Retinal degeneration 1
RGC- Retinal ganglion cells
RNA- Ribonucleic acid
ROS- Reactive oxygen species
RPE- Retinal pigment epithelium
rpm- Revolutions per minute
RT- Reverse transcription
SCN- Super chiasmic nucleus
secs- Seconds
S.E.M- Standard error of mean 
SDH- Succinate dehydrogenase
SHIRPA- Smithkline, Harwell, Imperial, Royal London hospitial Phenotype Assesment
SNP- Single nucleotide polymorphisms
TAG- Triacylglycerol
TCA- Tricarboxylic acid cycle
TF- Transcription factor
TFBS- Transcription factor binding sites
TMS- Trimethylsilyl
TUNEL- Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling
UCP-1- Uncoupling protein 1
pg- micro gram
UK- United Kingdom
pi- micro litre
pm- micro metre or micron
UTR- Untranslated regions
UV- Ultra violet
V-Volts
VLDL -Very low density lipoprotein
W- Watts
WT- Wildtype
WAT- White adipose tissue
XLOA- X-linked optic atrophy
XR- X-linked recessive
ZS- Zellweger disorders
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CHAPTER
I
Introduction
1.1 General Introduction
Hereditary optic atrophies comprise a group of disorders in which the cause of optic nerve 
dysfunction appears to be hereditable based on familial expression or genetic analysis 
[Newman, 1999; Biousse and Newman, 2001] (Table 1.1.). They typically present as 
symmetric, bilateral, central visual loss caused by degeneration of retinal ganglion cells 
(RGCs) that form the optic nerve fibres and/or loss of the supporting microvascular tissue 
surrounding the optic nerve. Optic nerve damage is usually permanent and, in many diseases, 
progressive. Once optic atrophy is observed, substantial nerve injury has already occurred.
Leber's hereditary optic neuropathy (LHON) [Leber, 1871; Wallace et al, 1988] and dominant 
optic atrophy (DOA) [Kjer, 1959; Alexander et al, 2000] are the two most frequent hereditary 
optic neuropathies with monosymptomatic expression [Yu-Wai-Man et al, 2009]. Autosomal 
DO As are the most common form (prevalence 1: 50,000) and three loci have been reported: 
OPA1 (3q28-q29; OMIM 165500), OPA4 (18ql2.2-ql2.3; OMIM 605293), and OPA5 
(22ql2.1-ql3.1; OMIM 610708). OPA1 accounts for about 90% of DOAs and is due to 
mutations in the OPA1 protein (OMIM 605290). LHON (OMIM 535000) is a maternally 
inherited mitochondrial disorder.
In contradistinction, optic neuropathy can also be part of a more complex syndrome. The 
autosomal recessive optic atrophies are often multi systemic diseases involving the central 
nervous system (CNS) and other organs. Loci of syndromic recessive optic atrophy include: 
OP A3 (3-methylglutaconic aciduria Type III (MGA-III) or Costeff syndrome; OMIM 
606580), and WFS1 (Wolfram syndrome; OMIM 606201).
There are also acquired types of optic atrophy which may be due to blood supply changes in 
the eye or optic nerve (anterior ischaemic optic neuropathy or posterior ischemic optic 
neuropathy), maybe secondary to inflammation or swelling within the optic nerve (optic 
neuritis), maybe a result of pressure against the optic nerve (such as from a tumour), or maybe 
related to metabolic diseases e.g., diabetes, trauma, glaucoma, or toxicity caused by alcohol, 
tobacco or other poisons.
Only the sequence of OPA1 and OP A3 are known. The locus position of OPA2, OPA4, OPA5 
and OPA6 has been refined to a critical disease region but none of them have been identified 
as yet.
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Disorder Locus Inheritance Gene Location
Autosomal dominant 
optic atrophy
OPA1
OPA4
OPA5
AD
3q27-q29
18ql2.2-ql2.3
22ql2.1-ql3.1
Autosomal recessive optic 
atrophy
ROA1 
(OPA6)
AR 8q21-q22
X-linked optic atrophy OPA2 XR Xpl 1.4-pl 1.21
Wolfram syndrome - AR 4p 16.1 
4q22-q24
Behr’s syndrome - AR ?
MGA-III
Autosomal dominant 
optic atrophy and cataract
OPA3
AR
AD
19ql3.2-ql3.3
Leber’s optic neuropathy - mtDNA Mutations at bp 
11778,3460,14484
Abbreviations: AD=Autosomal dominant, A 
recessive, mtDNA= mitochondrial DNA, DNi
£= Autosomal recessive, XR= X-linked 
\=  Deoxyribonucleic acid, bp=base pair.
Table 1.1. Genes associated with hereditary forms of optic atrophy.
1.2 OP A3 is associated with syndromic optic neuropathies
OPA3 mutations have been associated with the recessive neuroopthamalogical syndrome 
MGA-III and autosomal dominant optic atrophy and cataract (ADOAC). A common 
characteristic of both disorders is early onset bilateral optic atrophy where RGCs are lost and 
visual acuity is impaired from an early age.
1.2.1 3-Methylglutaconic aciduria syndromes
3-methylglutaconic aciduria (MGA) is used to describe a group of heterogenous disorders that 
impair the body’s ability to make energy in the mitochondria. This impairment is 
characterised by an abnormal organic acid profile of 3-methylglutaconic acid and 3- 
methylglutaric acid which can be detected in the urine. To date, five different types of MGA 
have been described (Table 1.2.). MGA seems to be most prevalent amongst the Jewish 
population of Iraq. However, a high concentration of Type V is found in the Saguenay region
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of Canada. This tends to show that the disease is more frequent in insular areas where there is 
an increased chance that both parents are carriers, a higher birth rate and higher numbers of 
consanguineous marriages. As all types of MGA show recessive inheritance it is likely that 
consanguineous marriages where both parents are carriers increase the chances of having a 
sick child.
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Common
Name
OMIM Mutated
Gene
Gene
Location
Mode of 
Inheritance
Urinary
Metabolites
Symptoms
MGA-I AUH
600529,
MGA-I
250950
AUH Chr 9 Autosomal
Recessive
Very high levels of 3- 
methylglutaconic and 
3-hydroxyisovaleric 
acids.
Speech delay, delayed development of both 
mental and motor skills (psychomotor delay), 
abnormal muscle tone (dystonia), and spasms and 
weakness affecting the legs (spastic 
quadriparesis) and metabolic acidosis.
MGA-II Barth
Syndrome
TAZ
300394,
Barth
302060
TAZ Xq28 X-linked
Recessive
Moderate increase in 
3-methylglutaconic 
and 3-methylglutaric 
acid, normal levels of 
3-hydroxyisovaleric 
acid.
Dilated cardiomyopathy, neutropenia, skeletal 
myopathy, and abnormal mitochondria. By 
electron microscopy, the mitochondria showed 
concentric, tightly packed cristae and occasional 
inclusion bodies.
MGA-m Costeff
Optic
Atrophy
Syndrome
OPA3
606580,
MGA-III
258501
OPA3 19ql3.2-
13.3
Autosomal
Recessive
Urinary excretion of 
3-methylglutaconic 
and of 3-
methylglutaric acid is 
increased.
It is characterized mainly by degeneration of the 
optic nerve. Other nervous system problems 
occur such as an inability to maintain posture, 
poor muscle tone, the development of certain 
involuntary movements (extrapyramidal 
dysfunction) and a general decrease in brain 
function.
MGA-IV MGA-IV
250951
Genetic
factors
unknown
Inheritance
unknown
A clinically heterogenous group of disorders with 
variable psychomotor retardation, hypertonicity, 
hypotonia, optic atrophy, dysmorphic features, 
seizures, cardiomyopathy and hepatic 
dysfunction. Some patients have elevated lactic 
or citric acid cycle intermediates, and some have 
abnormalities of the mitochondrial electron 
transport chain.
MGA-V MGA-V
610198,
DNAJC19
608977
DNAJC19 3q26.3 5-10 fold increase in 
both plasma and urine 
3-methylglutaconic 
and 3-methlyglutaric 
acid.
Early-onset dilated cardiomyopathy with 
conduction defects, nonprogressive cerebellar 
ataxia, testicular dysgenesis, and growth failure 
in addition to 3-methylglutaconic aciduria 
[Chitayat et al, 1992; Davey et al, 2006],
Table 1.2. Overview of all five methylglutaconic aciduria syndromes. The syndromes were divided into four different disease 
categories by Gibson et al, 1993. In 2006 Davey et al, added MGA-V to the list.
1.2.2 3-Methylglutaconic aciduria Type III or Costeff syndrome
MGA-III (OMIM 258501) presents with early-onset bilateral optic atrophy, late-onset 
spasticity, extrapyramidal dysfunction, and cognitive deficit. Urinary excretion of 3- 
methylglutaconic acid and of 3-methylglutaric acid is increased. The disease was first 
reported by Costeff et al, in [1989]. Disease characteristics include, infantile optic atrophy 
sometimes associated with infantile-onset horizontal nystagmus; extrapyramidal movement 
disorder, dominated by chorea, with onset before age ten years, which is often severe enough 
to restrict ambulation. Some are confined to a wheelchair from an early age. About half the 
patients developed spastic paraparesis during the second decade of life. Ataxia and cognitive 
defects are common, but usually of mild degree. Nine of the 10 families described by Costeff, 
including all of those with multiple affected siblings, belonged to the Iraqi Jewish community 
in Israel, a group with an estimated minimal prevalence rate of 1:10,000, with a carrier rate 
estimated to be 1:10 [Anikster et al, 2001]. The disorder bore some similarity to Behr 
syndrome (OMIM 210000) but the neurological aspects were distinctive.
The occurrence of MG A in this disorder was discovered by Chitayat et al, [1992], only then 
was it designated MGA-III. Elpeleg et al, [1994] reported 11 new patients of Iraqi Jewish 
origin with the same clinical syndrome associated with MGA and reviewed the clinical and 
biochemical findings in 36 patients. The report defined a homogeneous group of patients with 
MGA-III. They differed from patients with MGA-I by the normal 3-methylglutaconyl-CoA 
hydratase activity in their fibroblasts and differed from patients with MGA-II by the absence 
of cardiomyopathy, short stature, and neutropenia. In addition, the mode of transmission in 
MGA-III is autosomal recessive, whereas MGA-II appears to be X-linked.
1.2.3 Symptoms and genetics of the other syndromes of 3-Methylglutaconic aciduria
1.2.3.1 3-Methylglutaconic aciduria Type I (MGA-I)
MGA-I is a very rare autosomal recessive disorder where fewer than 20 cases have been 
reported. The clinical features are nonspecific and variable, ranging from minimal to severe 
symptoms. The characteristic features include speech delay, delayed development of both 
mental and motor skills (psychomotor delay), dystonia, spasms and weakness affecting the 
arms and legs (spastic quadriparesis) and metabolic acidosis [Shoji et al, 1999; Ijlst et al, 
2002; Am and Funanage, 2006; Di Rosa et al, 2006]. Furthermore, tissues with higher
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requirement for oxidative metabolism, such as the CNS, cardiac and skeletal muscle, are 
predominantly affected [Gunay-Aygun, 2005]. Patients with MGA-I excrete higher levels of 
3-methylglutaconic acid and of 3-methylglutaric acid than those affected by other variants of 
MGA.
The excretion of organic acids in MGA-I is due to mutations in the AU-specific RNA-binding 
enoyl-CoA hydratase {AUH) gene. This gene provides instructions for producing 3- 
methylglutaconyl-CoA hydratase, an enzyme that is involved in processing the amino acid 
(aa) leucine. This aa is broken down in the mitochondria during the process of energy 
production. The isolated deficiency of 3-methylglutaconyl-CoA hydratase [Duran et al, 1982] 
leads to a build up of 3-methylglutaconic acid, which is eliminated in the urine. It is believed 
that other genes or environmental factors also contribute to the development of this disorder.
The precise etiology of the increased organic acid excretion in MGA II-V has not been 
elucidated.
1.2.3.2 3-Methylglutaconic aciduria Type II (MGA-II) or Barth syndrome
Barth syndrome was first reported by Barth et al, [1981, 1983]. He described a large pedigree 
showing X-linked inheritance of a disorder characterized by dilated cardiomyopathy 
associated with skeletal myopathy, neutropenia and growth retardation [Walsh et al, 1999; 
Ijlst et al, 2002; Barth et al, 2004]. Dilated cardiomyopathy presents within first year of life or 
even prenatally [Barth et al, 2004]. Cognitive development is normal, although an associated 
learning disorder has been described. Abnormal mitochondria have been observed by electron 
microscopy which showed concentric, tightly packed cristae and occasional inclusion bodies. 
The incidence of Barth syndrome is approximately 1 in 200,000 male infants. Female carriers 
of the Barth syndrome gene appear to be healthy. This could be due to a selection against cells 
that have the mutant allele on the active X chromosome.
Mutations in the tafazzin (TAZ) gene cause Barth syndrome. This gene provides the 
instructions for making a protein called tafazzin which is thought to be involved in the 
metabolism of cardiolipin. Barth syndrome was the first identified inborn error of metabolism 
that directly affects cardiolipin. Cardiolipin is a component of the inner mitochondrial 
membrane (IMM) and is required for the optimal function of many proteins within the 
mitochondria, particularly the electron transport chain. It is also involved in mitochondrial-
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mediated apoptotic process. The appropriate content of cardiolipin appears to be critical for 
these functions. Cardiolipin is synthesized de novo in mitochondria and is rapidly remodelled 
to produce cardiolipin enriched in linoleic acid. Mutations in TAZ result in a decrease in tetra- 
linoleoyl species of cardiolipin and an accumulation of monolysocardiolipin within cells from 
Barth syndrome patients. This results in abnormalities in the structure and function of 
mitochondria, leading to the heart defects and other problems seen in this disorder.
1.2.3.3 3-Methylglutaconic aciduria Type IV (MGA-IV)
Only one case of MGA-IV (autosomal recessive, with severe psychomotor phenotype and 
cerebellar dysgenesis) has been described. Chitayat et al, [1992] described an 18 year old 
male proband with MGA, severe psychomotor retardation, and cerebellar dysgenesis, which 
they designated MGA-IV. He was the offspring of consanguineous Italian parents. At birth, 
he was hypotonic, with absent reflexes and respiratory distress. Congenital deformities 
included bilateral inguinal hernia, undescended testes, subaortic stenosis with biventricular 
hypertrophy and right simian crease with left bridged simian crease. The signs and symptoms 
of MGA-IV are variable and overlap with Types I-III. The incidence of MGA-IV and the 
genetic factors involved in causing MGA-IV are unknown.
1.2.3.4 3-Methylglutaconic aciduria Type V (MGA-V)
The fifth type of MGA is a novel autosomal recessive disorder that shares some clinical 
similarity with X- linked Barth syndrome and the other MGAs. It was described by Davey et 
al, [2006], who reported 18 patients with dilated cardiomyopathy and ataxia from 11 
consanguineous Canadian Dariusleut Hutterite families. Disease phenotype is characterized 
by early onset dilated cardiomyopathy with conduction defects, non-progressive cerebellar 
ataxia causing significant motor delays, testicular dysgenesis, prenatal and postnatal growth 
failure and MGA. Urine and plasma samples consistently showed a 5- to 10-fold increase in 
3-methylglutaconic acid and 3-methylglutaric acid. Additional features included 
normochromic microcytic anaemia in 12 patients, mild to borderline nonprogressive mental 
retardation in 10, a mild increase in hepatic enzymes with microvesicular hepatic steatosis in 
5 and optic atrophy in 4. The onset of cardiomyopathy was always before the age of 3 years, 
and over 70% of affected individuals died from either progressive cardiac failure or sudden 
cardiac death. Candidate genes were sequenced and identified homozygosity for a splice-site 
mutation in the DNAJC19 gene in all 16 patients for whom DNA samples were available. The
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protein encoded by DNAJC19 shares sequence similarity with Timl4, an integral IMM 
protein that participates in mitochondrial protein import.
1.2.4 OPA3- Autosomal Dominant Optic Atrophy and Cataract (ADOAC)
More recently OP A3 has also been associated with ADOAC (OMIM 165300). This optic 
atrophy, cataract and neurological disorder was first described by Garcin et al, in [1961]. 
The disorder was found in 14 persons in 7 sibships of 4 generations with several instances of 
male-to-male transmission. A blue-dot cerulean cataract was usually recognised in the first 
decade. However, mutations causing this disorder were not identified until Reynier et al, 
[2004] found two different mutations of the OP A3 gene in another family: gly93 to ser and 
gin 105 to glu, respectively. No abnormalities were found in the respiratory chain, the 
mitochondrial membrane potential, or in the organisation of the mitochondrial network of 
fibroblasts obtained from one affected patient. However, the fibroblasts showed increased 
susceptibility to staurosporine-induced apoptosis. Although Garcin et al, [1961] described the 
phenotype as a neurodegenerative disorder, Reynier et al, [2004] noted that the neurological 
signs are mild or even absent in affected patients. They suggested the disease would be more 
appropriately designated ADOAC.
1.2.5 Cataracts as part of ADOAC
1.2.5.1 What is a cataract?
A cataract is a clouding of the crystalline lens or its surrounding transparent membrane, which 
lies behind the iris and the pupil. The lens is mostly made of water and protein. The protein is 
arranged in a precise way that keeps the lens clear and allows light to pass through it. Either 
through age or disease, cataracts can result from changes in lens architecture, from disruption 
of intracellular ordered arrangement of proteins or from changes in organisation of lens fibres 
due to aberrations in growth or differentiation. These changes will obstruct the passage of 
light and cause a reduction in vision.
1.2.5.2 Causes o f  cataract
Cataracts are the leading cause of blindness in the world. It is also the most treatable cause of 
visual problems both in childhood (congenital cataract) and in adults (age-related cataract). 
The incidence of congenital cataract is approximately 1-6/10,000 live births, and the condition 
can occur in isolation or as part of a more complex syndrome. There are also certain factors
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that can increase your risk of getting cataracts e.g., exposure to UV light, exposure to 
radiation, diabetes, hypertension and advanced age.
1.2.5.3 Genetics o f cataract
Hereditary cataracts that have been characterized so far show Mendelian inheritance and 
either result from single-gene mutations or from chromosomal translocations. They can be 
inherited in an autosomal dominant, recessive or X-linked mode. Over 26 of the 39 mapped 
loci for isolated congenital or infantile cataracts have been associated with mutations in 
specific genes. Of the cataract families for whom the mutant gene is known, about half have 
mutations in crystallins, about a quarter have mutations in connexins, with the remainder 
divided among the genes for heat shock transcription factor-4, aquaporin-O, and beaded 
filament structural protein-2. There is often some correlation between the pattern of 
expression of the mutant protein and the morphology of the resulting cataract. However, 
inheritance of the same mutation in different families or even the same mutation within the 
same family can result in radically different cataract morphologies and severities. This 
suggests that additional genes or environmental factors might modify the expression of the 
primary mutation associated with the cataracts. Conversely, cataracts with similar or identical 
clinical presentations can result from mutations in completely different genes.
1.3 Pathophysiology of the non-syndromic optic neuropathies
The non-syndromic optic neuropathies are by definition limited to a single cellular target, i.e., 
the RGCs. LHON and DO A are non-syndromic with early and preferential involvement of the 
small axons that form the papillomacular bundle (PMB) [Yu-Wai-Man et al, 2009]. Loss of 
these cells leads to a reduction of optic nerve tissue and thinning of the nerve along its length. 
Pupil function is less affected than visual function suggesting that the retinotectal fibres 
responsible for the pupil light reflex (PLR) are less susceptible to damage than the 
retinogeniculate fibres. Visual field defects, including diffuse or sectorial scotomas, can 
usually be observed but are highly variable.
1.3.1 OPA1- Autosomal dominant optic atrophy and neurological defects
Autosomal dominant optic atrophy (ADOA) is the most common form of non-glaucomatous 
optic atrophy and in the general population has an incidence of 1/50,000 [Votruba et al, 1998] 
and a prevalence of 1/10,000 [Kjer et al, 1996]. Generally it presents in childhood as slowly 
progressive bilateral loss of visual acuity, constriction of peripheral visual fields, central
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scotomas, and colour vision abnormalities. ADOA is caused by mutations in the optic atrophy 
1 gene (OPAl) [Alexander et al, 2000, Delettre et al, 2000] mapped to chromosome 3q28- 
q29 and has variable clinical expression and penetrance [Toomes et al, 2001].
OPAl comprises 30 exons and is ubiquitously expressed, with highest expression in the retina, 
but also abundantly in brain and muscle [Alexander et al, 2000; Wang et al, 2006]. Common 
to all isoforms of OPAl are a GTPase, dynamin-like domain; a central domain; aC-terminal 
coiled coil domain presumably involved in protein-protein interaction; and an N-terminal 
mitochondrial targeting sequence that directs the protein to the IMM, facing the 
intermembrane space [Olichon et al, 2002]. OPAl has been linked to two important 
mitochondrial activities: fusion [Cipolat et al, 2004], that in equilibrium with fission regulates 
mitochondrial morphology [Ishihara et al, 2006], and caspase-dependent apoptosis through 
mitochondrial cristae remodelling [Frezza et al, 2006; Olichon et al, 2003]. The equilibrium 
between mitochondrial fusion and fission appears very dynamic and links mitochondrial 
morphology to mitochondrial function [Ishihara et al, 2006] and vice versa. Recent reports 
have also associated common OPAl mutations, predicted to generate a truncated OPAl 
protein and typical of uncomplicated ADOA phenotypes, to impaired oxidative 
phosphorylation with mitochondrial fragmentation in fibroblasts, and increased susceptibility 
to apoptosis [Zanna et al, 2008; Olichon et al, 2007].
1.3.2 OPA2- X-linked optic atrophy
The first report of X-linked optic atrophy (XLOA) appeared in 1947 and described eight 
males in a four generation kinship [Lysen and Oliver, 1947]. The next report appeared in 1967 
where two brothers and a nephew with apparent XLOA displaying progressive optic atrophy, 
sensorineural hearing loss, and a polyneuropathy [Rosenberg and Chutorian, 1967].
A Dutch pedigree with XLOA was described by Volker-Dieben et al, [1974] and Went et al, 
[1975]. Age of onset was early childhood, and the progressive loss of visual acuity was very 
slow. Optic discs were sharply outlined and completely pale. Some affected males were 
mentally retarded and showed minor abnormalities on neurologic examination including, 
hyperactive knee jerks, absent ankle jerks, extensor plantar reflexes, dysarthria, tremor, 
dysdiadochokinesia, difficulty with tandem gait. Female carriers showed no abnormalities and 
no abnormality was described in obligatory heterozygotes. Four males from this Dutch
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kindred were subsequently studied and linkage analysis placed the gene in the Xpl 1.4-Xpl 1.2 
interval [Assinkera/, 1997].
Katz et al, [2006] reported 6 males with decreased visual acuity from early childhood; visual 
acuities ranged from 20/30 to 20/100, and all had significant optic nerve pallor all from a 3- 
generation family in Idaho. Obligate female carriers were clinically unaffected. Linkage 
analysis suggested the O PAl locus.
1.3.5 Leber’s hereditary optic neuropathy
LHON was first described by Leber in 1871 and is the first disease to be associated with the 
mitochondrial genome. The condition is inherited through the female line by maternal 
transmission of mtDNA. The majority of patients with LHON are males in their 20s, but 
atypical cases may be found in females who may present at any age between 10 and 60 years.
The condition appears suddenly and usually affects both eyes. There is often an acute, severe, 
painless loss of vision; both eyes may either be affected simultaneously or sequentially, with a 
gap of a few days or weeks between the onset of symptoms. Visual field defects usually affect 
central field vision, the peripheral field being spared. The optic disc may appear normal in the 
acute stage. Colour vision problems may be present affecting the red-green axis and there may 
be some pain during eye movements. There is considerable variation in symptoms between 
patients, but most typically cases show disc hyperaemia, dilated capillaries on the disc surface, 
deformed blood vessels and swelling of the peripapillary nerve fibre layer (NFL). There is a 
modest degree of disc elevation and no dye leakage on fluorescein angiography. Visual 
prognosis is poor although there is often some visual recovery. The majority of patients will 
exhibit permanent loss of vision with a final visual acuity 6/60, although this will vary with 
the type of mutation.
There are three primary mutations of mtDNA in LHON, viz at bp 11778, 3460, and 14484. 
The mutation at bp 11778 causes a change in the NADH hydrogenase sub-unit four of 
complex I in the respiratory chain, and is present in 64% of cases of LHON. The mutation at 
bp 3460 is present in 10% of patients while that at 14484 bp is found largely in the United 
Kingdom (UK) and Netherlands accounting for 25% of cases.
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The majority of these mutations result in partial defects of the respiratory chain function 
leading to deficits in ATP and an increase in oxidative stress. The presence of myelin 
pathology and a multiple sclerosis likeness in some patients, especially those with the 11778 
mutation, supports the suggestion that oxidative stress is important in LHON. The visual 
prognosis of the condition appears to depend on the type of mutation, with the 11778 mutation 
patients having the worst prognosis.
A commonality to all these diseases is the selective loss of RGCs within the retina.
1.4 The Mitochondrion -  a unifying theme
The prevalence of neuronal diseases associated with abnormalities of mitochondrial proteins 
encoded by the mitochondrial or the nuclear genomes indicates an important functional 
relationship between mitochondria and neurons. In 1988 Wallace identified the first 
substitution in the mtDNA causing LHON which was originally described by Leber in 1871, 
thereby beginning the list of optic neuropathies linked to mitochondrial dysfunction 
[Newman, 2005]. The discovery in the year 2000 that the genetic cause of the most common 
group of ADOA is O PAl, a nuclear gene encoding a mitochondrial dynamin [Alexander et al, 
2000; Delettre et al, 2000], together with the finding that OP A3, the third gene identified as 
involved in primary optic neuropathies, encodes a mitochondrial protein [Da Cruz et al, 2003; 
Ryu et al, 2010] definitively demonstrates that the optic nerve is highly dependent on 
mitochondrial functions.
1.4.1 Structure
Mitochondria are bacterium size, membrane-bound organelles in the eukaryotic cell and were 
descended from prokaryotic endosymbionts about two billion years ago. Mitochondria do not 
exist stably as distinct, individual, autonomous organelles but form a highly dynamic semi- 
tubular network. They are 0.5pm- 1.0pm across and exhibit a complex internal architecture 
(Fig 1.1.).
The organelle is encompassed by two membranes, an outer mitochondrial membrane (OMM) 
that defines the external boundary of the organelle and an IMM exhibiting numerous folds, 
known as cristae, that project into the mitochondrial interior. The outer and inner membranes 
divide the mitochondrion into two distinct compartments, the inner membrane space, which is 
located between the inner and outer membranes and the mitochondrial matrix, which is 
enclosed by the IMM.
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Figure 1.1. The Mitochondrion structure.
[http://academic.brooklyn.cuny.edu/biology/bio4fv/page/mito.htm -  accessed 10.6.10]
The mitochondrion is especially complex as it is the only cellular organelle under the dual 
control of both the nuclear and its own (mitochondrial) genomes. The mitochondrial genome 
is a multicopy, maternally inherited, 16,596bp circular double stranded DNA that encodes for 
13 polypeptides, all of which are structural components of the respiratory chain complexes, 
along with two ribosomal RNAs and 22 transfer RNAs, which are needed for the translation 
of the 13 mtDNA specified proteins.
1.4.1.1 Fusion and Fission
In the past decade a new concept of mitochondrial presence and spatial distribution in the host 
cell was articulated based on microscopy observation, which suggested the fusion and fission 
of different mitochondria: the mitochondrial network concept. Mitochondria form a highly 
dynamic semi-tubular network in the cell, the morphology of which is regulated by 
movements along the cytoskeleton and the balance of mitochondrial fusion and fission events. 
Equilibrium between fusion and fission controls the morphology of the mitochondria which is 
necessary for maintaining normal mitochondrial function. They can appear as dots or 
elongated tubules depending on the prevailing forces.
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Recent studies have indicated that mitofusins (MFN1 and MFN2) and OPAl are essential for 
mitochondrial fusion whereas FIS1 and DRP1 are essential for mitochondrial fission. The 
overall morphology of the mitochondrial population depends on the relative activities of these 
two sets of proteins. In addition to the regulation of mitochondrial shape, these molecules also 
play important roles in cell and tissue physiology. Perturbation of mitochondrial fusion results 
in defects in mitochondrial membrane potential and respiration, poor cell growth and 
increased susceptibility to cell death. These cellular observations may explain why 
mitochondrial fusion is essential for embryonic development. Two inherited neuropathies, 
Charcot-Marie-Tooth Type 2A and ADOA are caused by mutations of MFN2 and OPAl, 
suggesting that proper regulation of mitochondrial dynamics is particularly vital to neurons. 
Mitochondrial fission accompanies several types of apoptotic cell death and appears important 
for progression of the apoptotic pathway.
1.4.2 Function
Mitochondria are the driving force behind life and serve four fundamental biological roles (i) 
provision of ATP, (ii) mediation of cell death by apoptosis, (iii) heat production, and (iv) 
contribute to the genetic pool. In addition mitochondria play a crucial role in:- P-oxidation, 
citrate cycle (tricarboxic cycle, Krebs cycle), degradation of aa, parts of the haem- 
biosynthesis, parts of the steroid metabolism, parts of the uric acid cycle, mitochondrial 
protein synthesis, the pyruvate dehydrogenase complex and are responsible for the 
decarboxylation of pyruvate. The main metabolic functions of mitochondria are shown in Fig 
1 .2 .
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Figure 1.2. Schematic representation of mitochondrial metabolism. Respiratory chain complexes 
or components encoded exclusively by the nuclear genome are light orange. Complexes 
containing some subunits encoded by the nuclear genome and others encoded by mitochondrial 
DNA are dark orange. CPT, carnitine palmitoyltransferase; PDHC, pyruvate dehydrogenase 
complex; CoA, coenzyme A; TCA, tricarboxylic acid; CoQ, coenzyme Q; Cyt c, cytochrome c 
[Siegel et al, 2006].
1.4.2.1 ATP production - Electron transport chain and oxidative phosphorylation
Mitochondria generate most of the cellular energy by OXPHOS, and produce most of the 
toxic reactive ROS as a by-product. Genetic defects that inhibit OXPHOS also cause the 
redirection of OXPHOS electrons into ROS production, thus increasing oxidative stress. A 
decline in mitochondrial energy production and an increase in oxidative stress can impinge on 
the mitochondrial permeability transition pore (mtPTP) to initiate programmed cell death 
(apoptosis). The interaction of these three factors appears to play a major role on the 
pathophysiology of degenerative diseases.
The electron transport chain is located in the IMM and comprises some 80 proteins organized 
in four enzymatic complexes (I-IV). Complex V generates ATP but has no electron transfer
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activity. Electron transfer between these complexes is accomplished by two electron shuttle 
molecules; Coenzyme Q (also known as ubiquinone) from Complexes I and II to Complex III 
and cytochrome c from Complex III to Complex IV. These enzymes are encoded by either 
mitochondrial or nuclear DNA (Fig 1.2.). Therefore a deficit of either mitochondrial or 
nuclear DNA may lead to malfunction of OXPHOS.
Metal centres and other co-factors in these complexes act, in essence, as a molecular wire, 
carrying electrons from the strongly reducing products of the Kreb cycle (NADH, succinate) 
to highly oxidizing dioxygen which is reduced to water. The direct oxidation of these 
substrates by O2 would release a great deal of energy as useless heat.
Instead, indirect oxidation occurs, whereby during a series of redox reactions, electrons travel 
down the chain releasing their energy in controlled steps (Fig 1.3.). These reactions drive the 
active transport of H+ ions from the mitochondrial matrix, through the inner membrane to the 
intermembrane space, creating an electrochemical proton gradient across the IMM. Complex I 
(NADH coenzyme Q reductase) accepts electrons from the Krebs cycle electron carrier 
nicotinamide adenine dinucleotide (NADH), and passes them to Coenzyme Q, which also 
receives electrons from complex II (succinate dehydrogenase). Coenzyme Q passes electrons 
to complex III (cytochrome bci complex), which passes them to cytochrome c. Cytochrome c 
passes electrons to Complex IV (cytochrome c oxidase), which uses the electrons and 
hydrogen ions to reduce molecular oxygen to water. This electrochemical proton gradient 
allows ATP synthase (ATP-ase) to use the flow of H+ through the enzyme back into the 
matrix to generate ATP from ADP and inorganic phosphate. Although electron transport 
occurs with great efficiency, a small percentage of electrons are prematurely leaked to 
oxygen, resulting in the formation of the toxic free-radical superoxide.
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Figure 1.3. The electron transport chain in the mitochondrion is the site of oxidative 
phosphorylation in eukaryotes. The NADH and succinate generated in the citric acid cycle is 
oxidized, providing energy to power ATP synthase. [http://inoxx.net/?p=26 -  accessed 10.6.10]
Fibroblasts from patients with ADOA (OPAl), ADOAC (OP A3) and LHON have a common 
coupling defect of OXPHOS associated with reduced efficiency of ATP synthesis 
[Chevrollier et al, 2008]. Their fibroblasts showed that in the routine respiratory state a 
greater proportion of their respiratory capacity was used compared to controls (80% versus 
60%), thus retaining a low ‘reserve’ capacity to face greater energy requirements. In LHON 
this defect is associated with mtDNA point mutations that affect various subunits of Complex 
I. Fibroblasts from DOA patients carrying frame shift/stop codon/splicing 
(haploinsufficiency) mutations in the OPAl gene have recently been shown to display a 
defective ATP synthesis mainly when driven through complex I substrates [Zanna et al, 
2008].
The consequences of complex I dysfunction may go beyond the immediate effects on energy 
conservation and ROS production. There is mounting evidence tightly linking complex I 
dysfunction with predisposition to apoptosis [Zanna et al, 2005; Porcelli et al, 2009]. There is 
also a tight connection between fission/fusion, mitochondrial network dynamics, control and 
regulation of apoptosis lOlichon et al, 2003; Frezza et al, 2006; Suen et al, 2008 ]. There are 
many intricacies of how different genetic defects, in the nuclear and in the mitochondrial
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genomes, affect different biochemical systems and cell functions implicated in mitochondrial 
homeostasis. However, in many cases these may converge towards common final pathways, 
one of which may link complex I dysfunction and RGCs neurodegeneration [Carelli et al, 
2007].
1.4.2.2 Mitochondrial mediated apoptosis
Death of RGCs in LHON occurs in an apoptotic manner, so that changes in the mitochondrial 
respiratory chain and/or in oxidative stress could play a role in the induction of apoptosis in 
LHON [Wong et al, 2002; Ghelli et al, 2002]. Cells depleted of Opa3 and Opal are sensitive 
to apoptosis. The IMM where Opa3 and Opal are expressed is also the site of apoptogenic 
proteins such as cytochrome c or the apoptosis-inducing factor. About 90% of cytochrome c is 
stored in vesicles created by infolding of the IMM; the remaining 10% is located in the 
intermembrane space. Cytochrome c physiologically functions as an electron transfer protein 
in many different redox processes.
The mitochondrial pathway of apoptosis (Fig 1.4.) functions in response to various types of 
stress such as ultraviolet light, pro-oxidants, viral infections, chemotherapeutic agents, 
ischaemia, inflammatory cytokines, neurotoxins, and many others can induce a variety of 
intracellular changes, such as increased calcium levels, NO release, ceramide activation, and 
antioxidant depletion. Those alterations cause damage to mitochondrial inner and outer 
membranes causing (i) the release of cytochrome c into the cytosol in the first phase of 
apoptosis, activating caspase 9 [Bossy-Wetzel et al, 1999]; (ii) the Bcl-2 family proteins 
(located in the OMM) to form complexes and enter the mitochondrial membrane, regulating 
the release of cytochrome c and other proteins [Adachi et al, 1997]; (iii) the decrease of IMM 
potential, mediated by opening of the mitochondrial permeability transition pore [Susin et al, 
1996]; (iv) electron transport alterations, oxidative phosphorylation dysfunction, and storage 
of free radicals [Greenlund et al, 1995]. An alternative pathway may induce swelling and 
rupture of mitochondrial membranes, which may lead not only to caspase activation and 
apoptosis but also to necrosis due to a breakdown of ATP production and the creation of ROS. 
But the crucial step toward irreversible death commitment in many systems is the release of 
cytochrome c.
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Figure 1.4. Mitochondrial mediated apoptotic signalling.
[http://www.biocarta.com/pathfiles/h_mitochondriaPathway.asp -  accessed 10.6.10]
1.4.2.3 Heat production
Non-shivering thermogenesis in brown adipose tissue (BAT) is the main mechanism for 
thermoregulatory heat production in small mammals and newborns. BAT is highly specialized 
for this non-shivering uncoupling protein 1 (UCP-1) mediated thermogenesis. UCP-1 is 
restricted to brown fat, where it provides a mechanism for the enormous heat-generating 
capacity of the tissue. UCP-1 mediated thermogenesis uncouples the respiratory chain, 
allowing for fast substrate oxidation with a low rate of ATP production (Fig 1.5.)
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Figure 1.5. UCP-1 and m itochondrial proton leak. 
[www.fucotin.com/Portals/8/images/Figure03.jpg- accessed 10.6.10]]
Despite known defects in the electron transport chain no patients with MGA-III or ADOAC 
are known to suffer from any thermoregulation defects.
40
1.5 The Vertebrate Retina
The retina is approximately 0.5 millimetres (mm) thick and lines the back of the eye. A radial 
section of a portion of the retina reveals that the RGCs (the output neurons of the retina) lie 
innermost in the retina closest to the lens and front of the eye, and the photo sensors (the rods 
and cones) lie outermost in the retina against the pigment epithelium and choroid (Fig 1.6.).
Mammalian retinas contain a variety of cell types [Masland, 2004] which are packaged into 
highly ordered anatomical layers each with a specialized function. The vertebrate retina is 
composed of three layers of nerve cell bodies and two layers of synapses. The outer nuclear 
layer (ONL) contains cell bodies of the rods and cones, the inner nuclear layer (INL) contains 
cell bodies of the bipolar, horizontal and amacrine cells and the ganglion cell layer (GCL) 
contains cell bodies of ganglion cells and displaced amacrine cells. Dividing these nerve cell 
layers are two synaptic (inner and outer plexiform) layers.
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Figure 1.6. A simplistic wiring diagram of the retina emphasises only the sensory photoreceptors 
and the ganglion cells with a few interneurons connecting the two cell types. 
[www.webvision.med.utah.edu/sretina.html- 10.6.10]
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In the retina, the photoreceptors synapse directly onto bipolar cells, which in turn synapse 
onto ganglion cells, which will then conduct action potentials to the brain. A significant 
amount of visual processing arises from the patterns of communication between neurons in 
the retina. About 130 million photoreceptors absorb light, yet roughly 1.2 million axons of 
ganglion cells transmit information from the retina to the brain. The processing in the retina 
includes the formation of center-surround receptive fields of bipolar and ganglion cells in the 
retina, as well as convergence and divergence from photoreceptor to bipolar cell. In addition, 
other neurons in the retina, particularly horizontal and amacrine cells, transmit information 
laterally (from a neuron in one layer to an adjacent neuron in the same layer), resulting in 
more complex receptive fields that can be either indifferent to color and sensitive to motion or 
sensitive to color and indifferent to motion.
1.5.1 The Retinal Ganglion Cell Layer
Adult RGCs are a heterogeneous, finite population of post mitotic neurons. Though mainly 
located within the innermost nucleated layer of the mature retina, the somata of some RGCs 
are displaced from this GCL to the inner plexiform layer (IPL) [Dann et al, 1988]. The 
distribution of RGCs is very non-linear. In the perifoveal macula the RGCs are concentrated 
and stacked six or seven cells deep [Polyak, 1941; Fine and Yanoff, 1979]. Further from the 
fovea the numbers of RGCs decreases becoming relatively sparse in the periphery with each 
of the cells quite distant from the others.
RGCs have been categorised into different classes in a number of species including the mouse 
[Doi et al, 1995; Sun et al, 2002a; Badea and Nathans, 2004 and Kong et al, 2005]. RGCs 
can be categorized by their morphology, such as soma size and dendritic field dimensions. As 
the morphology of RGCs is a direct reflection of the underlying neural connectivity, it 
remains the most common way of identifying and classifying retinal neurons. However, 
studies of the rat [Huxlin and Goodchild, 1997; Sun et al, 2002b] and mouse [Sun et al, 
2002a] retina have shown that with the exception of the largest ganglion cells, considered 
homologous to the alpha cells first identified in the cat [Peichl, 1991], there is considerable 
overlap in both soma and dendritic field measurements of RGCs in these rodents.
More recent cell-filling methods to assess types of RGCs include: a single cell injection with 
diffusible markers, such as Lucifer yellow or neurobiotin; a sparse delivery of lipophilic dyes 
by particle bombardment; expression of genetically encoded histochemical or fluorescent
42
reporters; and a photofilling method [Badea and Nathans, 2004; Masland and Raviola, 2000]. 
The systematic surveys indicate that the human, monkey, cat, rabbit, and mouse each contain 
approximately 10 to 15 types of RGCs.
RGCs have also been classified based on their processing of visual (image-forming and non­
image-forming) information that is sent to the brain: (i), M-cells, with large center-surround 
receptive fields that are sensitive to depth, indifferent to colour, and rapidly adapt to a 
stimulus, (ii), P-cells, with smaller center-surround receptive fields that are sensitive to colour 
and shape, (iii), K-cells, with very large center-only receptive fields that are sensitive to 
colour and indifferent to shape or depth, (iv), Intrinsically photosensitive RGCs (ipRGCs) and 
(v), a population that is used for eye movements.
Among the different cell types in the retina, RGCs are the only ones whose axons leave the 
retina, transmitting visual information to the brain.
1.5.2 The Optic Nerve
Visual information is transmitted from the retina to the brain via the optic nerve, also called 
the cranial nerve II. The optic nerve is the second of twelve paired cranial nerves but is 
considered to be part of the CNS as it is derived from an out pouching of the diencephalons 
during embryonic development. Consequently, the fibres are covered with myelin produced 
by oligodendrocytes rather than Schwann cells of the peripheral nervous system. Similarly, 
the optic nerve is ensheathed in all three meningeal layers (dura, arachnoid, and pia mater) 
rather than the epineurium, perineurium, and endoneurium found in the peripheral nerves. 
This is an important issue, as fibre tracks of the mammalian CNS (as opposed to the 
peripheral nervous system) are incapable of regeneration and hence optic nerve damage 
produces irreversible blindness. The fibres from the retina run along the optic nerve to nine 
primary visual nuclei in the brain, from whence a major relay inputs into the primary visual 
cortex (Fig 1.7.).
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Figure 1.7. Scheme showing central connections of the optic nerve and optic tracts. [Henry 
Gray (1825-1861). Anatomy of the Human Body. 1918.]
RGCs integrate signals within the retina and are the point at which these are converged to 
action potentials. Since these activities are highly energy dependent and the axon path to the 
CNS is long, these cells are vulnerable to a range of metabolic and ischaemic insults that can 
act within the retina and along the course of the axon.
1.5.3 RGCs vulnerability to physiological and biochemical insult
It is interesting that despite OP A3 and OPAl mutant proteins being ubiquitously expressed 
and therefore defective in every cell, the optic nerve is the major clinically affected organ. 
There must therefore be some aspects of its structure and/or function that make it uniquely 
vulnerable to certain physiological and biochemical insults -  below some of these aspects are 
discussed.
1.5.3.1 Energy deficits
By virtue of their unmyelinated stretches, RGC axons are bioenergetically weak elements of 
the CNS. The relative oxygen consumption of the retina is higher than that of the brain and so
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being one of the highest oxygen-consuming tissues of the body [Yu and Cringle, 2001], 
RGCs are also mainly made up of the smaller calibre P-cells and these have the lowest 
volume (energy source) to surface area (energy demand) ratio. They also have a thinner 
myelin sheath and a rapid rate of firing [Sadun, 1998]. Their large energy consumption makes 
them highly dependent on an abundance of mitochondria for energy production, although 
there is a high level of mitochondrial enzyme activity in RGCs [Andrews et al, 1999]. Thus 
these fibres have the most disadvantageous condition in terms of energy requirements among 
the axons of the optic nerve. Therefore, if any energy depletion did occur the PMB which is 
composed mostly of these smaller type axons together with a few M-cells (which in the PMB 
are of considerably smaller calibre [Sadun et al, 2000]), would be a highly vulnerable 
component of the optic nerve particularly at the prelaminar (unmyelinated) portion. This 
vulnerability, however, cannot be explained by a simple energetic deficit since photoreceptors 
have a much higher oxidative demand than RGCs and other mitochondrial disorders 
characterised by more severe complex I defects do not universally cause optic atrophy. RGCs 
may be preferentially involved because they are more sensitive to subtle imbalances in cellular 
redox state or increased reactive oxygen species (ROS) levels or vulnerable due to their 
unique structure.
1.5.3.2 Lamina cribrosa
The pathway taken by the optic nerve axons as they cover the five centimetres (cms) between 
the eye and the visual centres is stressful for the cells. On leaving the eye, axons turn through 
90 degrees to enter the optic nerve head. At the optic nerve head, about 1.2 million 
unmyelinated RGC axons exit through an opening in the sclera approximately 1.5 mm across 
(Fig 1.8.). In doing so, they pass through the lamina cribrosa which is a series of successive 
perforated collagen plates that mark the anatomical transition from the unmyelinated (pre­
laminar) to the myelinated (post-laminar) segment of the human optic nerve.
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Figure 1.8. The terminal portion of the optic nerve and its entrance into the eyeball. [ Henry 
Gray (1825-1861). Anatomy of the Human Body, 1918.)
The pre-laminar section has a much higher concentration of mitochondria to support the 
higher energy demands of unmyelinated nerve conduction and it is likely that active processes 
involving the cytoskeletal architecture are needed to maintain this sharp mitochondrial 
gradient [Bristow et al, 2002; Barron et al, 2004]. Pathological mechanisms which disrupt this 
unique structural feature would lead to impaired axonal transport and set up a vicious circle 
with fragmentation of the mitochondrial network at the lamina cribrosa, exacerbating even 
subtle mitochondrial energy deficits and eventually precipitating apoptotic cell death.
1.5.3.3 Spatial distribution o f  mitochondria along the optic nerve
At the ultrastructure level a high mitochondrial density level can be seen in the prelaminar 
NFL and a low density in the postlaminar region. This difference has previously been 
attributed to mechanical compression of RGC axons or a hold up of the axoplasmic flow of 
organelles at the lamina cribrosa [Hollander et al, 1995]. However, no reduction in axonal 
diameter has been found in the laminar region. A potential explanation for the hold up of 
axoplasmic flow is the small size of the P-cells in the PMB. The small size of axons in the 
PMB may impart anatomical constraints for the axoplasmic transport of mitochondria. 
Mitochondria are typically about 0.5wm -  1.0 um across. Their biogenesis is carried out
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within the RGC soma and they are replicated through organelle splitting and budding. Hence 
the RGCs must transport the mitochondria along their very long axons to distribute them 
along strategic, energy dependent locations in the optic nerve. These are mainly the 
unmyelinated portions of the axons within the eye (Fig 1.9.).
Myelination confers a great advantage for the cell since it allows saltatory conduction of 
action potentials that reduces the energy demand for the cell. The unmyelinated portion of the 
RGC axons has much slower conduction velocities and requires far greater energy to restore 
the electrical potential, as compared to the posterior myelinated portion of these same axons, 
which are energy and temporally efficient because of saltatory conduction [Waxman, 1978]. 
Recent studies of human retina and optic nerve specimens using electron microscopy and 
histochemical stains for the mitochondrial respiratory complexes, such as COX, elegantly 
showed an inverse relationship between the mitochondrial activities and myelination 
[Minckler et al, 1976; Andrews et al, 1999; Bristow et al, 2002].
These findings indicated an asymmetric distribution of mitochondria along the RGC axons 
that matches the energy and functional requirements of the axons related to their state of 
myelination (Fig 1.9.). Some particular areas that require high concentrations of mitochondria 
are the gap junctions; the prelaminar and laminar regions of the optic nerve head (where 
mechanical and hydrostatic factors come into play); under the nodes of Ranvier in the post- 
laminar portion of the optic nerve (where most of the sodium/potassium pump work occurs); 
and finally the synaptic terminals (Fig 1.9.).
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Figure 1.9. The retinal ganglion cell system. Diagrammatic view of pattern for staining of COX. 
On the left side is a sagittal view of the human eye. The boxed part is enlarged and schematically 
illustrated, with emphasis on the RGC cellular system. Mitochondrial distribution is shown from 
the RGC somata through the unmyelinated (COX+) portion of the axon in the nerve fibre layer 
(NFL), NFL and penetrating the lamina cribrosa at the optic nerve head. Mitochondrial 
accumulations are represented within the varicosities within the NFL, and in the prelaminar 
region. There is a drastic decrease in mitochondrial numbers within the postlaminar portion 
(COX-). Mitochondria, in this part of the RGC axon, are mostly located under the unmyelinated 
nodes of Ranvier. On the right side is illustrated a histological sagittal section of a normal 
human eye showing a parallel transition from the retina to the optic nerve head, the lamina 
cribrosa and a portion of the myelinated postlaminar optic nerve. The ocular tissue was stained 
by a method using immunoperoxidase for myelin basic protein [Carelli, 2004].
1.5.3.4 Light exposure
RGCs are unusual in that they are the only portion of the CNS exposed to light. It has been 
suggested that light, particularly blue light, has a detrimental influence on mitochondria which 
already exist in a compromised energetic state [Osbourne et al, 2006] but not on mitochondria 
in healthy ganglion cells. Ganglion cell mitochondria are particularly prevalent in the non­
myelinated intraocular portions of the axon when compared with the myelinated extraocular 
regions [Bristow et al, 2002; Barron et al, 2004; Carelli et al, 2004] and these intraocular 
portions are unprotected from light (400-760 nm) impinging onto the retina. Light can be 
absorbed by mitochondrial enzymes such as cytochrome and flavin oxidases causing the
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generation of ROS. Under normal physiological conditions, mitochondria possess a number 
of antioxidant defence mechanisms which prevent such reactive intermediates becoming toxic 
[Lin and Beal, 2006; Morin and Nicolas, 2006]. However, in compromised mitochondria ROS 
may be produced in excess of the cellular capacity to detoxify such species and this can then 
lead to apoptotic cell death.
1.6 Mechanisms for retinal ganglion cell degeneration
RGC death is the final common pathway of virtually all diseases of the optic nerve. Research 
into the events leading to the death of RGCs has delineated several mechanisms that might be. 
responsible. 1) Axoplasmic transport block
2) Glutamate induced excitotoxicity
3) Free radical generation
4) Nitric oxide neurotoxicity
5) Apoptosis
1.6.1 Axoplasmic transport block
An axons length can be 1,000 or 10,000 times the diameter of the cell body but no protein 
synthesis takes place in the axon. Only the cell body and proximal dendrites 
contain ribosomes, the protein manufacturing organelles. Therefore, mitochondria, lipids, 
synaptic vesicles, proteins and other cell parts are constantly transported from the cell body 
down the length of the axon to maintain normal axonal function. Transport of molecular 
inclusions and organelles within axons occurs both away from the cell body (anterograde 
direction) and towards the cell body (retrograde direction) by processes that require energy, 
microtubules and certain protein motors.
The energy for axonal transport is generated by mitochondrial OXPHOS. Mitochondria are 
transported bi-directionally (antero-retrograde) with the ‘fast component’ of the axonal 
transport [Grafstein, 1995; Hollenbeck, 1996]. Their ‘saltatory’ movements are based on 
motor proteins. Essentially, the microtubule based motility is supported by kinesin for 
anterograde transport and by dynein for retrograde. Moreover, mitochondria can also use actin 
microfilaments which represent, most likely, an auxiliary system involved in local transport 
[Grafstein, 1995; Hollenbeck, 1996]. Both kinesin and dynein present an ATPase activity that 
is activated by microtubule binding.
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The hypothesis holds that mammalian neuronal growth and maintenance depends upon the 
viability of this axoplasmic flow. It is therefore conceivable that any energy depletion due to 
mitochondrial dysfunction has the potential of affecting axonal transport, including that of 
mitochondrial transport itself (Fig 1.10.).
Postlaminar
region
Central visual 
field defect
Lamina
cribrosa
Prelaminar
region
•  Mitochondria 
_  Cytoskeletal tracts 
: Myelination
• • 
t  •
• • t • •
f  Vicious \
Profound ATP depletion 
& increased production 
toxic free radicals
Apoptotic cell death
Non-maintenance of 
sharp mitochondrial 
gradient
Destabilisation of 
mitochondria after 
recruitment to 
appropriate regions
Impaired axonal 
transport
ATP deficiency in 
high ATP demand 
region
Disturbed
cytoskeletal-
mitochondrial
interactions
Figure 1.10. Schematic flow diagram showing the mechanisms that would result into the non­
maintenance of the sharp mitochondrial gradient at the optic nerve head and how this 
constitutes the first step in a vicious cycle of events that would eventually lead to apoptotic cell 
death [Yu-Wai-Man et a l, 2005].
1.6.2 Glutamate induced excitotoxicity
Glutamate is the main fast excitatory neurotransmitter in the mammalian nervous system and 
is present in very high concentrations. At chemical synapses, glutamate is stored in vesicles. 
Nerve impulses trigger release of glutamate from the presynaptic cell, glutamate receptors, 
such as the A-methyl D-aspartate (NMDA) receptor bind glutamate and are activated. 
Because of its role in synaptic plasticity it is believed that glutamic acid is involved in 
cognitive functions like learning and memory in the brain.
Glutamate induced excitotoxicity occurs when extracellular glutamate levels are increased 
either due to increased release or decreased uptake from the synapse. High glutamate
50
concentrations activate several types of cell receptors, including MNDA receptors that can 
allow entry of excessive amounts of calcium leading to neuronal damage and eventual cell 
death by inappropriate activation of complex cascades of nucleases, proteases and lipases. 
They directly attack cell constituents including the mitochondria and this leads to the 
generation of highly reactive free radicals and activation of the nitric oxide (NO) pathway 
[Naskar and Dreyer, 2001]. The resulting interaction between intermediate compounds and 
free radicals leads to DNA nitrosylation, fragmentation and activation of the apoptotic 
programme.
1.6.3 Free radical generation
Free radicals are not only generated through the activation of glutamate receptors but also 
through OXPHOS, the process by which mitochondria capture the energy in pyruvate and 
fatty acids (FA) and store it as ATP. This is especially true in the retina which has a very high 
metabolic rate.
A small proportion of oxygen that enters OXPHOS is converted to toxic by-products, oxygen 
radicals (free radicals). Most of these are detoxified by protective cellular enzymes and 
vitamin antioxidants. If they are not neutralized, free radicals can damage lipids, proteins, and 
nucleic acids. This damage is more severe at the site of free radical generation, i.e., the 
mitochondria. Mitochondria are deficient in protective cellular mechanisms, most of which 
reside in the cytosol. OXPHOS dysfunction increases free radical production. This creates a 
vicious cycle which increases mitochondrial DNA damage and causes more OXPHOS 
dysfunction and more free radical generation. Cellular damage in mitochondrial disorders is 
due to free radicals and energy deficiency. Both these factors can also trigger necrosis and 
apoptosis.
1.6.4 Nitric oxide neurotoxicity
Another important activated enzyme is nitric oxide synthase, which catalyses the production 
of NO from L-arginine. NO synthase is an enzyme in the body that contributes to 
transmission from one neuron to another, to the immune system and to dilating blood vessels. 
It does so by synthesis of NO from the terminal nitrogen atom of arginine in the presence of 
NADPH and dioxygen (O2). NO is found through out the body and is particularly abundant in 
the central and peripheral nervous system. NO mediates a diverse range of physiological 
functions associated with neurons. Studies have also identified skeletal muscle as a major
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source of NO in the body [Kobzik et al 1994] where NO regulates both metabolism and 
muscle contractility.
NO neurotoxicity occurs through the reaction of NO with superoxide anion to form 
peroxynitrite and other more reactive free radical species. Peroxynitrite is extremely toxic and 
acts by S-nitrosylating both proteins and nucleic acids, thus destroying them. NO can also 
have a profound effect on mitochondria inhibiting mitochondrial respiration, which in turn 
would create more free radicals and cause additional membrane depolarization. It has been 
reported by Barsoum et al, [2006] that mitochondria undergo fission in response to NO in 
cortical neurons of primary cultures. This fission by NO occurs long before any neurite injury 
or neuronal cell death is observed. Furthermore, fission is accompanied by ultrastructural 
damage of mitochondria, autophagy, ATP decline and generation of free radicals. The N O- 
initiated neurotoxic cascades are important components of the mechanism of cell death in 
many neurodegenerative disorders [Christopherson et al, 1997].
1.6.5 Apoptosis
There are two morphologically distinct types of cell death- necrosis and apoptosis (Table
1.3.).
Apoptosis Necrosis
Morphologic Criteria
Membrane blebbing Loss of membrane integrity
Cell shrinkage and formation of apoptotic bodies Cell swelling and lysis
Lack of inflammatory response 
Lysosomal preservation
Significant inflammatory response 
Lysosomal leakage
Biochemical Criteria
Induction by physiological stimuli 
disturbances 
Energy requirement 
Macromolecular synthesis 
requirement
De novo gene transcription 
Nonrandom fragmentation of DNA
Induction of non-physiological 
disturbances
Lack of energy requirement 
Lack of macromolecular synthesis 
requirement
Lack of de novo gene transcription 
Random digestion of DNA
Table 1.3. Both morphologic and biochemical characteristics are distinctive between apoptotic 
and necrotic cells.
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Necrosis is classically marked by cellular swelling, disruption of organelle and plasma 
membranes, random DNA fragmentation, and uncontrolled release of cellular constituents 
into extra-cellular space usually resulting in inflammation. The process of apoptosis which is 
a process rather than an event is characterised by an orderly pattern of inter-nucleosomal 
DNA fragmentation, chromosome clumping, cell shrinkage and membrane blebbing 
[Kaushik, 2003]. This is followed by disassembly of cells into multiple membrane-enclosed 
vesicles that are engulfed by neighbouring cells without inciting inflammation.
All animal cells are programmed for carrying out self-destruction when they are not needed, 
or when damaged. It has been labelled a programmed cell death, or cell suicide. It is not 
unique to RGCs alone. Under either physiological or pathological conditions, apoptosis is 
driven by interactions among several families of protein i.e., caspases, Bcl-2 family proteins, 
and inhibitor of apoptosis proteins (LAP). Other proteases such as granzyme B, calpain and 
cathepsin have also been demonstrated to play a vital role in apoptosis occurring under certain 
physiological states.
Apoptosis occurs via two main signalling pathways (Fig 1.11.) the extrinsic (death receptor) 
pathway or intrinsic (mitochondrial) pathway. The extrinsic pathways involve the delivery of 
Granzyme B through perforin to the cells as well as receptor ligation that triggers caspase-8 
activation. In the intrinsic pathways, caspase-9 is activated following release of mitochondrial 
components to form the Apaf complex. Some forms of intracellular stress can also induce the 
activation of caspase-12. Both the extrinsic and intrinsic pathways converge on the activation 
of caspase-3 or caspase-7. IAPs can suppress these pathways either by blocking the activation 
of caspase-9 or by directly inhibiting caspase-3 activity.
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Figure 1.11. Schematic diagram showing the major apoptotic signalling pathways. 
[http://www.biooncology.com/pipeIine/apoptosis/index.html -  accessed 10.6.10]
1.7 The Human homologue O P  A3
Linkage analysis, undertaken by Nystuen et al, in [1997] in MGA-III affected families, 
originating from inbred Iraqi Jewish populations, allowed the mapping of the causative gene 
{OPA3) to chromosome 19q 13.2-13.3. Anikster et al, [2001] sought candidate genes within 
the minimal disease region [D19S412-D19S918, Nystuen et al, 1997]. They sequenced four 
genes and identified an intronic G-to-C mutation of a gene, designated OP A3, corresponding 
to complementary DNA (cDNA) clone FLJ22187 which segregated with the MGA-III 
phenotype. The patients exhibited a homozygous intronic G-to-C (-1 position of intron 1 in 
the 3' (acceptor) splice site) change that abolished messenger ribonucleic acid (mRNA) 
expression in fibroblasts from affected patients.
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Northern blot analysis demonstrated a primary transcript of approximately 5.0 kb that is 
ubiquitously expressed most prominently in skeletal muscle and kidney (Fig 1.12.). In the 
brain, the cerebral cortex, the medulla, the cerebellum, and the frontal lobe had slightly 
increased expression compared to other parts [Ankister et al, 2001]. The protein product is a 
20 kiloDalton (kD) peptide which is predicted to contain an N-terminal mitochondrial leader 
sequence (aa 1-18) followed by a sorting/cleavage signal (the peptide, NRIKE, at aa residues 
25-29) and a C-terminal peroxisomal targeting signal.
Figure 1.12. Northern blot analyses by 619-bp probe to human OPA3 cDNA. A, Probe 
hybridised to 5.0-kb band and secondary 8.0-kb band in all tissues tested. Expression appeared 
greatest in skeletal muscle and kidney. The lower panel shows the band for 0-actin, which served 
as a control for RNA loading. B, Same bands on human multiple-tissue northern blot, 
demonstrating expression in all parts of brain. C, 5.0-kb and 8.0-kb bands of RNA from normal 
fibroblasts (N-l and N-2), which hybridised with OPA3-cDNA probe, whereas no bands 
appeared on use of RNA from fibroblasts from one Iraqi Jewish patient [Ankister et al, 2001].
At present the mitochondrial location of OPA3 is debatable. Proteomic profiling of EMM 
proteins extracted by alkali treatment [Da Cruz et al, 2003] and sequence analysis [Ankister et 
al, 2001; Reynier et al, 2004] suggest that OPA3 is localised to the IMM. However, Ryu et al, 
[2010] using subcellular fractionation suggests that OP A3 is localised to the OMM.
At the beginning of this thesis OP A3 was described as a 2 exon gene consisting of a 5' 
untranslated region (UTR), an open reading frame (ORF) encoding 179 aa, and >970 
nucleotides of 3' UTR sequence which spans approximately 57 kilobases (kb) on human 
chromosome 19ql3.2-ql3.3 [Anikster et al, 2001]. Recently however, OPA3 has been shown
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to consist of 3 exons and is expressed in two transcripts [Huizing et al, 2010]. In human, both 
transcripts show ubiquitous expression, with transcript of OPA3A (exons 1-2) showing lower 
expression in the brain and transcript of OPA3B (exons 1-3) showing higher expression in the 
testis. Huizing et al, [2010] also performed localisation studies of the two transcripts in 
normal fibroblasts. Green fluorescent protein (GFP) was fused to either the C-terminus 
(OPA3A-GFP, leaving the putative mitochondrial signal free), or the N-terminus (GFP- 
OPA3, leaving the potential peroxisomal signal free). OPA3A-GFP localised only to the 
mitochondria. With expression of GFP-OPA3 mitochondrial localisation was lost and GFP 
co-localized with a peroxisomal marker. This confirms a functional peroxisomal sorting 
signal in OPA3A although peroxisomal localisation only occurred in the absence of the N- 
terminal mitochondrial signal. OPA3B however, only localised to mitochondria whether or 
not its SEK signal was available indicating that its C-terminal SEK is not a functional 
peroxisomal targeting signal. NRIKE was also shown not to be essential for mitochondrial 
localisation [Huizing et al, 2010; Ryu et al, 2010]. With a mutated/deleted NRIKE signal the 
protein still predominantly localised to the mitochondria. It was only with the leader 
sequence disrupted as well that a more diffuse cellular distribution was seen.
1.7.1 Function of human OP A3
Whilst the function of the protein remains unknown, there are several lines of evidence that 
support mitochondrial function. Firstly, most primary optic atrophies are caused by 
mitochondrial defects [Carelli, 2004]. Secondly, most of the other MGA syndromes i.e., 
MGA-I and MGA-II and MGA-V are known to be associated with mitochondrial defects. 
Also the presence of MGA in the urine itself suggests mitochondrial involvement. Increased 
MGA is a common finding in many mitochondrial respiratory disorders [Gibson et al, 1993; 
Ibel et al, 1993].
Recent experiments in cell lines [Ryu et al, 2010] showed that OP A3 affects mitochondrial 
morphology. HeLa cells transfected with C-terminally myc-tagged OP A3 showed that 
overexpression of wildtype OPA3 lead to extensive ring-like fragmentation. This ring-like 
morphology was also seen in cells transfected with patient mutant OPA3 (G93S)-YFP. 
Abnormal mitochondrial morphology was also seen in HeLa cells knockdown for endogenous 
OPA3 using siRNA, these cells had more elongated and tubular mitochondria. This 
fragmentation was shown to be caused by OP A3 residues 83-102 as deletion of these residues
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resulted in no morphological changes to the mitochondria. This was thought to be due to the 
failure of OP A3 with deleted 83-102 residues to localise to the OMM.
Ryu et al, [2010] also examined cells for increased sensitivity to apoptosis as altered 
mitochondrial morphology is closely related to apoptotic sensitivity [Youle and Karbowski, 
2005]. Cells with fragmented mitochondria attributable to overexpression of wildtype OP A3 
showed normal cytochrome c distribution indicating that OPA3 overexpression alone is not 
sufficient to induce spontaneous apoptotic cell death. However, treatment with staurosporine 
significantly increased the redistribution of cytochrome c from the mitochondria to the cystol 
in cells with OPA3-YFP compared to cells with mito-YFP showing that induced 
mitochondrial fragmentation augments the sensitivity to staurosporine induced apoptosis. In 
cells transfected with patient mutant OP A3 (G93S) cytochrome c appeared in the cytosol in 
the absence of external apoptotic stimuli. Reynier et al, [2004] also saw increased 
susceptibility to staurosporine induced apoptosis in fibroblasts from ADOAC patients 
harbouring the OP A3 mutation (G93S). However, the fibroblasts showed no abnormalities in 
the organisation of the mitochondrial network or in the respiratory chain or in the 
mitochondrial membrane potential. Contradictory to the Reynier et al, [2004] results, 
Chevrollier et al, [2008] showed that fibroblasts of ADOAC patients had enhanced complex 
V activity and reduced cytochrome c oxidase (COX) activity. However, this reduction in 
COX activity is unlikely to be the cause of the mitochondrial defect as respiratory chain 
activity was readily stimulated by adenosine diphosphate (ADP) indicating that COX activity 
is not the rate limiting step. Overall, the fibroblasts showed normal mitochondrial ATP 
production but with reduced efficiency of ATP synthesis. Wanders et al, [1992] also showed a 
reduced efficiency in ATP synthesis in digitonin-permeabilised fibroblasts of MGA-III 
patients. Cells exhibited a 50 % reduction in adenosine-5'-triphosphate (ATP) production and 
a four-fold increase in lactateipyruvate ratio [Wanders et al, 1992] both of which are 
indicators of impaired mitochondrial function. Recently, a zebrafish model of MGA-III with a 
null allele of opa3 [Pie et al, 2010], demonstrated normal mitochondrial oxidative 
phosphorylation (OXPHOS), but increased sensitivity to inhibitors of the electron transport 
chain. Expression of OP A3 mRNA is also very high in tissues of high ATP production such 
as the cerebral cortex.
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Overall, the evidence so far suggests that OPA3 is localised to the mitochondria with 
mutations causing disturbances in mitochondrial dynamics, respiratory chain activity and an 
increased sensitivity to apoptosis
1.7.2 Mutations of the human OP A3 gene
Mutations in OPA3 can cause diseases with recessive as well as dominant modes of 
inheritance. All cases of MGA-III described to date have been caused by homozygous 
mutations which are predicted to abolish all protein activity. In ADOAC only one copy of 
OP A3 needs to carry a missense change, which probably exhibits a dominant negative effect 
but manifests as a milder phenotype. Seven mutations of OPA3 have been reported so far 
(Table 1.4.)
Sequence
change
Protein
change
Clinical
designation
Mode of 
inheritance
Comments Reference
IVS1-1G>
C
MGA-III Recessive Allele frequency 
of 10% in Iraqi 
Jews.
Anikster et 
al, 2001
c.320-
337del
p.Q108-
E113del
MGA-III Recessive Reported in a boy 
bom of
consanguineous 
Kurdish Turkish 
parents.
Kleta et al, 
2002
c.277G>A p.G93S ADOAC Dominant Reynier et 
al, 2004
c.313C>G p.Q105E ADOAC Dominant Reynier et 
al, 2004
c.-38A>G MGA-III Aetiology
uncertain
Found in a 
heterozygous 
state, functional 
significance 
unknown.
Neas et al, 
2005
c.231T>C Silent
polymorphism
N/A Allele frequency 
in normal 
population 61%.
Neas et al, 
2005
c.415C>T p.Q139X MGA-III Recessive Ho et al, 
2008
Abbreviations: N/A= not applicable, del= deletion.
Table 1.4. Mutations reported in the OP A3 gene.
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1. MGA III- IVS1 -1G-C mutation
Anikster et al, [2001] identified the acceptor splice site mutation, IVS1-1G-C, a homozygous 
G-C change at -1 position of OP A3 intron 1 in the 3’ acceptor splice site resulting in the 
obliteration of the intron 1 splice site. This mutation abolishes mRNA expression in 
fibroblasts in several Iraqi Jewish patients and accounts for 100% of disease-causing alleles in 
the Iraqi Jewish population.
2. MGA III- 320-337 deletion
Kleta et al, [2002] reported a novel mutation in OP A3 in a Kurdish-Turkish patient with optic 
atrophy and 3-methylglutaconic and 3-methylglutaric aciduria previously carrying a diagnosis 
of MGA-IV. Sequencing revealed an in-frame deletion of 18 bp at positions 320-337 in exon 
2 resulting in the deletion of the 6 aa between residues 108 and 113 i.e., QRHKEE. This was 
the first mutation found in an individual of non-Iraqi Jewish origin.
3. ADOAC- 227G>A mutation
In affected members of a French family with ADOAC first described by Garcin et al, [1961], 
Reynier et al, [2004] identified a heterozygous 277G-A transition in exon 2 of the OPA3 
gene, resulting in a gly93-to-ser (G93S) substitution.
4. ADOAC- 313C>G mutation
In affected members of a family with ADOAC, Reynier et al, [2004] identified a 
heterozygous 313C-G transversion in exon 2 of the OP A3 gene, resulting in a glnl05-to-glu 
(Q105E) substitution.
5. MGA III- c.-38A>G
Neas et al, [2005] screened 13 patients with neurological abnormalities and MGA for 
mutations in the OP A3 gene. In a single patient a sequence variation in the 5' UTR was 
identified c.-38A>G. The significance of the 5' UTR sequence variation remains open to 
speculation.
6. MGA III- c.231T>C
Neas et al, [2005] also detected the sequence variation c.231T>C in 12 out of the 13 patients. 
This is a silent polymorphism and therefore does not appear to have any pathological 
significance.
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7. MGA III- c.415C>T
This was a nonsense mutation, found in the homozygous state in an individual of Indian 
origin with MGA-III. It is the second mutation found to date in an individual of non-Iraqi 
Jewish origin [Ho et al, 2008].
In 2009, 980 patients were screened for suspected hereditary optic neuropathies [Ferre et al, 
2009]. The entire coding sequence of OP A3 was screened in 14 patients belonging to three 
unrelated families. They presented with bilateral optic atrophy and posterior cataract which 
was inherited as an autosomal dominant trait. Two mutations were found in exon 2: 227G>A 
and 313C>G both of which have been previously reported by Reynier et al, [2004]. Both 
mutations segregated with the disease and were absent in healthy relatives and 400 control 
chromosomes.
At present the limited number of mutations found does not permit any genotype-phenotype 
correlations. Even in the Iraqi Jewish population which all have the same mutation there is 
variability in the phenotype, sometimes within the same family.
1.8 Hypotheses
1) That OP A3 is an important gene and its characterization will help us better understand 
retinal development and ganglion cell survival.
2) That RGCs die through compromised mitochondrial function which initiates cell death 
either by apoptotic or non-apoptotic signalling.
3) Its normal function is important for the health of organs with high energy requirements.
4) Peroxisomal dysfunction plays a role in the disease phenotype.
5) That the Opa3U22P mouse mutant will be a clinically relevant model of MGA-III.
1.9 Mouse model of Opa3
This thesis made use of an A-ethyl-A-nitrosourea (ENU) induced point mutation in the murine 
Opa3 gene creating the first model of the human disorder MGA-III. The pathophysiology of 
the mouse model was assessed using a range of visual, neurological, behavioural and 
metabolic tests. Findings were compared with those from clinical studies of patients with an 
MGA-III/ ADO AC disease in the hope of producing a clinically relevant model.
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CHAPTER 
II
General Materials and Methods
2.1 DNA preparation and purification
2.1.1 Sample preparation
Genomic DNA was prepared from tail biopsy and tissue samples using two different methods 
depending on the experimental procedure.
For genotyping of mice from tail biopsies a DirectPCR lysis reagent (Viagen) was used. This 
is a quick and crude DNA preparation method. Genomic DNA was isolated from biopsy of 
mouse tail tissue in 200pl of Viagen lysis solution containing 2mg/ml of Proteinase K. This 
was incubated at 55°C for 5-6 hrs followed by 45 mins in a water bath at 85°C to inactivate 
the Proteinase K. Samples were then spun down to minimise uptake of debris into PCR 
preparation.
For PCR or sequencing where a pure DNA sample was required the Wizard SV genomic 
purification kit was used. The tail biopsy or tissue sample was added to the Digestion Solution 
Master Mix made up as follows:- 200pl nuclei lysis solution, 50pl 0.5M EDTA, 20pl of 
20mg/ml Proteinase K and 5pl of 4mg/ml RNase A solution. This was incubated for 16-18 hrs 
in a 55°C oven. Then 250pl of SV lysis buffer was added and vortexed.
2.1.2 Purification o f genomic DNA from lysate using microcentrifuge
While the lysate was still warm it was transferred to a minicolumn assembly and then 
centrifuged at 13,000g for 3 mins. The liquid in the collection tube was discarded and 650pl of 
SV wash solution was added to the minicolumn and centrifuged at 13,000g for 1 min. This step 
was repeated four times. After which the minicolumn was centrifuged at 13,000g for 1 min 
with no solution in it to dry out the binding matrix. The minicolumn was then placed in a new 
collection tube. 250pl of room temperature nuclease free water was added and incubated at 
room temperature for 2 mins. The minicolumn was then centrifuged at 13,000g for 1 min. The 
eluted water contains the DNA. For a more concentrated solution of DNA the eluted water can 
be put back into the minicolumn and centrifuged again.
2.2 RNA isolation
Heart, muscle, brain, kidney, liver and eye tissue of wildtype Opa3 animals were collected in 
RNALater.
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2.2.1 RNA purification and quantification
Total RNA was purified using an RNeasy Mini Kit (Qiagen). As the tissue was stabilised in 
RNALater it can be cut up for homogenisation at room temperature. RNA is very unstable so 
frozen samples should not be allowed to thaw and fresh samples should be homogenised 
immediately. The tissue was disrupted and homogenised in 600pl of RLT buffer using a rotor- 
stator homogeniser until it was uniformly homogenised. The lysate was then centrifuged for 3 
mins at full speed. The supernatant was removed and transferred to a new microcentrifuge 
tube. It is this supernatant that is used in all subsequent steps. To this supernatant one volume 
of 70% ethanol was added and was immediately mixed by pipetting. 700pl of the sample was 
then added to an RNeasy spin column and placed in a 2ml collection tube. This was then 
centrifuged for 15 secs at 10,000 revolutions per minute (rpm). The flow through was 
discarded and 700pl of RWI buffer was added to the RNeasy spin column. The column was 
then spun again for 15 secs at 10,000 rpm and the flow through discarded. After which 500pl 
of RPE buffer was added to the spin column and centrifuged for 15 secs at 10,000 rpm to wash 
the spin column membrane. This was repeated with the RPE buffer but centrifuged for 2 mins. 
The spin column was then placed in a new centrifuge tube and centrifuged for 1 min on full 
speed. This step eliminates the carry-over of any residual RPE buffer. The spin column was 
then placed in a new centrifuge tube and 50pl of RNase free water was added and this was 
centrifuged for 1 min at 10,000 rpm to elute the RNA. The sample can then be stored at -20°C 
short term or -80°C long term.
RNA was quantified using the Picodrop spectrophotometer (Picodrop, UK).
2.3 cDNA synthesis (reverse transcription)
cDNA was synthesised from 0.5pg total RNA using Qiagen’s Quantitect Reverse Transcription 
Kit. This kit is an RT-PCR method for efficient reverse transcription and removal of genomic 
DNA. A detailed protocol can be found in the instructions with the kit. So, briefly, while the 
tube of RNA template thawed on ice, the Genomic DNA Elimination Reaction Components 
were mixed in a tube comprising of (Table 2.1.).
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Component Volume/reaction Final concentration
gDNA wipeout buffer IX 2 pi lx
Template RNA Variable (up to lpg)
RNase free water Variable
TOTAL VOLUME 14pl
Table 2.1. Genomic DNA elimination reaction components.
This solution was incubated for 7 mins at 42°C then placed immediately on ice. During this 
incubation a reverse transcription master mix was prepared on ice (Table 2.2.).
Reverse transcription master 
mix
Volume/reaction Final concentration
Quantiscript reverse 
transcriptase
lpl
Quantiscript TR buffer 5x 4pl lx
RT Primer mix lpl
Entire genomic DNA 
elimination reaction
14pl
TOTAL VOLUME 20pl
Table 2.2. Reverse transcription reaction components.
This solution was incubated for 30 mins at 42°C then for a further 3 mins at 95°C to inactivate 
the Quantiscript reverse transcriptase. The solution can then be stored at -20°C and used for 
PCR.
2.4 Agarose gel electrophoresis
Agarose gel electrophoresis was the method selected for the visualisation of the PCR products. 
The 2% gel was prepared by dissolving 3g of agarose (molecular biology grade, Sigma) in 150 
mis of lx TBE buffer. Agarose solution was heated in a microwave for 2-3 mins until the 
agarose was completely dissolved. Then 5pl ethidium bromide solution (lOmg/ml) was added 
to the agarose. The solution with ethidium bromide was poured into a casting tray with a comb 
to form wells. After a 40 min delay for the gel to solidify, 20pl of PCR product was loaded into 
each well. DNA hyperladder IV (Bioline) was used for estimation of band sizes.
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The gel was electrophoresed at 120V until adequate separation of the bands. The gel was 
visualised on a UV transilluminator (UVP, England) and the image of the gel was captured 
with BioDoc-It and visiDoc-It system (UVP, England) equipped with a thermal printer (Sony, 
Japan).
2.5 Tissue fixation for wax embedding
Tissue fixation and subsequent wax embedding are routinely used techniques of histology 
procedures for morphological studies. The purpose of the fixation is to preserve the structure 
and components of the tissue. Two different length protocols were used for the fixation of 
tissues for embedding in wax depending on the tissue type. All tissues were processed for the 
xylene embedding wax method.
After dissection, tissues from all mice ages were fixed in a solution of 4% PFA pH 7.4 (Sigma, 
Germany) for 24 hrs at 4°C. Tissues were then washed twice in PBS for 30 mins, placed in a 
new tube with fresh PBS and left overnight at 4°C. The following day they were processed by 
one of the two protocols below.
2.5.1 Fixation o f eyes for wax embedding
A longer fixation protocol was used for eyes as the lenses were not removed for sectioning. If 
the lens is not fixed sufficiently it can move in the block and cannot be sectioned properly. 
However, if the lens is fixed for too long it will shatter spreading debris over the slide. This is 
preferable to being under-fixed.
The first step in the process is dehydration. This process is carried out using a series of 
increasing grades of ethanol (Fisher solutions, UK). Eyes were first soaked in 50% ethanol 
solution for 30 mins, then 70% ethanol for lhr, 90% ethanol for 2 hrs (twice) then 90% for 
another hr. Finally, in 100% ethanol for 2 hrs and again in 100% ethanol for one more hr.
Once the eyes are dehydrated it is important to carry out a clearing step. The eyes were put in a 
new glass vial and soaked for 15 mins in a solution of 50% xylene/50% ethanol. The solution 
was then changed and the eyes were left in 50% xylene/50% ethanol overnight. Eyes were then 
soaked in 100% xylene for 1 hr (twice). After the clearing step, the excess of xylene was 
removed and the eyes were put in warm wax in glass vials in a histology oven at 56°C. After 2
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hrs the wax was removed and new wax was added to the eyes for another 2 hrs. The eyes were 
then collected, orientated in a plastic mould and embedded in new wax. The samples in the 
mould with the wax were left for 30 mins on a -12°C cold plate to solidify then stored at 4°C. 
Blocks were sectioned at 7pm in a Microm microtome (Microm, Germany) using a sharp blade 
(Nakura systems, Japan).
2.5.2 Fixation o f other tissues for wax embedding
For the lung, skeletal muscle, heart, liver and kidney the same protocol was used, except the 
dehydration step was shorter. The tissues were first soaked in 50% ethanol solution for 30 
mins, then 70% ethanol for lhr, 90% ethanol for lhr (twice), then 100% ethanol for lhr 
(twice). The samples then continued with the clearing step as in the protocol for the eyes.
2.6 Frozen tissues for cryostat sectioning
Fresh tissue samples were collected and cut to an appropriate size and orientation. A small cup 
was made out of foil (just big enough to hold the tissue and be filled with OCT). Then the 
tissue was placed in the OCT. A cold-resistant plastic beaker was filled with iso-pentane. The 
foil cup was placed in the beaker containing iso-pentane and then the beaker was placed into 
liquid nitrogen. When the OCT had solidified the foil cup was removed from the iso-pentane 
and placed in liquid nitrogen. Samples were stored at -80°C.
2.7 Histology
Histochemistry is the science that uses different chemistry on cells or tissues to show and 
identify their microscopic structure. The basic nature of histology slide staining is to stain with 
two or more contrasting dyes that will highlight specific areas or entities with one colour, and 
leave a counterstaining background colour.
All histologically stained sections were observed via bright field microscopy using Leica 
DMRA2 microscope (Leica, Germany).
2.7.1 Haematoxylin and eosin
The most routine stain used is the haematoxylin and eosin (H&E) stain. The H&E stain uses 
two separate dyes, haematoxylin is a dark purplish dye that will stain the chromatin (nuclear 
material) within the nucleus, leaving it a deep purplish-blue colour. Eosin is an orange-pink to 
red dye that stains the cytoplasmic material including connective tissue, and leaves an orange-
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pink counter stain. This counter stain acts as a sharp contrast to the purplish-blue nuclear stain 
of the nucleus, and helps identify other entities in the tissue such as cell membranes.
The process of performing the H&E stain is relatively simple. Slides were selected then taken 
through 2 changes of 100% xylene for 2 mins each and then put in decreasing concentrations 
of ethanol. Two washes were carried out in 100% ethanol for lmin each, then 1 min in 95% 
ethanol followed by 1 min in 70% ethanol. The slides were then washed under the tap for 1 
min before being immersed in Harris’s haematoxylin (BDH, England) for 2 mins. Harris 
haematoxylin stains everything on the slide and holds fast to the tissue when rinsed. Therefore, 
after staining and before using the eosin stain, it is necessary to rinse under the tap for 5 mins 
until the excess haematoxylin has been removed from everything except the nucleus.
After that the slides were stained in 1% eosin (Surgipath, UK) for 10 mins. The slides were 
then washed for 15 secs under the tap before running in a reverse manner through the ethanol 
series. 15 secs in 70% ethanol, 30 secs in 90% ethanol then two washes for 2 mins each in 
100% ethanol and finally two washes in 100% xylene for 2 mins each for clearing. The slides 
were mounted with D.P.X permanent medium for microscopy (BDH, England).
2.7.2 Oil red-O stain
Oil red-O is a lysochrome (fat-soluble dye) diazo dye used for staining of neutral triglycerides 
and lipids on frozen sections and some lipoproteins on paraffin sections.
Unfixed frozen sections must first be fixed in 10% buffered formal saline for 5 mins. After 
which they are rinsed in water for 2 mins then rinsed in 60% isopropyl alcohol (prepared with 
distilled water) for a further 1 min. Slides are then stained for 10 mins with Oil red-O (Sigma- 
Aldrich) in an air tight container, then washed in 60% isopropyl alcohol for 30 secs. After 
which they are transferred to a water bath flat on the bench (no running water) for 5 mins. 
Slides are then counterstained with Mayer’s haematoxylin solution for 5 secs and then washed 
in running water for 5 mins. The slides should then be kept in the water before mounting with 
an aqueous mounting medium.
Staining should show unsaturated hydrophobic lipids (i.e. triglycerides, cholesterol esters) in 
red, phospholipids in pink and the nuclei in blue.
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2.7.3 Toluidine Blue stain
Toluidine Blue is a metachromatic dye used in staining bone and cartilage.
Bone sections were rinsed in 100% xylene twice for 2 mins, then through an alcohol series, of 
100% alcohol for 2 mins (twice), 2 mins in 95% alcohol then 2 mins in 70% alcohol. Sections 
were then washed in running tap water until clear. Sections were then transferred into toluidine 
blue dye for 30 secs and again washed in running tap water until clear. They were then drained, 
blotted dry with filter paper and allowed to air dry for a few minutes. After which they were 
transferred into 100% xylene for 2 mins (twice) before being mounted under a coverslip using 
D.P.X mountant.
Staining should show Meta chromatic substances in red, pink or purple and nuclei and other 
components in blue.
2.8 Perfusion fixation
Transcardial perfusion under terminal anaesthesia is a method commonly used for tissue 
fixation in immunohistochemical localization protocols. This method takes advantage of the 
subjects circulatory system to deliver the fixative solution evenly throughout the body tissue, 
with optimal penetration of the brain. This is the optimal method of tissue preservation because 
the tissues are fixed before autolysis begins and are less susceptible to artefacts caused by 
handling. Fixation preserves the ultrastructure, and stabilizes protein and peptide conformation. 
The perfusion process should take place in a fume hood for best personal protection.
The mouse is anaesthetised using 0.2 ml euthatal. The withdrawal reflex must not be present 
before procedure begins to ensure adequate depth of anaesthesia. The chest cavity is opened to 
expose the heart. A needle is inserted into the left ventricle and clamped in place. A scissor 
incision is then made into right atrium to allow perfusate to exit circulation. Blood can then be 
flushed from the body using 0.2M phosphate buffer for about 30 sec. When the fluid exiting 
the mouse is clear of blood the flush line should be removed and a new one with 4% PFA 
should be added. 4% PFA must be made up fresh on the day of procedure. Muscle contractions 
and blanching of the liver and mesenteric blood vessels are signs of good perfusion. Perfusion 
is complete when all muscle contractions have stopped, the liver and mesenteric vessels are 
blanched and the desired amount of preservative has passed through the circulatory system.
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2.9 Embryo collection
To generate embryos for analysis, heterozygous Opa3 males and females were selected for 
inter cross matings. All mice were maintained on a 12/12-hr light-dark cycle the mid-point of 
the dark cycle being 2am and for the timed mates 2pm on the day of the appearance of the 
vaginal plug is designated 0.5 days post coitum (dpc). All embryos were dissected from 
maternal tissue and Reichert’s membrane removed in PBS with 10% newborn calf serum. The 
recovered embryos were staged according to Mouse Atlas [Kaufman, 1994]. The tails of the 
embryos were added to 200pl of Viagen lysis solution. Samples were digested and genotyped 
as described for genotyping offspring. Embryos were either fixed in 10% NBF for sectioning 
or 95% ethanol of skeletal analysis.
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CHAPTER 
III
Splicing, expression and putative functional analysis of
optic atrophy gene Opa3
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3.1 Introduction
Aims of chapter
- Use of RT-PCR to confirm a 3rd exon of Opa3 and assess for alternative splicing.
- To analyse the expression of splice variants in various adult mouse tissues.
- To screen British adult patients with optic atrophy but without OPA1 mutations, for 
mutations in the OP A3 gene by direct genomic sequencing.
- To use biological databases for gene sequence analysis, protein structure predictions and 
effects of mutations on human protein structure.
- Use of bio-informatic programs for characterisation of putative transcription factor binding 
sites (TFBS) to enable further functional predictions of Opa3.
At the beginning of this project in 2006 the mouse orthologue of Opa3 was considered to be a 
2 exon gene located on chromosome 7 at 19,813,753 bp -  19,833,210 bp with a single 
transcript length of 3,289 bp and a translation length of 179 residues. However, the 
appearance of a novel expressed sequence tag (EST) in the murine Ensembl database (version 
50) indicated the possible presence of a 3rd exon (Fig 3.1.) prompting a re-examination of the 
genomic structure of the Opa3 locus. The C57BL/6JCrl mouse was used to further 
characterise the Opa3 gene structure.
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Figure 3.1. Page from murine Ensembl (version 50) showing Opa3 and EST 3727961.
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The function of Opa3 remains unknown, so with the use of bio-informatic databases the 5 kb 
proximal sequence of the mouse Opa3 gene was compared with other mammalian 
orthologous sequences to look for highly conserved regions. Searches for TFBS that are 
conserved are important evidences of which proteins may be involved in Opa3 gene 
transcriptional regulation. Identification of transcription factors that regulate Opa3 expression 
is a step forward to better understand its transcription rules and its function.
This chapter reports the confirmation of a 3rd exon of Opa3 which creates a novel splice 
variant of murine Opa3. This finding prompted the screening of a panel of patients with optic 
atrophy in whom mutations in the gene for ADO A (OPA1), mapping to chromosome 3q28- 
qter, had not been found in a previous survey of mutations. Bio-informatic programs were 
also used to characterise possible upstream TFBS for putative functional analysis.
3.1.1 Use of bio-informatic analysis
With the increasing availability of bio-informatic tools the genomic sequence of Opa3 was 
first assessed to determine if there was a 3rd exon of Opa3. Traditionally there would have 
been two possible methods for the prediction of a 3rd exon. An intrinsic method, which uses 
statistical features such as codon frequencies, open reading frame lengths and the location of 
potential splice sites to distinguish coding from non-coding sequences of the genome [Burge 
and Karlin, 1997] or an extrinsic method, which tries to find similarities between genomic 
sequences and known proteins [Gish and States, 1993]. Both have their advantages and 
limitations. The extrinsic method cannot be used, as Opa3 showed no homology to any 
known proteins. The intrinsic method which is able to detect genes with no homologues in the 
protein database would be appropriate for Opa3 but the accuracy of this method is limited 
[Burge and Karlin, 1998]. It was therefore decided to use a recent addition to the methods for 
predicting coding regions and functional elements in genomic sequences, that of phylogenic 
footprinting.
The rationale behind the phylogenic footprinting approach is simple: functional regions are 
under selective pressure and tend to be more highly conserved than non-functional regions 
that are subject to random genetic drift, so local sequence similarity usually indicates 
biological functionality. Several recent studies have used cross-species sequence comparison 
to identify functional regions in large genomic sequences [Sandelin, 2008; Chen et al, 2006]. 
It is now widely accepted that comparative sequence analysis is a universally applicable tool
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for genome analysis and annotation, therefore, being a powerful approach for understanding 
phylogenetic relationships, annotating genes, and detecting functional regulatory elements.
3.1.2 Multispecies DNA sequence comparison for phylogenic footprinting- What species 
to select?
Phylogenic footprinting is not only useful for gene annotation, e.g., to look for undiscovered 
exons but can also be used to detect regulatory regions to shed light on gene function. A range 
of species were compared to reveal conserved non-coding sequences upstream of Opa3. 
These sequences can then be used to search for TFBS for putative functional analysis. Before 
this, species selection and the number of species selected for comparison is an important step 
to consider.
Comparing the genomic sequences of species at different evolutionary distances one can 
identify coding sequences and conserved non-coding sequences with regulatory functions and 
determine which sequences are unique for a given species. DNA sequences of species that 
diverged ~40-80 million years ago from a common ancestor, such as humans and mice 
reveals conservation in both coding sequences and a significant number of non-coding 
sequences. Those whose functions have been assigned have been transcriptional regulatory 
elements of nearby genes [Gumucio et al, 1996; Hardison et al, 1997] or genes as much as 
200 kb away [Loots et al, 2000]. A question remains as to whether most of the conserved non­
coding sequences are present because of functional constraints or are the result of a lack of 
divergence time. Comparing species with a larger evolutionary related distance, such as 
humans and pufferfish, which diverged approximately 450 million years ago, primarily 
reveals coding sequences as conserved [Aparicio et al, 2002]. This is due to the fact that 
protein coding sequences are tightly constrained to retain function and thus evolve slowly, 
resulting in readily detectable sequence homology even over this large phylogenetic distance. 
Therefore, the addition of distantly related organisms (^^450 million years) to a multi-species 
sequence comparison improves the ability to classify conserved elements into coding 
sequences and non-coding sequences. However, one should be aware that at such large 
evolutionary distances it is difficult to definitively distinguish between yet undiscovered 
coding sequences and functional non-coding sequences.
At the other end of the scale comparing sequences from closely related species, such as 
humans and chimpanzees, identify sequences that have changed and genomic rearrangements
73
that have occurred in recent evolutionary history [Frazer et al, 2003]. Some of these recent 
genomic events identified by comparison of orthologous sequences between closely related 
species may be responsible for gene differences between the organisms and are of interest 
because of their potential functional consequences. Thus, by adding a closely related organism 
to a multispecies comparative sequence analysis, one can identify not only coding sequences 
and functional non-coding sequences but also those genomic sequences which may be 
responsible for traits that are unique to the reference species.
A range of species was therefore chosen that were closely related, such as human and 
chimpanzee, and more evolutionary divergent species such as the dog and cow (Fig 14.). Frog 
was initially added to the list but showed no conservation with any of the other species.
3.1.3 Identification of TFBS for insight into gene function
Control of transcription initiation is a pivotal mechanism for determining whether or not a 
gene is expressed and how much mRNA and consequently protein is produced. A promoter is 
a sequence that initiates and regulates the transcription of a gene. Protein binding sites in a 
promoter represent the most crucial elements and the corresponding proteins are called 
transcription factors (TFs). Understanding a regulatory system requires detailed knowledge of 
both the trans-acting TFs and the respective promoter cA-elements (binding sites). TFs work 
by binding to specific DNA sites among a vast excess of structurally similar non-specific sites 
to either increase or decrease the affinity of RNA polymerase for the sequence, thereby 
altering the rate of mRNA production [Alberts et al, 1989].
The identification of DNA regulatory regions is one of the most important and challenging 
problems in the functional annotation of genomes. Traditionally, DNA binding specificity 
was determined experimentally primarily with in vitro techniques such as DNase I 
footprinting and electromobility shift assay. However, these processes are very costly and 
time consuming. With the availability of working draft genomes of many species 
computational identification of regulatory elements becomes a valuable alternative to in vitro 
techniques.
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3.1.4 Predictive programmes for identification of TFBS
Computational TFBS prediction provides reliable results in application to prokaryotes and 
yeast. However, in higher eukaryotes accurate and reliable TFBS prediction is a huge 
challenge.
Online applications, such as Matlnspector, MATCH and ConSite have been built to predict 
TFBSs embedded in promoter sequences. However, it should be noted that TFBS searches 
only identify sites where the TF could bind, but not necessarily will bind. Several different 
methods and predictive programmes were used.
3.1.4.1 Mulan- MultiTF
Mulan (Multiple sequence Local AligNment and conservation visualisation tool), is a novel 
method and a network server for comparing up to 20 draft and finished-quality sequences of 
different species to identify functional elements conserved over evolutionary time. Mulan 
brings together several novel algorithms: the threaded blockset aligner (TBA) multi-aligner 
program for rapid identification of local sequence conservation, and the multiTF program for 
detecting evolutionarily conserved TFBS in multiple alignments. In addition, Mulan supports 
two-way communication with the GALA database; alignments of multiple species 
dynamically generated in GALA can be viewed in Mulan, and conserved TFBS identified 
with Mulan/multiTF can be integrated and overlaid with extensive genome annotation data 
using GALA.
3.1.4.2 Genomatix- Matlnspector
Matlnspector is a tool for TF analysis. It utilises Genomatixs’ MatBase the comprehensive TF 
knowledge database which locates TFBS in sequences of unlimited length. Matlnspector 
assigns a quality rating to matches (called matrix similarity) and thus allows similarity based 
filtering and selection of results. For every single matrix, an individually optimised similarity 
score is specified, minimising the number of false positive hits in non-regulatory sequences. 
Each matrix definition is quality tested, resulting in superior usability for functional analysis 
of regulatory regions. Matlnspector is described in Quandt et al, [1995].
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3.1.4.3 TFSEARCH
The TFSEARCH program was written by Yutaka Akiyama in 1995. The TFSEARCH 
searches highly correlated sequence fragments against TFMATRIX TFBS profile database in 
the 'TRANSFAC databases by GBF-Braunschweig. There has been no publication on the 
TFSEARCH program yet.
3.1.4.4 PReMod
PReMod is a database of genomewide ds-regulatory module (CRM) predictions for both the 
human and the mouse genomes. The prediction algorithm, described previously in Blanchette 
et al, [2006], exploits the fact that many known CRMs are made of clusters of 
phylogenetically conserved and repeated TFBS. Contrary to other existing databases, 
PReMod is not restricted to modules located proximal to genes, but in fact mostly contains 
distal predicted CRMs. TFBS can occur everywhere in the genome and are by no means 
restricted to regulatory regions. Sites outside regulatory regions are known to bind their TFs 
[Kodadek et al, 1998], and it is the context that differentiates a functional binding site 
affecting gene regulation from a mere physical binding site [Elkon et al, 2003].
3.1.5 Use of TRANSFAC and PWM
Numerous DNA footprinting and biochemical studies carried out over the last decade have 
identified close to 500 vertebrate-specific TFs and information regarding the DNA sequences 
they recognise. The TRANSFAC database (http://transfac.gbf.de/TRANSFAC/) [Wingender 
et al. 1996; Matys et al. 2003] represents the most comprehensive collection of TF binding 
specificities and has been increasingly linked with other databases such as TFSEARCH and 
PReMod (transfac 7.2). TRANSFAC summarises TF as position weight matrices (PWMs) for 
review, see Stormo, [2000].
A weight matrix pattern definition is superior to a simple IUPAC (International Union of Pure 
and Applied Chemistry) consensus sequence as it represents the complete nucleotide 
distribution for each single position. It also allows the quantification of the similarity between 
the weight matrix and a potential TFBS detected in the sequence.
A major limitation in using PWMs to computationally identify functional TFBS is that many 
TFs bind to short degenerate sequence motifs (6-12 bp in length). More problematic in this
76
evaluation is that the TF can be shown to bind in vitro even if they show no in vivo activity. 
This suggests that there exist other conformational factors that regulate whether a given 
sequence in the DNA is available for binding. TFBS prediction programs like Matlnspector 
can infer the binding potential, although not the functionality of a site. Functionality can 
ultimately be proven only by a wet-lab experiment with defined settings, particularly since 
potential binding sites in a promoter can be functional in certain cells, tissues or 
developmental stages and non-functional under different conditions.
Study of the molecular basis of diseases by experimental methods is laborious and time- 
consuming, and at the structural level often nearly impossible, especially in cases where there 
are several missense mutations causing the disease. By involving advanced bioinformatics 
strategies like detailed promoter analysis of, for instance, orthologous or co-regulated genes 
can significantly reduce the number of test candidates. Precise and useful information about 
the effects of mutations on protein structure and function can readily be obtained by 
theoretical methods.
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3.2 Materials and Methods
3.2.1 Conserved region identification of Opa3 using comparative genomics
The identification of conserved regions around the Opa3 locus which may indicate the 
presence of a 3rd exon was facilitated by comparing the chromosomal regions spanning the 
human (Ensembl Chr 19 50780462-50722397 bp) and mouse (Ensembl version 50 
ENSMUSESTG00000010990 Chr 7 19813232-19841673 bp) gene locus using the Mulan 
software (mulan.dcode.org) [Ovcharenko et al, 2005]. The Evolutionary Conserved Region 
(ECR) Browser within Mulan was used to visualise phylogenetically core ECRs. To be core 
ECRs the sequences must be orthologous for 350 bp or more with greater than 77% sequence 
identity and would therefore be considered as highly likely to be functional. The human OP A3 
gene sequence was used as the reference sequence for annotation in Mulan.
3.2.2 Detection of mouse Opa3 exon 3 expression and novel splice variant by RT-PCR
To determine whether the core ECR downstream of exon 2 is transcribed, a series of RT-PCR 
reactions on six different types of wildtype C57BL/6JCrl mouse tissue were performed with 
the primers listed in Table 3.1. The primers were designed using the primer3input program 
(website frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) using the mouse Opa3 gene 
sequence in Ensemble. Primers were designed in the exon coding sequences close to the 
exon/intron boundaries (Fig 3.5.).
Primers Sequence 5'-3' Location Annealing Temp Product
FI GGCGAAGCTGTTCTACTTGG exon 1
R2 TTATTGCGCTGCTGAGTCTG exon 2 63oC 309bp
R3 GCGGTGTTTCGATGACTTCT exon 3 63 oC 307bp
Table 3.1. Oligonucleotide primers used to amplify Opa3 exons.
Total RNA was isolated from heart, skeletal muscle, brain, kidney, liver and eye tissue of 
adult C57BL/6JCrl wildtype animals (n=3) and collected in RNALater (Sigma). Total RNA 
was isolated using an RNeasy Mini Kit (Qiagen). RNA was quantified using the Picodrop 
machine. cDNA was synthesised from 0.5 pg total RNA using Qiagen Quantitect Reverse 
Transcription Kit (see Chapter II). RT-PCR was performed in 25 pi reactions for exon 1-2 and 
exon 1-3 transcript detection. RT-PCR contained 2pl template DNA, 1.5 pi of FI and 1.5 pi
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of R2 or R3, 13 pi Taq polymerase mastermix (BioMix Red; BioLine, UK) and dH20 to make 
up volume.
The general PCR conditions used were as follows: initial denaturation cycle of 15 mins at 
95°C; followed by 38 cycles of 45 secs at 95°C, 45 secs at 63°C, and 1 min at 72°C; and a 
final extension of 10 mins at 72°C. PCR products were visualised on 2% agarose gels stained 
with ethidium bromide.
3.2.3 Sequencing of mouse exons and transcripts
Genomic DNA and cDNA were isolated as per protocols in Chapter II. PCR products were 
amplified from genomic DNA and cDNA using primers located in flanking intron and UTR 
sequences (Table 3.2.). PCR amplification was performed in 25 pi reactions containing 100- 
200 ng template DNA, 1.25 pi of forward and reverse primers, 12.5 pi Taq polymerase 
mastermix (BioMix Red; BioLine, UK) and dH20 to make up volume.
Primers Sequence 5’-3’ Location Annealing Temp Product size
FI
R1
AGGC A AGTCCTTCCTT ACGC 
CCGTTCCCCTG AACT AGA AA
Exon 1 60°C 341 bp
F2
R2
AAGTATTGGGGGTGGAGCTT
GCCACATGGTCACAAACAAG
Exon 2 63°C 571 bp
F3
R3
GTGTTTGCAGTGGGGTGAG
ACAAGCCCAGACAACAGTCC
Exon 3 63°C 660bp
FI-2 
Rl-2
CGCCCAGTCAGCAAGGTT
TCAGAGACTGGATGGGCTCT
Exon 1-2 60°C 1080bp
Fl-3
Rl-3
CCATGGCGAAGCTGTTCTAC
TCAGGACACTGGAGTTCAGG
Exon 1-3 60°C 622bp
Table 3.2. Oligonucleotide primers used to amplify Opa3 for exon and transcript sequencing.
PCR conditions had to be optimised for each primer pair. Samples were placed in a Techne 
thermocycler. PCR conditions for exon 1 (F1,R1), transcript 1-2 (F I-2, Rl-2) and transcript 1- 
3 (FI-3, Rl-3) were an initial denaturation of 95°C for 5 mins, followed by 35 cycles of 94°C 
for 30 secs, 60°C for 30 secs, 72°C for 30 secs, with a final extension of 72°C for 5 mins. For 
exon 2 (F2, R2) and exon 3 (F3, R3) PCR conditions were an initial denaturation of 95°C for 5 
mins, followed by 35 cycles of 92°C for 1 min, 63°C for 1 min, 72°C for 1 min, with a final 
extension of 72°C for 5 mins.
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The PCR products were purified for sequencing using QuickClean (Bioline). QuickClean is a 
method for removing proteins (such as restriction enzymes, polymerases, etc.), primers, 
primer-dimers and dNTPs. The protocol allows the precipitation of nucleic acids >75bp 
without the need for organic solvents, glass milk or expensive spin-columns. All PCR 
products were sequenced in forward and reverse to confirm the sequence.
Mouse exon alignments were performed by ClustalW2 [Larkin et al, 2007].
3.2.4 Sequencing of human OPA3
3.2.4.1 Individuals and Pedigrees
With appropriate ethical approvals, up to 74 British adult patients with optic atrophy but 
without OPA1 mutations, were screened for mutations in the OPA3 gene by direct genomic 
sequencing. A panel of up to 46 controls (92 chromosomes) was also assessed. All the 
patients had been previously analysed to exclude mutations in the OPA1 gene. The patients 
came from two groups: 1. Patients with ADOA from families too small for linkage data and 2. 
Individuals with presumed sporadic optic atrophy.
All of the patients studied were adults, over the age of 21 years, with a mean age of 43 years 
(range 24 to 66 years). Although none had formal audiometry or neuroimaging, none had any 
neurological symptoms or physical signs on clinical examination. Whilst it is possible that 
some of the patients may have had mild neurological deficits, it appeared unlikely. There was 
no sign of late-onset spasticity, extrapyramidal dysfunction or cognitive deficit. The clinical 
diagnosis of optic neuropathy was based on visual loss, colour vision defects including a 
tritan defect, temporal pallor of the optic disc and familial occurrence, where a family history 
was available. Visual fields and visual evoked potentials were documented where possible. 
Blood samples were obtained from patients, with informed consent, and genomic DNA was 
prepared from these samples using standard methods [Thiselton et al, 2002].
3.2.4.2 Sequencing o f OP A3
In order to reduce the probability of screening error the entire coding region of the OP A3 gene 
and associated intron-exon boundaries were sequenced by direct bi-directional sequencing of 
DNA from all individuals. PCR products were amplified from patient DNA using primers 
located in flanking intron and UTR sequences (Table 3.3.). Standard 50 pi PCR reactions
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were performed for direct sequencing using 100-200 ng template DNA, 50 mM KC1, 10 mM 
Tris pH 8.8, 15 mM MgCh, 1% Triton X-100, 0.2 mM each dNTP, 0.1 pM each primer and 
0.2 pi Taq polymerase (Bioline). Typical cycling conditions were initial denaturation of 95°C 
for 5 mins, followed by 35 cycles of 95°C for 30 secs, 54-60°C for 30 secs (temperature 
optimized for each primer pair), 72°C for 30 secs, with a final extension of 72°C for 5 mins.
Primers Sequence 5’-3’ Location Annealing Temp Product size
FI
R1
CGTACATACGTACTGACGCA
AAGCAACCACCTGACAGG
Exonl 55°C 317bp
F2
R2
TCCCAGAGCGCAGCCTGAC
GCCAAGTTGCATCAAGATCCT Exon2 54°C 555bp
F3a
R3a
GGGACATCGAAGCACAGAGG
ACGTCGCTCCTTTTCCTTGCG Exon3 60°C 285bp
F3b
F3b
TGCCTGATGCTGGAGTATTGG
AGGCCAAGACAGAGACTTCG
Exon3 60°C 323bp
Table 3.3. Oligonucleotide primers used to 
sequencing.
3.2.4.3 Mutation analysis
amplify Opa3 exons for mutation analysis
Sequence homologues were obtained by PSI-BLAST [Altschuler et al, 1997], and
homologues for the OP AS domain sequence were collected from the Pfam database (seed: 6, 
full: 59 sequences). Multiple sequence alignments were performed by ClustalW2. Structural 
disorder in the protein and the effects of mutations on disordered regions were studied using 
three predictors, DisEMBL [Linding et al, 2003a], GlobPlot [Linding et al, 2003b] and 
PONDR [Romero et al, 1997]. The wildtype sequences were compared to the polymorphic 
sequences. The effects of mutations on aggregation propensities were studied by TANGO 
[Femandez-Escamilla et al, 2004]. The damaging effects of point mutations were analysed 
using SNPs3D [Yue et al, 2006], PolyPhen [Sunyaev et al, 2001] and Pmut [Ferrer-Costa et 
al, 2005]. The effects of mutations on protein stability were predicted by SCpred [Dosztanyi 
et al, 1997]. No structural analysis could be performed, due to the lack of tertiary structure 
predictions for the OP A3 protein.
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3.2.4.4 Statistics
95% confidence intervals were calculated for control allele frequencies based on sample size. 
The analysis used a two-tailed estimation of significance. Hardy-Weinberg equilibrium 
(HWE) was also assessed using a y2 test for patient and control groups. The Hardy-Weinberg 
calculator (scienceforall.org/2010/06/.../hardy-weinberg-equilibrium-calculator/) was used for 
statistical analysis.
3.2.5 Bio-informatics analysis of the 5' region
As a part of efforts to understand the physiological functions of the Opa3 gene the 5' 
untranslated region of Opa3 was studied. Comparative genomics and pattern-recognition 
programs were used to characterise possible binding sites and to determine which TF could be 
relevant for Opa3 gene expression.
3.2.5.1 M ulan/M ultiTF  f o r  evolutionary conserved TFBS search upstream  o f  Opa3
The sequences from an evolutionary and taxonomically divergent range of species were 
aligned using Mulan (Fig 3.2.) to compare the Opa3 5' untranslated region to identify ECRs.
dog
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Figure 3.2. A phylogenetic tree generated by Mulan depicting the evolutionary relationship of 
the seven species used in analyses of Opa3 based on the similarities of their genomes. The open 
circles represent common ancestors, and the numbers represent nucleotide substitutions per one 
kilobase of genomic sequence.
The -5000 bp to +280 bp genomic sequence of mouse Opa3 was compared with the 
corresponding human, rat, dog, cow, macaca and chimp sequences. The region analysed was 
5 kb as this is the approximate distance between Opa3 and the upstream gene Grp4 in mouse. 
Mulan's graphical alignment used the mouse sequence as the reference. The results were
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submitted to MultiTF (multitf.dcode.org) to identify conserved TF consensus sequences. The 
"optimised for function" search option in multiTF was used which weights PWM differently 
by minimising and balancing out the abundance of false-negative hits from different matrices.
3.2.5.2 TFBS searches with other programs
With the large number of TFBS produced from predictive programs when the whole 5 kb 
upstream sequence was used it was decided to use only the sequences that are evolutionary 
conserved upstream of Opa3. As this infers possible functionality it is hoped to reduce the 
number of false positives. The sequence from the conserved regions found from the alignment 
of the seven species in Mulan was used as the input sequence for Genomatix software 
Matlnspector [Quandt et al, 1995] and TFsearch [http://www.rwcp.or.jp/papia/] with a core 
similarity cut-off value of > 0.9. PReMod Mouse Mar. 2005 assembly (mm6, Build 34) was 
used for genome-wide CRM predictions. The selection of programs and high stringencies 
were chosen to complement each other for a richer and more accurate prediction of TFs in the 
5' region.
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3.3 Results
3.3.1 Opa3 third exon and splice variant
Mulan analysis of the mouse and human Opa3 loci revealed the presence of a core ECR 
downstream of exon 2 (Fig 3.3.).
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Figure 3.3. Mulan sequence conservation profile for the human and murine Opa3 loci. The 
horizontal axis displays the input sequence. Core evolutionary conserved regions (ECRs, > 1 1 %  
identity; > 350 bp) are depicted as dark red bars above each pairwise alignment. Opa3 coding 
exons 1 and 2 (blue), intergenic elements (red) and intron sequence (pink) are marked and the 
vertical axis shows the percent similarity of the human Opa3 orthologue to the mouse sequence. 
A conserved intergenic region, upstream of exon 1 of the Opa3 gene, can be seen in red (in 
addition to the one downstream of exon 2 corresponding to exon 3).
To confirm that the conserved region is an exon of Opa3, RT-PCR was performed on cDNA 
from seven different tissues. Primer pairs spanning exons 1 to 2 and exons 1 to 3 yielded the 
expected product sizes in all tissue cDNAs, showing that the conserved region was indeed 
transcribed (Fig 3.4B.). Primer pairs spanning exons 2 to 3 did not yield a product in any 
cDNA sample indicating that exon 2 and 3 do not splice together (Fig 3.4B.). These results 
demonstrate that exons 2 and 3 are alternatively spliced. This produced two different 
transcripts that are ubiquitously expressed in all adult mouse tissues tested.
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Figure 3.4. RT-PCR showing tissue expression of alternately splice variants of murine Opa3 in a panel of tissues 
(eye, brain, liver, heart, skeletal muscle, kidney). (A) Schematic diagram of Opa3 gene showing the location of RT- 
PCR primers used to verify 3rd exon and splice variant. (B) Exon 1 splices to exon 2 giving a product of 310 bp 
(1+2), or to exon3 giving a product of 307 bp (1+3). Primers FI and R3 did not give rise to a transcript product of 
Exons 1+2+3 suggesting they do not splice together.
3.3.2 Revised genomic structure of murine Opa3
The nucleotide sequence results of the three exons were aligned with the genomic DNA 
sequences reported in Ensembl and both sequences agreed (Genomic DNA sequences in 
Ensembl are from the C57BL/6JCrl mouse). Forward and reverse sequences can be seen in 
Appendix II. RT-PCR confirmed that the EST downstream of Opa3 is a 3rd exon. Therefore, 
the revised structure of murine Opa3 now consists of three exons and produces two transcripts 
Opa3a (exonl-2) and Opa3b (exonl-3) (Fig 3.5.). The nucleotide sequences of mouse exon 2 
and exon 3 highly resemble each other, suggesting a common evolutionary origin (Fig 3.5.).
86
> > > > > > > > > > > > > > > > > > > > F 1  
E x o n l - 2  ATGGTGGTGGGCGCGTTCCCCATGGCGAAGCTGTTCTACTTGGGCATCCGGCAGGTTAGC 6 0 
E x o n l - 3 ATGGTGGTGGGCGCGTTCCCCATGGCGAAGCTGTTCTACTTGGGCATCCGGCAGGTTAGC 60  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
E x o n l - 2  AAGCCGCTGGCCAACCGTATCAAGGATGCTGCCCGCCGCAGCGAGTTCTTCAAGACCTAC 12 0 
E x o n l - 3 AAGCCGCTGGCCAACCGTATCAAGGATGCTGCCCGCCGCAGCGAGTTCTTCAAGACCTAC 12  0 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
E x o n l - 2  ATCTGCCTACCGCCAGCCCAGCTGTACCACTGGGTGGAGATGCGGACGAAGATGCGCATA 1 8 0  
E x o n l - 3 ATCTGCCTACCGCCAGCCCAGCTGTACCACTGGCTAGAGATGCGGACCAAGATGCGCATC 1 8 0  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  ★ * * * * * * * * * * *  * * * * * * * * * * *
E x o n l  -  2 ATGGGTTTCCGGGGCACTACCATCAAGCCACTGAATGAGGAGGCAGCAGCAGAGCTGGGT 24  0 
E x o n l  -  3 ATGGGCTTCCATGCTGAGGCCATCAAGCCACTGAATGAGGATGCAGCGGCTGAGCTGGGT 24  0 
* * * * *  *  *  *  *  *  * * * * * * * * * * * * * * * * * * * * * *  * * * * *  *  *  * * * * * * * * *
E x o n l  -  2 GCTGAGCTGCTGGGCGAGGCCACCATCTTCATTGTGGGCGGAGGCTGCCTGGTCCTGGAG 3 00  
E x o n l  -  3 GCGAACCTGCTGGGTGAAGCCATCATCTTTGCTGCTGCGGGCAGCTGTCTGCTGCTGGAG 3 00  
* *  *  * * * * * * * *  *  *  * * * ★  * * * * * *  * *  *  * *  * * ★ *  * * *  *  * * * * * *
R2 < < < < < < < < < < < < < < < < < < < <
E x o n l  - 2 TACTGGCGCCACCAGACTCAGCAGCGCAATAAGGAGGAGGAACAGCGGGCAGCCTGGAAC 3 6 0 
E x o n l - 3  TTCTGGCGCCAGAAGTCATCGAAACACCGCAGGGAAGTGGCGCAGGTGGC- - CACGGTGC 3 58  
*  * * * * * * * * *  * *  *  *  *  *  *  *  * * *  *  * *  * * *  * ★ *  *  * *  *
R3 < < < < < < < < < < < < < < < < < < < <
E x o n l - 2  GCTC- - TGCAGGATGAGGTGGGCCGCCTGGCACTGGCCTTAGAGGCGCTGCAGGCTCAGG 4 1 8  
E x o n l  - 3 TGTCGCTGCGGGAGGATGTGGAATACCTGGAGAACATGCTGGACGAGGTGCAGGTGCAGG 4 1 8  
* *  * * *  * * *  * *  * * * *  * * * * *  *  * *  *  *  * * * * * *  * * * *
E x o n l - 2  CACAAGCGA TGCCC----------- TCCTTGAGTGCCCTGGAGG AGCTGCGGGAGGAGC 4 66
E x o n l  - 3 TGCAGGCAGCATTGCCCAGGAACTCACTGGATGAGCTGCGGGCAGAGCTGCGGGCAGAGC 4 78  
* *  * *  * * * * *  * *  *  *  * *  * * *  *  *  * * * * * * * * *  * * * *
E x o n l - 2  TGCAGGAGGTGC - GTGGTCAGGTCTGCAA---------------- TGC---------------------TCA----------------  5 0 0
E x o n l  - 3 TGCGGGCGGAGCTGCGGACAGAGTTGCAAGCAGAGTTGCGGGCAGAGCTTCAAGATGAGC 53  8 
* * * * * * * * * * * * * * *  * * * * *  * * *  * * *
E x o n l - 2  ----------------------------------------------- CTGTA CTTCCAAGTGCCAGG-------------------------------  5 2 0
E x o n l  - 3 TACAGAAGTTCAGAACCCAGATCTGTAAAGATTGCTATGAGCCAGAGCTTAAGCCTGAAC 5 98
* * * * *  *  *  *  *  * * * * *
E x o n l - 2  - -  CAGCATCTT---------------- CCAAGAAATAG 54  0
E x o n l - 3  TCCAGTGTCCTGAGGCCCCCAAGGAGTAG 6 2 7  
* * *  * * ★  * * * * * * * * *
Figure 3.5. Comparison of murine Opa3a (exonl-2) and Opa3b (exonl-3) transcripts. 
Transcripts show an 81% sequence identity. Exonl is blue. Alternative second exons are in 
black. Red shows first stop codon in each transcript. Alignment was generated by the ClustalW2 
p rogram.means  that the residues or nucleotides in that column are identical in all sequences 
in the alignment. means that conserved substitutions have been observed, according to the 
colour table in CLUSTALW2. M.M means that semi-conserved substitutions are observed. FI, R2 
and R3 show position of primers for identification of splice variants in section 3.3.1.
Alignment of the amino acid sequences of the two transcripts (Fig 3.6.) show that the two 
proteins are 61% homologous and the protein sequences contain 96 mismatches.
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E x o n l -2  
E x o n l -3
MWGAFPMAKLFYLGIRQVS KPLANRIKDAARRSEFFKTYICL PPAQLYHWVEMRTKMR1 6  0 
MWGAFPMAKLFYLGIRQVSKPLANRIKDAARRSEFFKTYICLPPAQLYHWLEMRTKMRI 60
★ ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★it* . ★★★★★★★★
E x o n l - 2  
E x o n l - 3
MGFRGTTIKPLNEEAAAELGAELLGEATIFIVGGGCLVLEYWRHQTQQRNKEEEQRAAWN 12  0 
MGFHAEAIKPLNEDAAAELGANLLGEAIIFAAAGSCLLLEFWRQKS S KHRREVAQVATVL 12 0
E x o n l - 2  
E x o n l - 3
ALQDEVGRLALALEALQAQAQAMPSLSALEELR
SLREDVEYLENMLDEVQVQVQAALPRNSLDELRAELRAELRAELRTELQAELRAELQDEL 18  0
EEL 1 5 6
E x o n l - 2  
E x o n l - 3
QEVRGQVCN AHCTSKCQAASSKK- 17  9
QKFRTQICKDCYEPELKPELQCPEAPKE 2 0 8
Figure 3.6. Amino acid sequence alignment of murine Opa3a (exon 1-2) and Opa3b (exonl-3). 
Peptides show a 61 % sequence identity. Alignment was generated by the ClustalW2 
program."*" means that the residues or nucleotides in that column are identical in all sequences 
in the alignment. ":" means that conserved substitutions have been observed, according to the 
colour table in CLUSTALW2. "." means that semi-conserved substitutions are observed.
3.3.3 Murine Opa3 protein
The Opa3 protein is of unknown structure and function. NCBI Blast was used for a protein- 
protein homology search of Opa3. There were no homologies to any other proteins except to 
Opa3 like proteins in other species. There are no other proteins in the human genome that 
contain the domain (PFamA) and using the conserved domain architecture program CD ART 
to find sequences with similar conserved domains, none were found.
3.3.4 Sequencing of human OP A3 and mutation analysis
Of the human DNA samples sequenced 97.6% amplified well and were analysed successfully. 
From the screening of the three exons in human OP A3, seven polymorphisms were detected. 
These were: one polymorphism in exon 2 T>C (231 bp), three polymorphisms in exon 3 
which were C>T (227 bp), G>A (379 bp) and G>A (389 bp), two intronic polymorphisms in 
the 5' UTR sequence, which were -38 bp A>G (-38 bp) and -80 bp G>A (-80 bp) and one 
intronic deletion c. 143-23. The polymorphisms A>G (-38 bp) and T>C (231 bp) have 
previously been reported [Neas et al, 2005]. Therefore, five novel polymorphisms were 
identified (Fig 3.7.).
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Figure 3.7. Electropherograms showing the two genotype patterns for the OPA3 c.227 C>T 
p.A76V SNP in (A) the control patients (C/C) and (B) the affected patient (C/T). (C) Genomic 
organization of human OP A3 gene showing all previously reported polymorphisms above the 
genomic structure with bold text showing mutations that cause ADOAC and italic text showing 
mutations that cause MGA III. All polymorphisms found in this report from genetic screening of 
British adult patients with optic atrophy are shown below the genomic structure. Grey box - 
coding regions, White box- untranslated regions (not to scale).
Disease causing mutations are typically located at conserved positions within a protein family, 
since these positions are usually essential for the structure and/or function of the protein 
[Miller and Kumar, 2001; Mooney and Klein, 2002; Shen and Vihinen, 2004]. All four of the 
exonic SNPs are located in the OPA3 protein domain and variants 227C>T (p.A76V) and 
379G>A (p.G127S) are highly conserved in human, mouse, rat, chimp and dog, whereas 
variant 389G>A (p.G130E) and 231T>C (which is a silent polymorphism) are not conserved.
The introduction of charged and polar aa, as well as residues that may change the orientation 
of the main chain such as prolines, are likely to have a destabilising effect at these positions. 
All aa and their SNPs are neutral and non-polar except threonine (T) which is polar neutral.
The effect of mutations on structural disorder was investigated by three different methods 
(Globplot, DisEMBL and PONDR). None of the exonic mutations were predicted to increase
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disorder by any of the programs except DisEMBL which showed that the p.A76V 
polymorphism created a new loop at peptides 65-73. Loops/coils are not necessarily 
disordered, however protein disorder is only found within loops. TANGO showed that none 
of the mutations increased propensity for beta aggregation.
The damaging effects of point mutations were analysed by PolyPhen and Pmut, which both 
predicted all changes to be benign. SNP3D was also used for prediction of deleterious 
mutations, and this predicts that mutation p.A76V will decrease protein stability but that 
p.G127S and p.G130E do not. SCpred, which evaluates the effect of mutations on protein 
stability, predicted p.A76V and p.G127S were in centres of stabilisation, but that p.G130E 
was not.
On balance, the 227C>T (p.A76V) sequence change is the only potential disease causing 
mutation. However, since the tertiary structure of OPA3 is unknown this bio-informatics 
inference is speculative. The frequency of this change in our panel of normal chromosomes is 
0 (Table 3.4.), but it is not possible to carry out 227C>T (p.A76V) segregation analysis in 
order to support the pathology of the mutation since the patient identified is a sporadic case of 
optic atrophy.
A goodness-of-fit y l  test was used to test for Hardy-Weinberg Equilibrium (HWE) by 
comparing the observed number of subjects for each genotype with the expected number of 
subjects assuming HWE. Some of the control and patient groups depart from HWE (Table 
3.4.). Departure from HWE may indicate sequencing errors or factors that disrupt HWE such 
as small N number.
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cDNA change Allelic Frequency 
Patients Controls 
N (frequency) N (frequency)
Statistics HWE 
Patients Controls
95% Cl for 
control alleles
c.-80 G>A G: 19/22 (0.86) 
A: 3/22 (0.14) 
G/A: 0
G: 45/50 (0.9) 
A: 5/50 (0.1) 
G/A: 0
P=0.00 P=0.00
G: 90 ± 8.32% 
A: 10 ±8.32%
c.-38 A>G A: 19/22 (0.86) 
G: 0
A/G: 3/22 (0.14)
A: 39/50 (0.78) 
G: 1/50 (0.02) 
A/G: 10/50 (0.2)
P=0.73 P=0.22
A: 78± 11.48%
G: 2 ± 3.88%
A/G: 20 ± 11.09%
c.231 T>C T: 3/21 (0.14)
C: 4/21 (0.19) 
C/T: 14/21 (0.67)
T: 5/50 (0.1)
C: 10/50 (0.2) 
C/T: 35/50 (0.7)
P=0.12 P=0.003
T: 10 ± 8.32%
C: 20 ± 11.09% 
C/T: 70 ± 12.7%
c. 143-23 del CT WT: 61/74 (0.82) 
Het: 12/74 (0.16)) 
Homo: 1/74 (0.02)
WT: 76/92 (0.83) 
Het: 14/92 (0.15) 
Homo: 2/92 (0.02)
P=0.64 P=0.18
WT: 83 ± 7.68% 
Het: 15 ±7.3% 
Homo: 2 ± 2.86%
c.227 C>T T: 0
C: 73/74 (0.98) 
C/T: 1/74 (0.02)
T: 0
C: (92/92) (1) 
C/T: 0
P=0.95 —
c.379 G>A A: 0
G: 73/74 (0.98) 
G/A: 1/74 (0.02)
A: 0
G:92/92 (1) 
G/A: 0
P=0.95 —
c.389 G>A A: 0
G: 73/74 (0.98) 
G/A: 1/74 (0.02)
A: 0
G:92/92 (1) 
G/A: 0
P=0.95 —
Table 3.4. Allelic frequencies of the OP A3 gene in patients with optic atrophy and health controls. HWE= Hardy Weinberg Equilibrium. If the p- 
value obtained is higher than 0.05 then the sample respects the equilibrium and is a good example of the whole population. CI= confidence interval, 
WT= wildtype, Het= heterozygote and Homo= Homozygote.
3.3.5 The evolutionary conservation of regions upstream of Opa3  exon 1
Multi-species Mulan conservation analysis of exon 1 and the 5 kb region upstream of Opa3 
revealed three discrete elements of non-coding ECRs that are conserved in all seven 
vertebrate lineages (Fig 3.8.) when using a >100 bp and >70% identity cut off, the classically 
defined stringency for the identification of functional mammalian regulatory elements 
[Pennacchio and Rubin, 2001]. These three elements are: -3538 bp to -3236 bp, -1326 bp to - 
1015 bp and -420 bp to -143 bp. When using a more stringent cut off (>200 bp and 77% 
identity) only the -1326 bp to -1015 bp region remains.
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Figure 3.8. Standard stacked-pairwise visualization (smooth graph) of Mulan alignments of 
murine Opa3 loci with 6 orthologous species. The mouse sequence was selected as the reference 
sequence. The horizontal axis displays the input sequence which was -5000bp to +280bp. The 
graphical representations of the other sequences are displayed according to their similarity to 
the base sequence: the closer they are to mouse, the higher is the conservation. Evolutionary 
conserved regions set as (ECRs >70% identity, >100bp. Lower ECR cut off was 60%). Figure 
shows regions of conserved sequence that are present in all species. Colour density by 
interspecies conservation (the darker the colour the more species the conserved region is in). 
Red indicates regions upstream of exon 1. Blue region shows conservation of Opa3 exonl 
sequence.
To assess if any of the ECRs are exons of OP A3 all upstream human ESTs between OP A3 
and GRP4 (of which there are three: DW461756, DW420344 and DW461531) were aligned 
with the 5 kb upstream sequence of human OP A3. None of the ESTs aligned with the 
conserved regions and do not overlap with OP A3 at the mRNA level, suggesting they are not
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exons of OP A3. However, DW414756 does have a small ORF and upstream ORFs of a gene 
are known to influence translation [Chatterjee and Pal, 2009] and therefore could potentially 
have a regulatory effect on the expression of OP A3.
3.3.6 Analysis of the Opa3 gene proximal sequence using phylogenetic footprinting and 
TRANFAC PWM searches
The results produced 53 TFBS’s (Table 3.5.) in the mouse Opa3 5 kb upstream region and 
consequently suggest many putative regulatory proteins that could potentially modulate Opa3 
expression.
Mulan alignment between mouse and the six other mammalian species showed nine multi 
conserved TFBSs all of which, except RBP-JK, were clustered in the most conserved region 
of -1326 bp to -1015 bp. Genomatixs’ Matlnspector found six TFBS’s in the conserved 
regions and TFSEARCH identified 18. PReMod produced four CRM’s, two were upstream 
and two downstream of Opa3. The two CRM’s upstream of Opa3 predicted 29 TFBS’s.
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TFBS
Official
mouse
Symbol
Bioinformatic
Program
NCBI 
Gene ID
P53 & P53 decamer Trp53 Mulan, Genomatix, PReMod 22059
HFH8 Foxfla Mulan , PReMod 15227
FoxOl Mulan, PReMod 56458
Fox04 Mulan, PReMod 54601
XFD1 Mulan, TFsearch
VDR Mulan, PReMod 22337
OLF1 EBF1 Mulan 13591
RBPJK Rbpj Mulan 19664
CRE-BP Atf2 TFsearch, PReMod 11909
CREB Crebl TFsearch, PReMod 12912
SP1 Genomatix, 20683
AP2F Tcfap2a Genomatix, 21418
CAAT Genomatix
EBOX Genomatix
E2F1 Genomatix 13555
Oct-01 Pou2fl TFsearch 18986
SRY TFsearch 21674
Stat TFsearch
HLF TFsearch 217082
Gata 1 TFsearch 14460
Gata2 TFsearch 14461
Gata3 TFsearch 14462
NRF2 Nfe212 TFsearch 18024
MZF1 TFsearch 109889
C/EBP a TFsearch 12606
C/EBP b TFsearch 12608
TFBS
Official
mouse
Symbol
Bioinformatic
Program
NCBI 
Gene ID
Ami-la Runxl TFsearch 12394
v-MYB TFsearch 17863
Nkx 2 TFsearch
S8 Prrx2 TFsearch 20204
Tel2 Telo2 PReMod 71718
E4F1 PReMod 13560
Pax2 PReMod 18504
Pax3 PReMod 18505
Pax4 PReMod 18506
Pax8 PReMod 18510
HfHl Foxql PReMod 15220
GR Nr3cl PReMod 14815
Freac-7 Foxll PReMod 14241
ATF PReMod
ATF3 PReMod 11910
ATF4 PReMod 11911
ATF6 PReMod 226641
TCF11 Nfe211 PReMod 18023
Cartl A lxl PReMod 216285
E4BP4 Nfil3 PReMod 18030
ChxlO Vsx2 PReMod 12677
Muscle initiator PReMod
Muscle initiator 19 PReMod
Muscle initiator 20 PReMod
PolyA downstream element PReMod
Cre-bpl/c-jun PReMod
Table 3.5. Putative TFBSs identified upstream of Opa3 using t 
official mouse symbol was added where they differed from the TFBS gene name given in the databases. NCBI gene IDs were omitted 
where they were unknown.
3.4 Discussion
3.4.1 Alternate splicing of Opa3
The Opa3 gene was previously believed to contain 2 exons and produce one transcript. The 
results here demonstrate that the murine Opa3 gene consists of three exons which produce 
two transcripts, similar findings were recently reported in human [Huizing et al, 2010]. The 
2nd transcript consists of the common exon 1 spliced directly to a third exon and skipping 
exon 2 altogether. No transcript was found containing all 3 exons. Exon 3 is conserved in all 
other species studied (mouse, human, rat, cow, dog, macaca and chimp) and closely resembles 
exon 2 suggesting a duplication event. Both isoforms are naturally expressed in a variety of 
tissues and are highly conserved between human, mouse and orthologs in other vertebrate 
species. The third exon of Opa3 was found to be expressed in heart, lung, muscle, brain, 
kidney, liver and eye tissue of adult C57BL/6JCrl wildtype mice. This revised intron-exon 
structure spans around 27 kb of genomic DNA, adding approximately 8 kb to the previously 
defined region.
Recent quantitative PCR assessment by Kate Powell, Cardiff University of the relative 
expression of isoform a to isoform b in wild type and homozygous mutant Opa3 A mice at P7 
and P30 shows that transcript b is expressed at less than ten-fold levels compared to transcript 
a in lens or retina, and that the presence of the mutation does not disturb this ratio. OPA3A 
deficiency in patients causes up-regulation of OPA3B in MGA-III patients [Huizing et al, 
2010].
3.4.2 Determination of OPA3 genetic variants in patients with optic atrophy
The three intronic and the exon 2 polymorphisms reported in this study were found with 
comparative frequencies in 50 unrelated control chromosomes from patients from the UK. 
This, together with the bio-informatic analysis, predicts that they do not change functionally 
important residues and are benign. The exon 3 polymorphisms were only found in one patient 
and in none of the unrelated control chromosomes. Polymorphisms G>A (379 bp) and G>A 
(389 bp) are unlikely to affect protein structure, while the polymorphism C>T (227 bp) may 
potentially be disease causing but as the protein structure of OP A3 is unknown and there are 
no other members of the protein family, results are inconclusive. We thus report five novel 
sequence changes in the OP A3 gene.
The absence of homozygous or heterozygous mutations in the OPA3 gene in this group of 
patients suggests that the optic atrophy seen in a cohort of patients without OPA1 mutations is 
not commonly caused by mutations in the OP A3 gene. The heterozygous mutation in OP A3 
reported by Anikster et al, [2001], may be excessively rare in an out bred population, such as 
that from the UK. Both Anikster et al, [2001] and Ho et al, [2008], suggest that OP A3 
mutations should be sought in samples from patients with optic atrophy which are atypical for 
the recessively inherited condition OP A3.
The sequence changes reported do not affect the coding region of the OPA3 gene. In 
particular, the 22 highly conserved aa of OP A3 (aa 10 to 32) at bp 28 to 91 are not affected. 
This region contains the mitochondrial targeting peptide, NRIKE, at aa residues 25-29. The 
sequence changes detected are not predicted to alter the splice sites. The mutation detection 
rate for sequence based screening is the highest of all methods currently in use. In this study 
direct bidirectional sequence analysis was performed in an attempt to avoid screening errors.
3.4.3 Mutations of OP A3
Mutations in OPA3 can cause diseases with recessive as well as dominant modes of 
inheritance. This bimodal effect of OP A3 mutations is not common but is also not unique. In 
general, disorders that have both dominant and recessive modes of inheritance are caused by 
mutations at different gene loci.
In Costeff syndrome autosomal recessive loss-of-function OP A3 mutations lead to severe 
multisystem disease with optic atrophy, 3-methylglutaconic aciduria, and psychomotor 
retardation [Anikster et al, 2001; Kleta et al, 2002]. The complete loss of OP A3 expression as 
a result of both copies of the OP A3 gene carrying a mutation results in a disorder that has a 
recessive mode of inheritance. Indeed, all cases of MGA-III described to date have been 
caused by homozygous mutations IVS1-1G>C or c.320_337del or the nonsense mutation we 
have identified (p.Q139X), and all of which are predicted to abolish all protein activity. 
However, heterozygous parents of patients with Costeff syndrome are not affected by optic 
atrophy or cataract, suggesting that haploinsufficiency of the OP A3 gene might have milder 
effects.
However, a different mode of inheritance of optic atrophy was reported by Reynier et al, 
[2004], whereby OP A3 mutations were responsible for ADO AC in two of the families 
studied. The two missense mutations p.G93S and p.Q105E segregated with disease in each
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family and were absent in healthy relatives and normal controls. Therefore, for ADOAC only 
one copy of OPA3 needs to carry a missense change, which probably exhibits a dominant 
negative effect but manifests as a milder phenotype. It appears therefore that either complete 
absence of OPA3 protein or an abnormal peptide will lead to disease.
3.4.4 Using TFBS as an insight into Opa3 function
During the analysis of the 53 predicted TFBS upstream of Opa3 several common functional 
themes emerged. Many of the TFs are involved in (1) retinal development and neuron 
development/survival, (2) cellular stress response/apoptosis, (3) bone/craniofacial 
development and (4) adipogenesis (see Table 3.6.).
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TFBS Neuronal / 
Retinal
Cellular stress 
response/Apoptosis
Craniofacial/
Bone
Adipogenesis
P53 & P53 decamer + + + +
CRE-BP + + + +
AP2F + + + +
CREB + + + +
Stat + + +
Oct-01 + +
Pax2 + + +
AML-la + +
ChxlO + +
RBPJK + +
Gata3 + +
FoxOl + + +
E2F1 + + +
Fox04 + +
C-EBP a+b + +
NRF 2 + +
MZF1 +
VDR + +
OLF1 + +
SP1 + +
Pax 3 + +
ATF(inc 3,4,6) +
Cartl +
HFH8 +
Gata2 +
GR +
Table 3.6. List showing common functional themes in the TFBSs found upstream of Opa3 and 
which TFBSs are known to play a role in these processes. TFBS were omitted where no evidence 
was found for their involvement in any of the functional themes listed.
Interestingly, these functional themes coincide with many of the phenotypic aspects observed
U 2 2 P  •in our mouse model (B6; C3-Opa3 [Davies et al, 2008]. The homozygote mice have 
reduced visual acuity consistent with the thinning of various retinal layers and a significant 
reduction in RGCs, extending to a distinct degeneration of axons within the optic nerve. 
Magnetic resonance imaging (MRI) scans show a considerable lack of visceral adipose tissue 
and the phenotype shows clinically apparent dysmorphic features in the bones of the head.
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3.4.4.1 Retinal development and neuron development/survival.
Adult Opa3 homozygote mice have a significant loss of cells from the retinal ganglion 
cell/nerve fibre layer and inner nuclear layer. Many of the predicted TFBSs upstream of Opa3 
(Table 3.6.) are known to be expressed in the retina. For example, during retinogenesis, all 
STAT (Signal Transducers and Activator of Transcription) proteins are expressed in the 
neuronal retina in distinct cell populations at different embryonic stages. Other proteins 
expressed during retinogenesis are Runxl, a novel marker for a restricted amacrine cell 
subtype and the homeobox gene CHX10 which is required for retinal progenitor cell 
proliferation early in retinogenesis and subsequently for bipolar neuron differentiation. RBP- 
JK is a key mediator of Notch signalling and this Notch signalling pathway is important at 
several stages of retinal development including the differentiation of RGCs and Muller glia. 
Mutant mice with reduced CREB expression show loss of refinement of retinogeniculate 
projections. Oct-1 is co-expressed with Sox2 and Pax6 during lens and nasal placode 
induction and during subsequent developmental stages. Other TFs are known to be involved 
in regulation of neuron development and survival e.g. GAT A binding protein 3 (GATA3).
3.4.4.2 Cellular stress response/Apoptosis
Previous studies have indicated that OP A3 may play a role in promoting increased cell death. 
Reynier et al, [2004] showed that human fibroblasts carrying the 227G>A (G93S) mutation 
were more susceptible to apoptosis induced by staurosporine than wildtype counterparts. The 
cellular stress response is a defence reaction of cells to damage that environmental forces 
inflict on macromolecules. In addition, cells can quantify stress and activate a death program 
(apoptosis) when tolerance limits are exceeded.
Some of the TFs identified here are involved in apoptotic response to DNA damage, such as 
Oct-1, E2F1 and STAT-1, which interacts with p53 to enhance DNA damage-induced 
apoptosis. FOXOl and FOX04, are implicated in the regulation of a variety of cellular 
processes, including the cell cycle, apoptosis, DNA repair, stress resistance, and metabolism. 
Pax3 is involved in anti-apoptotic cell survival. The Nrf2 transcription factor plays a key role 
in the cellular defense against oxidative and xenobiotic stresses through its capability to 
induce the expression of genes which encode detoxifying enzymes and antioxidant proteins.
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3.4.4.3 Bone/Craniofacial Development
The Opa3 homozygote mice are smaller than their wildtype littermates even during 
embryogenesis [Davies et al, 2008]. They show dysmorphic facial features and suffer from 
overgrown teeth possibly from a misalignment of the jaw. These phenotypes are suggestive of 
defects in bone and craniofacial development. Of the TFs identified to associate with Opa3 in 
this study a number are involved in wide ranging aspects of bone and craniofacial 
development.
Genes involved in craniofacial development can be categorised by their malformations: (A) 
Neural-tube defects, which are described as exencephaly when they occur in the cranial 
region, for example mice that are null for Pax3 (paired box gene 3); Tcfap2a (transcription 
factor AP-2a) and Cartl (cartilage homeoprotein 1). (B) Mice null for Pax2, ChxlO and AP-2 
show sensory organ defects, usually of the eye or ear. (C) Neural-crest defects which affect 
neural-crest specification, migration, proliferation and epithelial-mesenchymal induction. 
This large group includes many members of the Prrx (Paired-related) homeodomain families 
and Pax3. (D) Other TFs involved in skeletal development, e.g., ATF-2 mouse mutants have 
been shown to display chondrodysplasia and neurological abnormalities [Reimold et al, 1996] 
or Runxl which is expressed in various types of bone formation. The pattern of Runxl 
expression suggests that it could be potentially involved in incipient intramembranous bone 
formation during craniofacial development.
3.4.4.4 Adipogenesis
Many of the predicted TFs are proteins known to be involved in adipogenesis (the 
development of fat cells from preadipocytes). Interestingly, MRI scans of our Opa3 mouse 
model [Davies et al, 2008] show a striking lack of visceral adipose tissue in the Opa3 
homozygotes. Adipogenesis is a complex process that involves the integration of many 
different signalling pathways and TFs. The coordinated action of the peroxisome proliferator- 
activated receptor (PPAR) and the CCAAT/enhancer binding protein (C/EBP) family of TFs 
regulate the adipocyte differentiation program. C/EBP can induce many adipocyte genes 
directly, and in vivo studies indicate its important role in the development of adipose tissue. 
Other pro-adipogenic proteins include EBF1, which stimulates adipogenesis in NIH-3T3 
fibroblasts, STAT5a [Floyd and Stephens, 2003] and CREB [Zhang et al, 2004].
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By contrast, many TFs are anti-adipogenic including several members of the GATA-binding 
and forkhead families. Murine GATA-2 and GATA-3 are specifically expressed in white 
adipocyte precursors and their down-regulation sets the stage for terminal differentiation. 
Foxol inhibits adipogenesis at least partially by repressing PPARy gene transcription 
[Armoni et al, 2006]. Spl mediates repression of the C/EBPa promoter [Tang et al, 1999]. 
VDR, P53 and NRF2 are also known to inhibit adipogenesis.
The disease-related TFBS clusters described mirror major phenotypic features seen in the
i i  22p
B6;C3-Opa3 mouse. Identification of such TFBS may provide important future insight 
into factors which regulate Opa3 gene transcription, elucidating its transcriptional rules and 
providing important further clues to the function of the Opa3 protein.
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3.5 Conclusions
- Opa3 is a 3 exon gene where exons 2 and 3 are alternately spliced to produce two transcripts 
both of which are expressed in a wide variety adult mouse tissue and throughout embryonic 
development. Full characterisation of Opa3 may prove valuable for elucidating function and 
will be useful for carrier detection, genetic counselling, and for detecting mutations in 
individuals with optic atrophy.
- Five novel polymorphisms have been identified in humans, of which one may potentially be 
disease causing.
- Opa3 shows conservation between species but has no homology to any other known 
proteins.
- 53 TFBS have been identified which may be responsible for control of Opa3 expression and 
these fall into four functional categories: retinal development and neuron development 
/survival; cellular stress response/apoptosis; bone/craniofacial development and adipogenesis. 
These themes support studies of our mouse model, as they coincide with observed phenotypes 
of mice homozygous for the Opa3 mutation and are in line with the phenotypic features in 
patients with MGA-III. These TFBS provide useful clues as to the function of the Opa3 
protein and suggest new areas of research into the pathophysiology of MGA-III and optic 
atrophy.
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CHAPTER 
IV
Genotype/phenotype correlations and development of 
the mutant B6; C3- Opa3U22P mouse line
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4.1 Introduction
Aims of Chapter
« * 22p
-T o  develop the B6; C3-Opa3 mutant mouse on an appropriate background strain and
generation that minimises phenotype variability and with an appropriate severity that allows 
for ease of analysis of disease phenotype.
- Assess gross morphological defects and tissue pathology in adult homozygote and wildtype 
mice.
-T o  dissect at a range of embryonic time points to look for any pathology and embryonic 
lethality.
- Analysis of craniofacial dysmorphia observed in homozygotes and heterozygotes.
The mouse is an ideal model organism for the study of human disease. The similarities 
between the mouse and human are striking; both the mouse and human genomes are 
approximately the same size, both contain the same number of genes, both show an extensive 
conserved gene order and conserved gene function and mice are physiologically similar to 
humans.
A large genetic reservoir of potential models of human disease has been generated through the 
identification of >1000 spontaneous, radiation or chemically induced mutant loci. In the vast 
majority of these models, the mouse mutant phenotype very closely resembles the human 
disease phenotype and these models therefore provide valuable resources to understand how 
diseases develop.
  T 1 "?9PThis chapter deals with the development of the B6; C3-Opa3 mutant mouse on two
background strains and assesses gross morphological defects in adult, embryo and tissue 
pathology. Since there are no reports of craniofacial and skeletal anomalies in the 
corresponding human conditions, one of the aims was to characterise these malformations in 
this mouse model.
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4.1.1 Generation of Opa3 mutant mice: the L122P mutation.
The Opa3 mouse model was created by screening a panel of over 10,000 ENU mutagenised 
C3H mouse sperm DNAs for mutations in Opa3 by sequencing exons 1 and 2 of Opa3. This 
was carried out for our laboratory by Ingenium Pharmaceuticals (www.ingenium-ag.com). A 
heterozygous missense mutation was found in exon 2 coding for T to C transition at position 
365 in the open reading frame (c.365T>C) which changes a leucine into a proline within the 
peptide (Fig 4.1.).
MVVGAFPMAKLFYLGIRQVSKPLANRIKDAARRSEFFKTYICLPPAQLYHWVEMRTK
MRIMGFRGTTIKPLNEEAAAELGAELLGEATIFIVGGGCLVLEYWRHQTQQRNKEEE
QRAAWNALtoPQDEVGRLALALEALQAQAQAMPSLSALEELREELQEVRGQVCNAH
CTSKCQAASSKK
Figure 4.1. Peptide sequence of Opa3 showing the L122P mutation in exon 2. L= leucine 
(wildtype), P= proline (mutant)
The mutation is not the same as any of the published human disease causing mutations, but is 
highly predicted to be disease causing. The missense mutation affects an aa which is very 
highly conserved across human, mouse, rat and even insects and plants. The exon 2 mutation 
is located in a long helical secondary structure region, and the introduction of a helix breaking 
proline severely changes the predicted tertiary structure of the protein. Opa3 mRNA was 
present in all mouse tissues examined and its transcription was unaffected by the presence of 
the mutation [Davies et al, 2007]
Sperm were used (in vitro fertilisation with C57BL/6J females) to generate heterozygous 
hybrid Opa3+l~ ‘founders’ (the B6; C3-Opa3Ll22P mouse line). For ease of writing the 
nomenclature, homozygote mice throughout this thesis are referred to as Opa3~', 
heterozygotes as Opa3+l~ and wildtypes as Opa3+l+.
4.1.2 Strain background disease characteristics
When using an inbred strain for the phenotypic characterisation of a chosen mutation it is 
important to be aware of any background diseases that the strain might carry so as not to 
confuse them with any induced genetic defects. There are four types of background diseases 
that could influence ocular phenotypes; (i) systemic diseases that might affect the eye, (ii)
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known genetic defects, (iii) congenital abnormalities that might be polygenic and (iv) 
susceptibility genes that alter the response to an external stimulus.
The ‘founder’ mice were a hybrid of C57BL/6J and C3H/HeJ mouse strains. The ‘founders’ 
were bred to more congenic backgrounds on both of these strains.
4.1.2.1 C3H/HeJ Strain
C3H/HeJ mice are used as a general purpose strain in a wide variety of research areas 
including cancer, immunology and inflammation, sensorineural, and cardiovascular biology 
research. C3H/HeJ mice are homozygous for the retinal degeneration 1 mutation (Pde6brdl), 
which causes blindness by weaning age. There is also a high incidence of hepatomas in C3H 
mice. Despite the lack of exogenous mouse mammary tumor virus, virgin and breeding females 
may still develop some mammary tumors later in life. C3H/HeJ mice spontaneously develop 
alopecia areata at a reported incidence of approximately 0.25% by 18 months of age.
A spontaneous mutation occurred in C3H/HeJ at lipopolysaccharide response locus (mutation 
in toll-like receptor 4 gene, Tlr4Lps-d) making C3H/HeJ mice endotoxin resistant. C3H/HeJ 
(Tlr4Lps-d) mice are highly susceptible to infection by Gram-negative bacteria, such as 
Salmonella enterica. The C3H/HeJ substrain is homozygous for an inversion on Chromosome 
6 named In(6)lJ. The inversion covers 20% of Chromosome 6 between D6Mitl24 (-30.3 cM) 
and D6M itl50 (-51.0 cM) but has no apparent effect on phenotype.
The C3H/HeJ mice used by Ingenium carry the Pde6brdl mutation which would affect the 
retinal phenotype. Therefore, R d l allele-specific PCR genotyping was used to direct breeding 
with wild-type C57Bl/6JCrl and the removal of the Rdl allele of PdeB (carried by the C3H
L 1 2 2 Ppaternal line) was thus ensured. For breeding the Opa3 mutation to a more congenic 
C3H/HeJ background a C3H strain from Medical Research Council (MRC), Harwell that does 
not carry the Pde6brdI mutation was used.
4.1.2.2 C57BL/6J Strain
C57BL/6J mice have been widely used as an inbred control strain in many studies. However, 
they also represent an important model of diet-induced diabetes, and they exhibit glucose 
intolerance, which is independent of obesity. Blood glucose levels of non-obese C57BL/6J
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mice, measured using an intraperitoneal glucose tolerance test, reveal that plasma glucose 
levels rise much higher and take longer to regain the resting level than in other mouse strains.
The C57BL/6J mouse has a deletion of the nicotinamide nucleotide transhydrogenase (Nnt) 
gene on chromosome 13, a nuclear-encoded mitochondrial protein involved in p-cell 
mitochondrial metabolism. This deletion is an in-frame five-exon deletion in Nnt that removes 
exons 7-11. This results in a complete absence of Nnt protein in these mice.
Nnt is located in the IMM and involved in p-cell mitochondrial metabolism. It was therefore 
thought prudent to genotype the mice for Nnt and breed the mutation out of the colony as Opa3 
is also thought to be expressed in the IMM.
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4.2 Materials and Methods
4.2.1 Mouse strains and husbandry
The founder mice were 50:50 C3H/C57BL/6J hybrids originating from the screening of Opa3 
by Ingenium Pharmaceuticals as outlined in section 4.1.1. The colony was maintained by 
crossing mice heterozygous for Opa3 (genotyped by PCR) to C57BL/6JCrl (Charles River, 
UK) or C3H/HeJ (MRC, Harwell) mice to create two separate lines on different backgrounds. 
Opa3+/ mice at each generation were inter-crossed to obtain homozygous Opa3''' mice for 
analysis. Mice used in this study were from generation 1 (G l) (strain background 50:50 
C3H/C57BL/6JCrl), generation 3 (G3) (background approx 95% C57BL/6JCrl or C3H/HeJ) 
and generation 4 (G4) (background approx 97.5% C57BL/6JCrl or C3H/HeJ).
Mice were housed in hard bottomed polypropylene experimental cages in groups of same sex 
siblings with mixed genotype. Lighting was controlled on a 12 hr light: 12 hr dark cycle and all 
mice were tested during the light phase. The housing facility temperature was maintained at 
21°C and the relative humidity was also controlled at 60%. The mice had ad libitum access to 
water and standard dry laboratory food.
4.2.2 Genotyping offspring
All mice were genotyped for Opa3 and initially for Rdl and Nnt.
4.2.2.1 Opa3 genotyping
Opa3 PCR genotyping was carried out to distinguish wildtype and mutant alleles using a 
forward primer mOPA3 exon 2: 5'-GGACGAAGATGCGCATAATGG-3! and a reverse 
primer mOPA3 exon 2: 5'-GTACAGTGAGCATTGCAGACC-3'. PCR amplification was
performed in 25 pi reactions containing 0.2 mg genomic DNA, 20 pmol of forward and reverse 
primers, lOmM Tris-Hcl pH 8.3, 50 mM KC1, 1.5 mM MgCU, 200 pM of each dNTP and lpl 
of Taq DNA polymerase (Bioline). The samples were placed in a Techne thermocycler for 35 
cycles of 1 min denature at 92°C, 1 min anneal at 63°C and 1 min extension at 72°C with a 
final extension at 72°C for 5 mins. This provided a product size of 343bp. An enzyme digest 
using Pstl enzyme (sequence CTGCAG; lOpl) on the 343bp product from the wild type (T 
allele) provides a major product of 205bp and on the recessive type (C allele) it provides a 
major product of 247bp ( Fig 4.2.).
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Hyperladder IV
300bp -----
200bp -----
lOObp -----
•247bp
•205bp
Figure 4.2. Agarose gel of PCR products for genotyping the Opa3 colony 
4.2.2.2 R d l  gen o typ in g
Rdl genotyping was carried out as a multiplex reaction, with the following three primers in 
equal combination: RD3: 5'-TGACAATTACTCCTTTTCCCTCAGTCTGA-3', RD4: 5'- 
GTAAACAGCAAGAGGCTTTATTGGGAAC-3', and RD6: 5'-TACCCACCCTTCCTAA 
TTTTTCTCAGC-3' [Gimenez and Montoliu, 2000; Qiao et al, 2003]. The samples were 
placed in a Techne thermocycler for 35 cycles of 30 secs denature at 95°C, 30 secs anneal at 
55°C and 30 secs extension at 72°C with a final extension at 72°C for 5 mins. The wild type 
Rdl allele was 300bp and the mutant allele was 450bp (Fig 4.3.) [Davies et al, 2007].
R d l +/+ +/+ +/- +/+ -/-
Figure 4.3. Mouse genotyping for selection of R d l +/+ and R dl + /- mice by multiplex PCR for 
R dl alleles. The wild-type fragment is 300 bp and the mutant allele is 450 bp.
4.2 .2 .3  N n t genotyp ing
Mice were genotyped by PCR for missing Nnt exons 7 to 11. Primers for Nnt exon 7 are: 
NntXn7 forward: 5'-GTGCATTGAACCCTCAAAGG-3' and NntXn7 reverse: 5'-
CAGGTAAGAAAGCTCCTGTTTT-3' [Freeman et al, 2006]. Primers for Nnt exons 6-12 are: 
Nnt6L4 forward: 5'-TCCCCTCCCTTCCATTTAGT-3' and Nntl2Ll reverse: 5'-
GTAGGGCCAACTGTTTCTGC-3' [Huang et al, 2006].
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The samples were placed in a Techne thermocycler for an initial denature of 10 mins at 95°C 
then 35 cycles of 30 secs denature at 94°C, 30 secs anneal at 60°C and 30 secs extension at 
72°C with a final extension at 72°C for 5 mins.
A 547bp product for exon 6-12 primers indicate that exons 7-11 of the Nnt gene are missing 
(genotype is -/-) (Fig 4.4A.). A 250bp product for exon 7 indicate that at least one allele is 
present (genotype can be +/+ or +/-) (Fig 4.4B.). From these two results the genotype of a 
mouse can be deduced.
Figure 4.4. PCR genotyping for selection of Nnt +/+ mice. (A) Product for exon 6-12 primers 
indicates presence of deletion in at least one allele of Nnt (genotype can be -/- or +/-). (B) Product 
for exons 7 indicate that at least one allele is present (genotype can be +/+ or +/-).
All PCR products were visualized on a 2% agarose gel run at 120V.
4.2.3 Histology of mouse tissues on C57BL/6JCrl and C3H background strains
Tissues from G3/4 adult C57BL/6JCrl and C3H mice (O p a 3 n=3, Opa3+l+ n=3) were taken at 
30 days old to assess for abnormal pathology. Retina, heart, lung, liver, kidney and muscle 
were taken from homozygote and wildtype animals and placed in 4% PFA. The tissues were 
fixed, dehydrated and processed as per protocols in Chapter II.
4.2.4 Embryology
Animals were paired/ mated and plugging was recorded. Embryos were collected and 
processed as per protocols in Chapter II.
4.2.5 Craniofacial Analysis
Craniofacial analysis was carried out by Prof Paul Sharpe, King’s College, London, using the 
following three techniques.
A. Exon 6-12 B. Exon 7
Product shows 
exon 7 to 11 are' 
deleted
Product shows 
exon 7 is not 
*  deleted.
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4.2.5.1 Skeletal preparations
Skeletons were harvested, fixed in 95% ethanol and stained with Alcian blue (0.03% w/v in 
95% ethanol with 20% acetic acid) overnight. After several washes with 95% ethanol, the 
skeletons were rehydrated, treated with 2% KOH for 12 hrs and then stained in 1% KOH 
containing 75 tig/ml Alizarin red S (Sigma-Aldrich) for 24 hrs. Excess stain was removed by 
clearing in 1% KOH / 20% glycerol and, after washing in 0.2% KOH / 20% glycerol, skeletons 
were stored in 50% glycerol.
4.2.5.2 MicroCT analyses
Specimens for microCT were scanned using a General Electric Locus SP microCT scanner 
(GE Healthcare). The specimens were immobilised using cotton gauze and scanned to produce 
14-28 pm voxel size volumes. The specimens were characterised further by making three- 
dimensional isosurfaces, generated and measured using Microview software (GE). Skull 
thickness measurements and bone histomorphometry on femur heads were made using the 
Direct Measures component of the Advanced Bone Analysis package of Microview.
4.2.5.3 Bone and cartilage analyses
For differential staining of bone and cartilage, 18.5dpc mice were fixed overnight in 95% 
ethanol, skinned, and eviscerated. Cartilage staining was carried out by soaking in a solution of 
76% ethanol, 20% glacial acetic acid, and 0.015% Alcian blue 8GX (Sigma-Aldrich) for 24 
hrs, differentiating for 7 days in 95% ethanol, macerating in 1% KOH for 24 hrs, and washing 
overnight under running tap water. Bone staining was carried out by transferring the heads to a 
freshly made 0.1% aqueous solution of Alizarin red S, with the addition of several drops of 1% 
KOH to enhance the darkness of the red colour. The samples were then washed for 30 mins 
under running tap water, decolourised in 20% glycerol in 1% KOH for 1-2 weeks, and 
prepared for storage in increasing concentrations of glycerol in 70% ethanol to a final 
concentration of 100% glycerol. Skeletal preparations were photographed in light-field, using 
a Leica stereomicroscope, while submerged in 100% glycerol.
4.2.6 Statistics
1 tailed, binomial exact test was used for all genotyping results. P values < 0.05 were 
considered statistically significant.
I l l
4.3 Results
4.3.1 Phenotypic m anifestations o f Opa3  mutation in G1 mice
In the heterozygous state, mice are phenotypically indistinguishable from their wildtype 
littermates and have no difference in survival rates. The homozygote mice show no gross 
abnormalities at birth except being usually smaller than their littermates. They display a 
phenotype which has a highly variable time of onset and variable lifespan. Some of the 
characteristics displayed include: ‘runted’ appearance at birth, frail weak appearance, 
craniofacial abnormalities, splayed gait and tremor (Fig 4.5.).
Figure 4.5. Visible traits associated with G1 Opa3 homozygous mice. (A) Wildtype on left, 
middle and right are homozygotes. Homozygote on the far right has a craniofacial defect. (B) 
Homozygote showing splayed gait [Davies et al, 2008].
Genotyping at around 21 days of age when they are weaned from their mothers showed a loss 
of homozygotes by this time. However, the proportion was not significantly different from the 
expected 25% (see Table 4.1.). The majority die within 12-16 weeks of postnatal age but in a 
few isolated instances animals have survived to seven months of age. It was not possible to 
investigate the progeny of Opa3 homozygote intercross or outcross matings due to the frail 
state of the homozygotes in terms of health and size. Intercrosses and outcrosses were set up, 
but pregnancy was never established.
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G e n e ra t io n l E x p e c te d O b s e rv e d
g e n o ty p e  (n= 105)
+/+ 26 .25  (25% ) 22  (21% )
+/- 52 .5  (50% ) 62  (59% )
-/- 26.25(25% ) 21 (20% )
Table 4.1. Obtained and predicted genotype viability of Opa3 G1 heterozygote inter-crosses 
(,n = 105). Number of homozygotes observed was 80% that of the expected number (1 
tailed, binomial exact test; P  = 0.141).
The highly variable longevity and onset of phenotype seen in the G1 mice is in part due to the 
mixed genetic background which made analysis of the phenotype difficult. It was therefore 
decided to breed the mutation to a more congenic C57BL/6JCrl background in the hope of 
reducing the variability in the time of disease onset. The time scale to make mice congenic 
(which would be 20 generations) was considered too long so the phenotype was again studied 
at G3 and G4.
4.3.2 Phenotypic manifestations of Opa3 mutation in G3/4 mice
In G3/4 mice there was no obvious perinatal difference between the Opa3 wildtypes and 
heterozygotes. Homozygotes were generally smaller at birth. Some of the litter were very 
pale at birth, these usually did not survive the next 24 hrs. These are known to occasionally be 
heterozygotes, as well as homozygotes.
Visible traits observed in the homozygote mice include: stunted growth, craniofacial 
abnormalities and splayed gait (Fig 4.6.). As the Opa3 homozygote mice become 
compromised they display, tremor, hunched physique (Fig 4.6D.), reduced body fat and have 
reduced locomotor activity. By G3/4 a very small number of heterozygotes displayed various 
aspects of the homozygote phenotype. Phenotype was assessed in-depth in Chapter V.
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Figure 4.6. Visible traits associated with the G3/4 Opa3 homozygous mice. (A) 
Homozygote in the foreground showing smaller size with wildtype sibling 
behind. (B) Wildtype showing normal leg postion. (C) Homozygote 
showing hind limb extension phenotype. (D) Homozygote showing hunching, 
splayed gait and craniofacial defects. Craniofacial phenotype has incomplete 
penetrance with (E) homozygote displaying craniofacial defects and (F) 
homozygote displaying normal cranium.
4.3.2.1 Opa3 m ouse viability
Matings were set up and progeny were observed to assess survival rates. Wildtypes were seen 
in expected numbers (Table 4.2.). Of the 42 heterozygotes observed three died within the first 
two days after birth and a further three heterozygotes were found dead at days 24, 29 and 41. 
This again suggests the presence of congenital defects in the heterozygotes as well as the 
homozygotes.
Generation 3 Expected Observed
genotpye (n=73)
+/+ 18.5 (25%) 19 (26%)
+/- 37 (50%) 42 (57%)
-/- 18.5 (25%) 12 *(17%)
Table 4.2. Obtained and predicted genotype viability of Opa3 G3 heterozygote inter-crosses (n = 
73). Number of homozygotes observed was 68% that of the expected number (1 tailed, binomial 
exact test; *P < 0.05).
By G3 there is a statistically significant loss of homozygotes by weaning at 21 days of age 
(Table 4.2.). This is a 12% increase compared to the G1 mice. Loss maybe more than this as 
many pups die very quickly around birth and DNA could not be procured quickly enough for 
a genotyping result. Also, the mothers were observed to eat dead/dying newborns so exact 
loss is difficult to estimate. The survival rate of each genotype at G3 is portrayed as a Kaplan- 
Meier survival curve (Fig 4.7.). The survival rate of the homozygotes at G3 can be seen to be 
to be statistically significantly different form that of the wildtype controls (F=0.000). Survival 
of the heterozygotes was not significantly different for wildtypes.
As the C57BL/6JCrl component of the genetic background increases, a greater percentage of 
mice are lost in the first few weeks of life. By G4 there is greater than 40% loss of the litter by 
weaning at 21 days. This increased loss can be portrayed as a Kaplan-Meier survival curve, 
which shows survival of the mice as they progressively become more congenic to 
C57BL/6JCrl with each generation (Fig 4.8.). The curves show the loss of all mice at each 
generation during the first 21 days, not just the homozygotes. The survival rate of mice at G4 
is significantly less compared to previous generations (P=0.000). At G4 the severity spectrum 
of the phenotype seems to have remained the same as at G1 but life span has decreased and
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onset of disease phenotype is less variable and earlier. This indicates the potential presence of 
a strain-specific modifier(s) on C57BL/6JCrl.
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Figure 4.7. Kaplan Meier survival curve showing decreased survival rate of G3 
homozygotes compared to heterozygote and wildtype mice from birth to 50 days 
of age. The survival rate of the homozygotes was statistically significantly less 
compared to wildtype controls (Long Rank (Montel-Cox) P=0.00).
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Figure 4.8. Kaplan Meier survival curve showing decreasing survival rates of 
mice at each generation from birth to 21 days of age as they progressively 
become more congenic to C57BL/6JCrl. The survival rate of the G4 
generation was statistically significantly less compared to the G1 genertion 
(Long Rank (Montel-Cox) P=0.00).
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4.3.2.2 General Tissue Histology
Sections were taken of six different tissue types from 30 day old G3/4 homozygote and 
wildtype mice and stained with H&E. The homozygote mice showed abnormal pathology in a 
number of tissues (Fig 4.9A&B.). A marked cardiomyopathy was also observed where left and 
right ventricular chambers were dilated (solid arrows). Both the interventricular septum and 
left ventricular free wall were thinned (Fig 4.9A.D.) (dashed arrows). The left and right 
ventricular myocardium had diffuse changes consisting of matrix expansion, inducing 
interstitial fibrosis, cardiac muscle fibre deposits, atrophy and hyperatrophy of residual muscle 
fibres, as well as vacuolation of muscle fibres (fig 4.9A.B.).
A.
Figure 4.9A. H eart histopathology o f 30 day old G3/4 C57BL/6JCrl hom ozygote mice compared  
to wildtype controls. (A&B) show photom icrographs of the left ventricular m yocardium . (C&D) 
are transverse sections through the base of the ventricles.
Retina showed considerable thinning in the majority of layers. Chronic changes were observed 
in the liver, which showed large areas of fat accumulation (Fig 4.9B.) (solid arrow). Although 
the skeletal muscle stained differently, the fibres were of similar size/shape and the number of 
nuclei were similar suggesting muscle structure was normal. The lungs and kidneys also 
appeared to be normal by H&E histology. This analysis will only detect gross pathology, but is 
very useful as a starting point for indicating abnormalities that require further investigation.
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Hepatic steatosis was analysed in Chapter VI and retinal thinning was further assessed in 
Chapters VII and VIII.
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Figure 4.9B. Histological examination of G3/4 C57BL/6J mouse tissues. 
Magnification x20
4.3.2.3 Embryology
Approximately 35% of homozygote mice in the C57BL/6JCrl G3/4 are lost at some point prior 
to weaning. To assess for any embryonic loss, embryos were collected at various time points 
between 13.5 dpc and birth. Of the homozygote embryos observed none showed any gross 
abnormality except being slightly smaller than the wildtypes (Fig 4 .10A.). The heterozygote 
embryos also showed no outward abnormalities but their size was variable, from as large as a 
wildtype to as small as a homozygote.
A . Opa3 +/+ Opa3 -/-
B.
+/+ +/- -/-
P0 10 (9.25) 19(18.5) 8 (9.25)
18.5dpc 3 (3.75) 9 (7.5) 3 (3.75)
13.5dpc 3 (3.25) 8 (6.5) 2 (3.25)
Figure 4.10. Em bryonic viability o f the Opa3 mice at 13.5 dpc, 18.5 dpc and P0. (A) M icrograph  
showing 13.5dpc em bryos. H om ozygotes display no gross abnormalities except sm aller size. (B) 
Table showing viability o f em bryos from heterozygote inter-cross matings. O bserved numbers in 
bold. Expected num bers in brackets.
The number of embryos collected did not allow for an accurate estimate of time of lethality but 
no dead embryos or empty/absorbing deciduas were observed at any time points between 13- 
18.5 dpc. This suggests that no homozygotes were being lost between approximately 11.5 dpc 
and birth. Genotyping results of homozygotes showed no statistical difference in observed 
numbers from the expected numbers (Fig 4.10B.). Observations of dead pups at birth would 
suggest a large proportion of the loss is at birth.
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4 .3 .3  P h en o ty p ic  m a n ifesta tio n s  o f  Opa3 m u tation  in G 3/4  m ice on  a C 3H  b a ck g ro u n d
In an attempt to increase the survival rate of the Opa3'f mice in order to improve the analysis 
of the phenotype a second line of mice was developed, outcrossed to a C3H background. A 
strain of C3H was obtained from MRC Harwell that did not carry the Pde6b mutation (which 
causes retinal degeneration). This removed the need for continued Rdl genotyping. By 
making the mouse more congenic to C3H and by removing the Nnt deletion, by selective 
breeding, a comparison of the Opa3 mutation on two different backgrounds could be made 
and effects of Nnt on the phenotype could be analysed.
The G3/4 mice on the C3H background showed no difference in visible traits compared to the 
same generation C57BL/6JCrl mice (Fig 4.11.). Also, there was no improvement in longevity 
on this genetic background, with 38% of homozygotes lost before weaning (Table 4.3.).
Figure 4.11. Visible traits associated with G3/4 C3H mice. W ildtype behind with homozygote in 
forefront displaying craniofacial defect, splayed gait, hunched posture and tail kink.
Generation 3/4 Expected Observed
genotype (n=163)
+/+ 40.75 (25%) 48 (29%)
+/- 81.5 (50%) 86 (53%)
-/- 40.75 (25%) 29 *(18%)
Table 4.3. Obtained and predicted genotype viability o f Opa3 G3/4 C3H heterozygote inter­
crosses (ai = 163). Number o f homozygotes observed was 72% that of the expected number (1 
tailed, binomial exact test; *P < 0.05).
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The G3/4 C3H mice do not carry the Nnt deletion. Therefore, because an almost equal number 
of homozygotes were lost on each background strain (G3/4 C3H-38%; G3 C57BL/6JCrl-35%) 
this suggests that Opa3 does not interact with Nnt and therefore has no effect on the Opa3U22P 
mouse phenotype. In addition, in the C57BL/6JCrl homozygote mice no correlation was ever 
observed between Nnt genotype and severity of mutant phenotype.
4.3.3.1 General Tissue Histology
Histology of G3/4 C3H tissues showed no differences in pathology when compared to the 
same G3/4 generation C57BL/6JCrl mice. As with the C57BL/6JCrl line, only the retina and 
liver (solid arrow showing fat deposits) appeared to be grossly abnormal (Fig 4.12.). Yet 
again, the muscle seems structurally normal but stains a different colour despite being 
processed in the same batch as the wildtype tissue.
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Figure 4.12. Histological examination of G3/4 C3H mouse tissues. Magnification x
4.3.4 Craniofacial M alformations
Adult mice and embryos ranging from 16.5 dpc to P4 were collected in 95% ethanol or 10% 
NBF and sent to the craniofacial department at Guy’s Hospital London. MicroCT scans were 
taken by Prof Paul Sharpe.
4.3.4.1 MicroCT scan analysis o f G1 adult mice
Some G1 homozygotes displayed a shortened nose and broader distance between eyes and 
this phenotype has incomplete penetrance in the homozygotes. From observation alone there 
is no outward difference in the heterozygotes (Fig 4.13. & 4.14.).
wild-type #269 heterozygote #264 homozygote #267
m andible
coronal
s u tu r e
n a s a l  b o n e
lambdotdal
suture sagittal
su ture igal bone
Figure 4.13. CTscan of the cranium of wildtype, heterozygote and homozygote littermates. Red 
line indicates measurement of mandible width. Green line indicates measurement of 
chondrocranium width.
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homozygote #278 homozygote #279 homozygote #302
j |^ an d ib le
Figure 4.14. CTscan of three other homozygotes showing the craniofacial phenotype. Red line 
indicates measurement of mandible width. Green line indicates measurement of 
chondrocranium width.
4.3.4.2 Summary o f the mutant phenotype on CT
The skulls of the heterozygote and homozygote mice generally appear to be larger than the 
skulls of wildtype mice suggesting that more bone ossification was occurring in the mutants. 
This correlates with analysis of bone development in the mutants at 18.5 dpc, following 
staining of the bone with Alizarin red. The microCT analysis also revealed that in general, 
the chondrocranium and dermatocranium of the homozygotes showed considerably more 
bone ossification than observed in the heterozygotes. The following notes highlight the 
changes in bone structure in the heterozygote and homozygote mutants compared to the 
wildtypes. It is important to bear in mind that a caveat to these conclusions is that the 
measurements taken are subjective to the manual positioning of individual reference points 
within the skull:
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Skull measurements taken:
Measurements were taken from wildtype (n=l), heterozygote (n=l) and homozygote (n=4) 
mice.
Mandible (red line on figures 33 and 34)
Lateral view of the mandible of the heterozygote and homozygote cranial skeletons showed 
that it was consistently broader than the lateral view of the wildtype mandible (red line):
Wt (#269): 4.47mm 
Het (#264): 5.59mm
Horn (#267): 5.97mm, Horn (#278): 5.83mm, Horn (#279): 5.14mm, Horn 
(#302): 4.82mm
Homozygotes displayed an average mandible width of 5.44mm ± S.D 0.55. In particular, note 
the increasing width and thickening of the condylar process within the mandible of the 
mutants.
-Chondrocranium length
Measurements taken along the dorsal length of the chondrocranium (from the supraoccipital 
bone to the nasal bone) confirm the skulls of the heterozygote and homozygote mice are 
longer than the skull of wildtype mice.
Wt (#269): 15.50mm 
Het (#264): 20.42mm
Horn (#267): 20.65mm, Horn (#278): 19.74mm, Horn (#279): 17.65mm,
Horn (#302): 19.38mm 
Homozygotes displayed an average chondrocranium length of 19.35mm ± S.D 1.25.
-Chondrocranium width (green line on figures 33 and 34)
Measurements taken across the dorsal view of the jugal bone (green line) provide 
controversial results regarding the width of the skulls of the heterozygote and homozygote 
mice compared to wildtype mice. These measurements do not support any consistent increase 
in the width of the skulls of heterozygote and homozygote mice.
Wt (#269): 11.30mm 
Het (#264): 11.68mm
Horn (#267): 11.30mm, Horn (#278): 9.21mm, Horn (#279): 9.20mm,
Horn (#302): 11.13mm
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Homozygotes displayed an average chondrocranium width of 10.21mm ± S.D 1.16. The 
craniofacial phenotype observed in the G1 homozygotes has been observed in G3/4 
homozygotes and heterozygotes. Embryos of G4 mice were sent to Guy’s Hospital London to 
assess for any abnormalities in development of the skull in the heterozygotes and 
homozygotes.
4.3.4.3 Embryonic bone and cartilage analysis in G4 mice
The majority of bones in the cranial skeleton of the heterozygote embryo developed similarly 
to the wildtype embryo (Fig 4.15.). Ossification of the bones of the frontal (f), parietal (p), 
interparietal (i) exoccipital (e) and tympanic ring (tr) was normal in heterozygote embryos. 
The heterozygote embryos did however exhibit some craniofacial abnormalities; greater 
ossification of the mandible (md) and premaxilla (premx), while the temporal (t) bone 
appeared misshapened and the bones of the maxilla (mx) appeared expanded. Further analysis 
of the development of these specific bone anomalies in the neonatal pups will be important.
At this stage of embryonic development, cartilage development in the wildtype and 
heterozygote embryos was comparable. There were no obvious defects in cartilage 
development in the heterozygote embryos (Fig 4.15.).
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Figure 4.15. Bone (Alizarin red) and Cartilage (Alcian blue) analysis of G4 embryos at 18.5 dpc.
4.3.4.4 Bone (Alizarin red) and Cartilage (Alcian blue) analysis at 18.5 dpc (NBF fixed  
embryos).
These embryos were fixed in NBF (rather than 95% EtOH) prior to be sent for bone and 
cartilage analysis. This treatment seems to have caused the skin surrounding the forebrain, 
midbrain and anterior hindbrain to collapse in both the heterozygote and homozygote 
embryos. This resulted in the embryonic skin becoming light and difficult to remove either by 
gentle agitation in 1 % KOH or by manually dissecting away the skin layer. For future studies, 
it would be better to fix the embryos in 95% EtOH rather than NBF.
The poor representation of cartilage staining in both the heterozygotes (Fig 4.16C.) and 
homozygotes (Fig 4.16D.) does not appear to be a result of the mutant phenotype. Rather, it 
appears that fixing these embryos in NBF led to the poor penetration of the Alcian blue stain 
and poor staining of the cartilage in these mutant embryos. Treatment with 1% KOH failed to 
remove the skin layer and following manual dissection of the skin from these embryos (Fig 
4.16E. and F.), it was clear that the cartilage had not been sufficiently stained. Re-treating 
these mutant embryos with Alcian blue resulted in an overall blue tinge to the embryo (data
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not shown) and did not identify cartilage typically observed at this stage of embryonic 
development (i.e. nasal cartilage, Meckel’s cartilage).
c; HOM
Figure 4.16. Bone and cartilage analysis of 18.5 dpc embryos fixed in NBF.
Staining of the bone with Alizarin red revealed that while both mutants exhibited 
abnormalities in bone ossification, these abnormalities were more severe in the homozygote 
embryo. Compared to the bone development in a typical 18.5 dpc embryo, in these mutants, 
ossification of the frontal (f) and parietal (p) bones of the cranial vault was evident but 
reduced and there was a marked reduction in ossification of the interparietal (i) bone in both 
the heterozygote (Fig 4 .16E.) and homozygote (Fig 4.16F.) embryos. While staining of the 
exoccipital bone (e) was evident there was poor ossification of the tympanic ring (tr), 
mandible (md), nasal bone (n), premaxilla (premx) and maxilla (mx) and there was no 
ossification of the supraoccipital bone (arrow) in either of the homozygote embryos.
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Analysis of the heterozygote embryo (Fig 4.16E.) also showed that while the temporal bone 
(t) had formed appropriately ossification of this bone was not complete. In comparison, the 
temporal bone (t) in the homozygote embryo (Fig 4.16F.) appeared to be abnormally shaped 
and with poor ossification.
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4.4 Discussion
These results demonstrate that the G1 homozygote mice displayed a highly variable 
phenotype and longevity which made analysis of the disease phenotype difficult. By G3/4 
onset of homozygote phenotype was more consistent but survival rates had decreased. Nnt
ii 22Pwas found to have no effect on disease phenotype and breeding the Opa3 mutation on to 
a C3H background showed no improvement in survival rates. H&E showed severe pathology 
of the retina and cardiac muscle which would be consistent with a metabolic disorder 
affecting tissues of high energy demand. Interestingly, liver pathology showed a large 
accumulation of fat. Craniofacial analysis in the G1 adult mice showed an increased skull size 
in homozygotes and heterozygotes with increased ossification of some bones. In the G3/4 
embryos the Opa3Ll22P mutation was found to affect bone development but not cartilage 
development.
Embryo genotyping and a lack of reabsorbing deciduas during development suggests that the 
vast majority of homozygotes are dying at birth. Why would a PO mouse die? The timing 
suggests a cardiac, circulatory, or pulmonary cause of death. At birth, the heart undergoes a 
critical metabolic switch from a predominant dependence on carbohydrates during fetal life to 
a greater dependence on postnatal oxidative metabolism. This remains the principle metabolic 
state throughout life, although pathologic conditions such as heart failure and cardiac 
hypertrophy reactivate components of the fetal genetic program to increase carbohydrate 
utilisation. The homozygotes do suffer with a severe cardiomyopathy, which is the likely 
cause of death, and Opa3 is thought to cause defects in oxidative metabolism which might 
have a severe effect after the postnatal switch to oxidative metabolism. Some pups however, 
appear very pale at birth, this can be an indicator of problems such as anaemia or a defect in 
the breathing centres of the brain which can lead to perinatal lethality.
Those homozygotes that did survive past birth had a dramatically shortened lifespan. 
Cardiomyopathy could be the primary cause of their death, or it could be a secondary 
consequence of either mitochondrial dysfunction or multiple organ failure. No attempts to 
breed from them have been successful. It must therefore be assumed they are sterile or 
metabolically/ endocrinologically incapable of either conception or very early pregnancy.
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The Opa3A mice are distinguishable from their littermates usually from birth due to their 
smaller size. It is often speculated that ataxic mutants are smaller than their littermates due to 
competition for food during the early stages of development [Lalonde and Strazielle, 2003]. 
This maybe a contributing factor during postnatal development. However, the homozygotes 
are observed to be smaller during embryonic development and therefore, postnatal ataxia/ 
skeletomuscular deficits cannot be solely to blame.
It can be seen from the Kaplan Meier survival curve (Fig 4.8.) that when the Opa3 mutation 
was made more congenic to C57BL/6JCrl longevity is decreased. There were a few possible 
reasons for a decrease in lifespan and earlier onset of phenotype. As the gene-pool becomes 
more limited, caused by continued inbreeding, deleterious genes become widespread and the 
inbred strain loses hybrid vigour. It is also possible for the phenotype to not be entirely 
controlled by the mutation at the causative locus. A phenotype associated with a single gene 
mutation can be modulated by the genotype at other loci. The effect of the genetic background 
(i.e. different strains of mouse) can be invoked in the intermediate situation (i.e. mixed 
background) where phenotypic variations can be observed among individuals who carry the 
same mutation in the same causative gene but differ in a number of other genes. A few of 
these genes can control part of the phenotypic variation and hence are called ‘modifier loci’. 
By using G3/4 (approximately 87% C57BL/6JCrl and 94% C57BL/6JCrl respectively), the 
mice have a variable genotype at each loci and therefore each mouse would be ‘modified’ in a 
different way, which created variability.
Another interesting point is that phenotypes associated with a mutation can vary among 
genetically identical individuals. This variation could be attributable either to incomplete 
penetrance, when a fraction of the individuals carrying the disease-associated genotype failed 
to develop the abnormal phenotype, or to variable expressivity, when individuals carrying the 
disease-associated genotype exhibit phenotypes with varying degrees of severity. The 
craniofacial phenotype in the heterozygotes and homozygotes is probably either incomplete 
penetrance or variable expressivity.
During the breeding of the Opa3L122p mouse to C57BL/6JCrl it was thought prudent to breed 
out the deleted Nnt gene carried by this strain. Nnt is expressed in the IMM and so might 
interact with Opa3. No correlation was found between severity of disease phenotype and Nnt
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genotype. After it was bred out of the colony no difference in phenotype or longevity was 
observed, suggesting Nnt does not interact with Opa3.
Changing the background to C3H had no significant effect on lifespan or onset/variability of 
disease phenotype. Therefore breeding to the C3H background was abandoned and all further 
experiments in this thesis were conducted on G3/4 C57BL/6JCrl mice.
4.4.1 Craniofacial malformations
The Opa3 mouse has a craniofacial defect showing shorter nose, wider set eyes and longer 
head. Some homozygotes also had problems with overgrown teeth from a jaw misalignment, 
possibly from the craniofacial abnormalities. There is also the potential of deformed hind 
limbs, since the abnormal walking pattern of splayed gait was detected before onset of 
neurological symptoms.
Although MGA-III is considered to be a mitochondrial disorder, there are certain aspects of 
the mouse phenotype that are not found in human MGA-III or diseases of mitochondria 
dysfunction. One such anomalous feature is craniofacial malformations. It is therefore of 
some interest in this context that OP A3 has a functional C-terminal peroxisomal targeting 
signal, albeit only in the absence of a functional N-terminal mitochondrial leader sequence. 
Mitochondria share some roles with the peroxisomes, small organelles with diverse, cell 
dependent functions, which are scattered throughout the cell and play a part in the breakdown 
of long-chain fatty acids. In addition to these shared roles, other lines of evidence have hinted 
at the possibility that Opa3 might have a functional role in the peroxisome.
However, expression of wildtype and mutant Opa3 in both human [Huzing et al, 2010] and 
mouse [Powell et al. submitted] cell lines have shown that Opa3 does not co-localization with 
peroxisomes. It therefore appears that Opa3 is an integral protein of the mitochondrion and 
that any observed differences between the human and mouse phenotype is probably due to 
species specific function.
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4.5 Conclusions
I 1 2 2 P
- The O pa3J mutation on a C3H and C57BL/6JCrl strain background showed no 
observable effect on lifespan or onset and variability of phenotype. Therefore, all future 
experiments were conducted on G3/4 C57BL/6JCrl mice.
- Nnt mutation had no observable affect on Opa3 homozygote or heterozygote lifespan or 
phenotype suggesting it does not interact with Opa3.
i i  2 2 P
- The Opa3 mutation causes severe tissue pathology in the retina, heart and liver.
- G1 adult homozygote mice display craniofacial defects including shortened nose and 
broader distance between eyes with increased bone ossification. This phenotype however has 
incomplete penetrance.
- The Opa3u22p mutation affects bone development but not cartilage development.
I 122P- The Opa3 mutation probably does not cause any gestational lethality but is involved in 
processes required for postnatal survival.
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CHAPTER 
V
The Opa3 2P mouse displays neurological and
behavioural deficits
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5.1 Introduction
Aims of chapter
-T o  use a generalised behavioural and functional mouse assessment protocol to identify and
i i  22Pcharacterise phenotypic variation in G3/4 Opa3 mice, which can be used as a guide in the 
design of more in-depth studies of abberant behaviours.
- Use of a range of neurological and behaviour phenotyping paradigms for assessment of 
several motor parameters to cover aspects of the human MGA-III phenotype.
- Analysis of MRI head scans for gross morphological defects of the brain, in particular the 
cerebellum.
The mouse continues to play a vital role in the deciphering of mammalian gene function and 
the modelling of human diseases. There are a number of mouse models of the primary optic 
neuropathies but until the generation of our mouse model B6; C3-Opa3Ll22P there were no 
models of Opa3.
In this chapter and the next two chapters our novel mouse carrying the L122P mutation was 
subjected to a systematic and comprehensive battery of tests that attempt to cover all aspects of 
the human disease and confirm the Opa3~l~ mutant mouse as a clinically relevant model of 
MGA-III. From there, this model can be used to elucidate the physiological role of Opa3 and 
thereby to cast light on the function of the OP A3 protein. This chapter deals with the 
neurological, behavioural and muscular aspects of the disease state.
When designing a battery of behavioural tests for any type of genetically, pharmacologically 
or physiologically manipulated mouse it is imperative to take into account any abnormalities 
that would impair the ability of the mouse to complete the task. Uncoordinated experimental 
approaches can bear a high risk of false negatives and/or false positive results. To this end it 
was felt that certain aspects of the human phenotype could not be analysed in our mouse 
model because of such impairments, for example, MGA-III patients have cognitive deficits. 
Behavioural tests to cover cognitive deficits generally require the ability of the mouse to 
memorise visual cues, which require good vision, or tests such as Morris water maze which 
require good motor skills. Our mouse model does not have the capability to complete such 
tasks due to visual and motor impairments so tests designed specifically for memory and
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learning deficits were omitted from our battery. However, cognitive and learning capabilities 
can be inferred from behaviours observed in tasks such as open field and rotarod.
Other factors which must be taken into account as they are known to influence the behaviour 
of a mouse include: genetic, experimental and developmental backgrounds, biological rhythm, 
age, litter size, sex of the test animal, pre and post weaning treatment and observation 
methods [Walsh and Cummins, 1976]. It is important to keep these parameters comparable 
throughout a single experiment. It is recommended that all phenotyping experiments are 
conducted at the same time of day because psychological and biochemical parameters change 
throughout the day. The ideal time for testing is the first half of the lights-on period (in the 
morning until early afternoon). All behavioural experiments presented here were conducted at 
this time of day and factors influencing behaviour were taken into account where ever 
possible.
5.1.1 Testing motor behaviour and co-ordination
One of the characteristic manifestations in several neurodegenerative diseases, including 
Costeff syndrome, is the loss of voluntary motor control and the development of involuntary 
movements. A detailed analysis of several motor parameters is often necessary to capture 
accurately the essence of such neurodegenerative disease states through repeated testing at 
predefined time intervals over the animal's life time. Here we investigated the performance of 
the mice on a variety of tasks designed to identify changes in motor control.
To test for changes in the animal's motor coordination and balance, the rotorod apparatus was 
employed at several time periods, as it has been shown to be a sensitive tool for assessing 
progressive neurological deterioration in animal models of syndromes such as Friedreich 
ataxia [Simon et al, 2004]. The wire hang, which is a test of motor ability function/grip 
strength, can be used in conjunction with rotarod for a more detailed neuromuscular analysis.
Gait analysis can also be assessed by analysis of footprint patterns [Carter et al, 1999] and can 
provide an insight into cerebella function which is involved in the integration of sensory 
perception, coordination and motor control. Similarly, turning patterns (the incidence and 
nature of turning) inform on asymmetrical brain function [Miklyaeva et al, 1995]. It should be 
noted though that turning patterns differ between males and females [Field et al, 1997].
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5.1.2 Exploratory and emotional behaviour
The Open Field Test [Walsh and Cummins, 1976; Crawley, 2000] was designed to measure 
behavioural responses such as locomotor activity and exploratory behaviours. Open field can 
also be used as a measure of anxiety.
Mice and rats tend to avoid areas that are brightly illuminated, novel or open, so the open field 
environment acts as an anxiogenic stimulus and allows for measurement of anxiety-induced 
locomotor activity and exploratory behaviours. The number of line crosses and the frequency 
of rearing are used as measures of locomotor activity and a low frequency of these behaviours 
indicates decreased locomotion. The number of central square entries and the duration of time 
spent in the central square are measures of exploration and anxiety [Podhorna and Brown, 
2002]. Anxiety can be inferred by whether the majority of exploration occurs in close 
proximity to the walls (thigmotaxis) or in the centre of the test arena. The open space in the 
centre of the field is expected to induce anxiety and be more aversive than near the arena wall. 
A low frequency/duration of these behaviours indicates low exploratory behaviour and high 
anxiety levels.
Stretch attend postures are "risk-assessment" behaviours which indicate that the animal is 
hesitant to move from its present location to a new position [Blanchard et al, 2001] and thus a 
high frequency of these postures indicates a higher level of anxiety. Grooming behaviour is a 
displacement response and is expected to be displayed in a novel environment [Espejo, 1997]. 
Repeated exposure to the open field apparatus results in time dependent changes in behaviour 
[Choleris et al, 2001]. At first, when the apparatus is novel to the animals, more fear-related 
behaviours (such as stretch attends and activity in the comers and walls of the open field) are 
displayed. However, with repeated trials, more exploration and locomotor activity (such as 
rearing and line crosses as well as more central square activity) can be observed. There are, 
however, strain differences in behaviour after repeated testing in an open field. With repeated 
exposure, some strains show increased activity while others show habituation and decreased 
activity levels and others showed no change [Bolivar et al, 2000]. The C57BL/6J mice show a 
reduction in locomotor activity with repeated exposures to the open field and C3H mice show 
little difference. As locomotor activity was the main parameter of interest the mice were only 
tested at one time point.
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The open field behaviour of mice can be affected by two behavioural dimensions; its 
exploratory drive and its fear drive. The interpretation of results can be confounded by these 
two underlying constructs and therefore the test should not be used as an individual measure 
of activity or anxiety but as an addition to compliment other tests in order to give a 
comprehensive analysis of the mouse’s lomomotor activity and/or emotionality. Light is an 
important anxiogenic factor that will strongly influence the ambulation in a mouse and 
experiments under various illumination intensities and factor analysis have shown that 
locomotion under dim lighting is a measure of activity rather than of fear [Trullas and 
Skolnick, 1993]. To limit the confounding effect of fear on activity levels the experiments and 
video recordings were conducted under red light conditions. As mice cannot see the red end 
of the spectrum, it was for them essentially dark conditions.
Based on the results of the SHIRPA screening a further 7 tests were chosen to cover aspects 
of the MGA-III syndrome: 1) Walking Pattern (motor function), 2) Rota-rod (motor function), 
3) Wire Hang (grip strength), 4) Open Field activity (emotionality, locomotor activity), 5) 
Metabolic testing (Chapter VI), 6) Optokinetic Drum (visual acuity Chapter VII) and 7) 
Pupillometry (Chapter VII).
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5.2 Materials and Methods
5.2.1 Body weight
A cohort of 64 Opa3 mice (Opa37 n=5, Opa3+l n=42, Opa3 +l+ n=17) were weighed 
every day from birth until 10 days of age and then every other day after that until they 
were 50 days of age.
5.2.2 SHIRPA
A cohort of 30 Opa3 mice (Opa3~' n=10, Opa3+/' n=10, Opa3 +l+ n=10) were evaluated on 
the primary SHIRPA screen [SmithKline Beecham Pharmaceuticals, Harwell MRC 
Mouse Genome Centre and Mammalian Genetics Unit, Imperial College School of 
Medicine (St Mary’s), Royal London Hospital, St Bartholomew’s and the Royal London 
School of Medicine Phenotype Assessment] (Fig 5.1.) at 30 days of age. Heterozygote 
‘founders’ were aged and assessed at two years of age (Opa3+l' n=4, Opa3+l+ n=4). 
SHIRPA is a protocol that identifies a wide range of phenotypes and is a sensitive screen 
for mouse neurological, neuromuscular and behavioural mutants [Rogers et al, 1997]. This 
protocol does not allow for detection of vision and eye abnormalities. Vision was 
therefore assessed in a subsequent chapter.
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Primary Screen
Behavioural Observation Profile
Tertiary Screen
Anxiety 
Learning and memory 
Prepulse inhibition 
Electromyography 
Electroencephalography 
Nerve conduction 
Magnetic Resonance Imaging
Secondary Screen
Locomotor Activity 
Food and water intake 
Balance and co-ordination 
Analgesia 
Histology 
Biochemistry
Figure 5.1. SHIRPA is a semi-quantitative protocol designed to characterise the phenotype of 
mice in three stages.
The first stage provides a behavioural and functional profile by observational assessment. 40 
separate measurements can be taken of each animal. Assessment of each animal begins when 
the animal is weighed and then placed in a cylindrical clear perspex viewing jar for 5 mins for 
observation of undisturbed behaviour (Fig 5.2.).
This was located on top of a grid, which was suspended above a piece of white paper. 
Behaviours were recorded without disturbing the animal and the amount of urination or 
defecation was monitored at the end of the observation period. Incidents of bizarre or 
stereotyped behaviour and convulsions were recorded separately.
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IViewing Jar
Figure 5.2. Perspex viewing jar for 5 mins of behavioural observation.
A metal plate was inserted under the viewing jar and the animal transferred and briskly 
dropped onto the floor of an arena without being handled (Fig 5.3.). The immediate reaction 
to the new environment was recorded as well as motor behaviour.
Figure 5.3. Arena for observations of motor behaviour.
5.2.2.1 Above Arena
The animal was removed from the arena and gripped by the tail. To test for vision, extension 
of forelimbs was observed when the mouse was lowered by base of tail from a height of 
approximately 15 cms above a wire grid. The mouse was then allowed to grip the grid and a 
gentle horizontal backwards pull was applied to assess grip strength. Whilst gently restrained 
on the grid the proximal part of the inner canthus was lightly touched with the tip of the fine 
wire probe, to look at ear retraction. Then the cornea was touched lightly, to look at eye-
143
blink response. The hind limbs were lifted clear for gentle lateral compression of mid digit of 
hind foot with fine forceps for withdrawal reflex. The animal was then held above the wire 
by tail suspension and lowered to allow the forelimbs to grip the horizontal wire and then 
released. Difficulty in lifting its back legs on to the wire would indicate muscular impairment.
The mouse was then held firmly in a supine restraint (Fig 5.4.) and the following observed.
4 L
Figure 5.4. Supine Restraint
Skin colour (gradations of plantar surface and digits of forelimbs), Heart Rate, Limb Tone, 
Abdominal Tone (Palpation of abdomen), Lacrimation, Salivation, Provoked Biting (a dowel 
rod is gently inserted between the teeth at the side of the animal’s mouth), Righting Reflex 
(animal is held by the tail and flicked backwards through the air such that it performs a 
backward somersault when released - landing position was observed), Contact Righting Reflex 
(animal was placed into a plastic tube and turned upside down), Negative Geotaxis (animal 
was placed on a horizontal grid. This was then raised to the vertical with the animal facing the 
floor and observed for 30 secs), Fear (freezing during transfer arousal), Irritability (struggling 
during supine restraint), Aggression (provoked biting or attack), Vocalization (provoked 
during handling). Any “Bizarre Behaviour” was noted at the end. The equipment and battery 
is described in detail at European Mouse Phenotyping Resource of standardised Screens; 
EMPReSS; http://empress.har.mrc.ac.uk/.
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5.2.3 W alking Pattern
Gait analysis was assessed on six Opa3 mice (Opa3‘ n=3 and Opa3+l+ n=3). To obtain 
footprints the hind and forefeet of the mice were coated with blue and red non-toxic paints 
respectively. The floor of the open field box was covered with white paper. A piece of 
plexiglass was used to create a lane in the open field and a play tube was placed at the other 
end to encourage the mouse to walk across the paper, leaving a track of footprints. In footprint 
analysis several step parameters are analysed; (i) Hind-base width, (ii) Front-base width which 
is the distance between left and right hind footprints and left and right front footprints, 
respectively and (iii) Distance from left or right front footprint/hind footprint overlap was used 
to measure uniformity of step alternation.
5.2.4 Rotarod
Balance and co-ordination (motor function) can be quantified using a rotarod (Fig 5.5.) which 
measures the ability of mice to remain on a rotating drum [Jones and Roberts, 1968].
datesar
Figure 5.5. Rotarod apparatus.
The motor function of a cohort of 24 mice (O p a 3 n=7, Opa3+l n=10 and Opa3+/+ n=7) was 
tested using an accelerating rotarod (Bioseb). Mice were trained to walk on the rotating drum 
at 21 and 22 days of age before testing began at 23 days of age and then continued every five 
days until the mice were three months of age. Testing commenced when the rod began to
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rotate, gradually accelerating from 4 to 40 rpm over a 5 min period. Mice were given three 
trials on each test day with a maximum trial time of 5 mins and an inter-trial interval of 20 
mins minimum. Testing ended automatically when the mouse fell off the rod. For those mice 
that held on to the rotating drum the latency to fall was recorded after two complete rotations. 
Latency to fall was taken as a measure of motor function.
5.2.5 Wire Hang
In the wire hang test, the ability to hang upside-down from a plastic mesh screen above a clear 
perspex box was tested. A cohort of 21 mice (Opa3+l+ n=7, Opa3+l n=7 and Opa3'' n=7) were 
tested from 23 days of age and every five days thereafter until they were three months of age. 
After mice were placed on the screen, the screen was waved gently in the air to force the mice 
to grip the wires (Fig 5.6A.). The screen was then immediately turned upside down above the 
perspex box which was filled with bedding to allow the mice to fall safely (Fig 5.6B.).
Figure 5.6. Wire Hang apparatus. (A) Each mouse was placed on the plastic mesh of a clear 
perspex box top. (B) The top is slowly inverted and suspended 30 cms above a clear Perspex 
box.
The total time the mice remained hanging on the wire was recorded as hanging time in 
seconds. Any mouse still gripping the cage top after 10 mins was removed and given the 
maximum score. Each mouse was tested four times over the test day, with an inter-trial 
interval of 20 mins minimum.
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5.2.6 Open Field activity
A cohort of 28 mice (Opa3+l+ n=9, 0pa3+l n=10 and Opa3'' n=9) were assessed in the open 
field. The open field test was used to assess spontaneous locomotor activity and anxiety- 
related conflict [Weisstaub et al, 2006], i.e., the conflict that arises between the drive to 
explore by venturing into the centre of the arena and safety by remaining in a comer or along 
a wall.
The apparatus for the open field test is a 60 x 60 cm square, 30 cms high made of grey 
plexiglass. Each mouse was placed in a centre of the field and its behaviour recorded for five 
mins. All activity was recorded by a video camera mounted above the open field and scored in 
real-time or recorded and scored later. The open field arena is partitioned into 25 equal-size 
squares (12 x 12 cms); 16 border squares and 9 centre zone squares. Lighting was a 60W red 
light. During each test session, individual mice were placed in the centre of the open field and 
observed for five mins. The parameters measured were:
Latency to reach peripheral squares ,
Percentage time spent in various parts of the field e.g., peripheral squares or 
corners or the middle area
Total number of central squares entered (defined as three or more paws entering 
into a central square)
Total number of peripheral squares entered (defined as three or more paws 
entering into a peripheral square)
Total number of squares entered
Number of rears against a wall (standing up on hind legs using the wall for 
support)
Number of rears in the periphery without using the wall (standing up on hind legs) 
Number of rears in the centre
Total activity, corresponding to the sum of the number of lines crossed and the number of rears 
observed during the five min trial, was calculated by averaging the single measurements 
obtained from each mouse within a group at each time point. The analysis was performed 
manually by examining the video recording. Moving time was counted with a stopwatch, 
distance travelled was measured counting number of squares travelled. Crossing was defined 
as three paws crossing one of the lines.
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5.2.7 Magnetic resonance imaging (MRI)
Mice were imaged using a Bruker Biospin Advance II 9.4T (400 mHz) horizontal bore (20 
mm bore) MRI system (Etlingen, Germany), equipped with SI 16 high performance gradient 
coil. Perfusion fixed mice (see Chapter II) were scanned using a 4 channel phased array 
mouse head surface coil (Bruker) coupled with a 750W linearly polarised 72mm ID volume 
coil (Bruker). For each animal a series of Turbo-RARE 3D scans with a RARE factor of 4, a 
FOV of 2.56 cm x 1.92 cm x 1.92 cm and a matrix of 512 x 384 x 384 giving a resolution of 
50pm x 50pm x 50pm. Images were acquired for 16 hrs with 1 average, an effective TE of 
50ms, a TR of 1550ms, fat suppression and a band width of 50KHz.
5.2.7.1 Volumetric measurements
The resulting MRI images were analysed using ParaVision (Bruker, Karlsruhe, Germany) a 
Bruker software package for multi-dimensional MRI/MRS data. Determination of the total 
cerebellar volume (mm3) was taken in one Opa3''~ and one Opa3+/+ mouse using Analyze 
region-of-interest software. Brain regions were defined manually, using atlases of the mouse 
brain for reference (www.hms.harvard.edu/research/brain/atlas.html). Target regions were 
defined in each slice, then the area of each region was calculated. These areas were converted 
to volumes for each slice, then summed for the whole brain to give total volume. Volumetric 
measurements were taken of cerebellum, brain excluding cerebellum and total brain in 
horizontal and plane.
5.2.8 Dual COX-SDH muscle histochemistry
The gastrocnemius muscle was harvested from 30 days of age mice (Opa3~'~ n=3, Opa3+l+ 
n=3).The muscle specimens were immediately frozen in OCT in an isopentane bath (-150°C) 
and stored at -80°C. Samples were raised to the sectioning temperature of -20°C. 15 pm thick 
serial sections were obtained using a cryostat (Microm HM560; Thermo Fisher, Walldorf, 
Germany) and placed on Polysine Slides (Thermo scientific). Histochemical staining for COX 
and SDH activity was performed using the following protocol (for solution recipes see 
Appendix I).
After sectioning, slides were allowed to air dry for 1 hr. During this time 0.8 ml of 5mM 3,3 
diaminobenzidine tetrahydrochloride (Sigma) and 0.2 ml 500pm cytochrome c (Sigma) were 
rapidly thawed and mixed. A few grains of catalase (Sigma) were added. Solution was 
mixed, applied to the section and then incubated for 45 mins at 37°C. Slides were then
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washed in 3 changes of 0.1M phosphate buffered saline pH 7.0 for 3 mins each. 0.8 ml of 
1.875mM nitroblue tetrazolium (Sigma), 0.1 ml of 1.30M sodium succinate (Sigma), 0.1 ml 
of 2.0mM phenazine methosulphate (Sigma) and 0.01ml of lOOmM sodium azide were 
rapidly thawed. These solutions were mixed, applied to section and incubated for 40 mins at 
37°C. After slides were again washed in 3 changes of 0.1M phosphate buffered saline pH 7.0 
for 3 mins each. Finally samples were dehydrated through an alcohol series. 2 mins in 50% 
ethanol, 2 mins in 70% ethanol, 2 mins in 90% ethanol, 2 mins in 100% ethanol and finally 10 
mins in 100% ethanol. Slides were then cleared and mounted with D.P.X permanent medium 
for microscopy (BDH, England). Slides were examined on a Leica DMR microscope and a 
Leica DC500 camera. Muscle fibres were counted on five different sections for each mouse 
using Image J.
5.2.9 Statistics
Statistical analysis of behavioural data was carried out with SPSS 16. Statistical differences 
between groups in rotarod and wirehang were analyzed by one-way ANOVA, followed by 
Bonferroni's post hoc test or Dunnet T3 post hoc depending on equal variance or not. Paired 
sample t test for within group comparisons. SHIRPA was analysed with Mann Whitney U 
and Student’s t test for open field. P values < 0.05 were considered statistically significant.
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5.3 Results
5.3.1 Body Weight
The Opa3'' mice weighed less than the Opa3+,+ and Opa3+/ mice from approximately one 
week old onwards and generally do not grow larger than the size of a ‘weaner’ (at 21 days of 
age a juvenile mouse is weaned from its mother to a separate cage) (Fig 5.7.). The dip off in 
weight gain seen around 20 days on all three curves corresponds with time of weaning from 
their mothers. There were very few numbers for the body weight of the homozygotes as most 
do not survive past weaning. Some Opa3+l' also died at birth and of the 43 Opa3+l that went 
through the testing seven (16%) did not survive to 50 days of age. There also seems 
difference in growth rates of the homozygotes compared to the wildtypes and heterozygotes.
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Figure 5.7. Growth curves of wildtype, heterozygote and homozygote G3/4 Opa3 mice from birth 
to 50 days of age. Symbols indicate mean body weight in grams. ± S.E.M. (The maximum N for 
each genotype was Opa3+l+ n= 17, Opa3+l' n= 42 and Opa.31' n= 5).
However, final body weights at 50 days of age were analysed in a box plot (Fig 5.8.). 
Homozygote body weight was found to be statistically significantly different (P=0.000) from 
wildtypes and heterozygotes but, no difference was observed between the wildtypes and 
heterozygotes.
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Figure 5.8. Box plot of final body weight at 50 days of age. The data are presented as a box plot 
(median, 25th and 75th percentile, whiskers with the highest and lowest values.
0Opa3+,+ n= 16, Opa3+l' n= 35 and Opa3^ n= 3) *** P = 0.000.
5.3.2 Primary SHIRPA Screening on Generation 3 and 4 (87% C57BL/6JCrl and 94% 
C57BL/6JCrl respectively)
The G3/4 mice underwent primary SHIRPA screening at 30 days of age. In the Opa3+/~ mice, 
there was no significant effect of genotype on all 40 of the separate behavioural measurements 
compared with Opa3+l+ littermates. It should be noted though, that despite not being 
significant a few Opa3+/ displayed some aspects of the homozygote phenotype such as lower 
body weight, hypoactivity and tremors.
In the Opa3~l~ mice, there was a significant effect of genotype on 11 of the 40 behavioural 
measurements compared with Opa3+l+ littermates (see Table 5.1 for description).
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Functional Parameter RESULTS Statistical
category Homozygotes Heterozygotes Wildtypes significance
body tone normal normal normal N/S
MUSCLE TONE abdominal tone normal normal normal N/S
AND limb tone normal normal normal N/S
STRENGTH grip strength moderate normal normal N/S
spontaneous activity normal normal normal N/S
lacrimation normal normal normal N/S
salivation normal normal normal N/S
STRESS heart rate normal normal normal N/S
touch escape mild response normal normal P=0.000
biting normal normal normal N/S
aggression normal normal normal N/S
vocalisation in observation jar normal normal N/S
irritability normal normal normal N/S
fear normal normal normal N/S
positional passivity normal normal normal N/S
transfer arousal brief freeze brief freeze normal P=0.001
righting reflex lands on side or back normal normal P=0.013
startle response jumps normal normal P=0.011
REFLEXOLOGY palpebral closure normal normal normal N/S
AND SENSORY pineal reflex normal normal normal N/S
FUNCTION corneal reflex normal normal normal N/S
toe pinch normal normal normal N/S
piloerection normal normal normal N/S
negative geotaxis normal normal normal N/S
visual placing
upon vibrassae 
contact normal normal P=0.000
tremor mild or marked Mild or marked normal P=0.023
body position normal normal normal N/S
tail elevation normal normal normal N/S
MOTOR pelvic elevation elevated normal normal P=0.023
BEHAVIOUR trunk curl normal normal normal N/S
limb grasping present normal normal P=0.000
wire manoeuvre difficulty grasping normal normal P=0.007
gait fluid but abnormal normal normal P=0.000
negative geotaxis normal normal normal N/S
locomotor activity low low normal P=0.000
respiratory rate normal normal normal N/S
defecation normal normal normal N/S
AUTONOMOUS urination normal normal normal N/S
FUNCTION skin colour blanched normal normal N/S
heart rate normal normal normal N/S
Table 5.1. List of all tests performed in the SHIRPA protocol. Aberrant behaviours observed in 
testing were not necessarily seen in all of the mice. Normal = no abnormal behaviour was 
observed in any of the mice. N/S= no statistically significant difference when compared to the 
wildtype.
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In the viewing jar, O p a 3 mice were only significantly different to Opa3+l+ mice in tremor: P 
< 0.05. In the arena, the Opa3 f' mice were significantly different from Opa3+l+ mice with 
respect to six measures: transfer arousal from the viewing jar to the arena: P =0.001; 
locomotor activity: P =0.000; startle response tested by the MRC standard click box: P < 
0.05; gait: P =0.000; pelvic elevation: P < 0.05 and touch escape: P =0.000. For behaviours 
measured outside of the arena, there were significant differences between the Opa3~1' and 
Opa3+l+ mice with respect to four measures: visual placing: P =0.000; limb grasping: P 
=0.000; wire manoeuvre: P < 0.01 and righting reflex: P < 0.05.
5.3.2.1 Primary SHIRPA screening o f aged heterozygous ‘founders’
Heterozygote ‘founders’ and their wildtype littermates were tested at two years of age, to 
assess whether ageing compromised the heterozygous mice. Due to deteriorating health and 
declining numbers it was not possible to test the Opa3 f~ mice beyond four months of age. No 
significant differences were observed in any of the 40 parameters tested between wildtypes 
and heterozygotes. Therefore, at two years of age the heterozygote ‘founders’ remain 
indistinguishable from their littermate controls.
From the results of the Primary SHIRPA Screening a battery of tests from the secondary 
SHIRPA screening was designed to give a more in depth analysis of the aberrant behaviours 
observed in the Opa3'f' mice and to cover aspects of the human MG A-III phenotype.
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5.3.3 Walking Pattern
Gait abnormalities were analysed by footprint patterns of mice while they walked along a 
narrow strip of paper. Peripheral nerve function can be assessed based on measurements made 
from walking tracks [De Medinaceli et al, 1982]. Cerebellar function can also be assessed 
where physiological symptoms of cerebellar dysfunction include ataxia, side-to-side truncal 
tremor, and an abnormal wide stance base in the gait [Gilman et al, 1981]. Footprint patterns 
of Opa3~' and Opa3+l+ mice at 30 days of age are illustrated in Fig 5.9.
+/+
+/+
Figure 5.9. Footprint pattern analysis in (A) homozygote and (B) wildtype mice. Hindfeet were 
coated in blue paint and forefeet were coated in red paint. Splayed gait can be observed in the 
homozygote by hind foot prints not overlapping with forefoot prints.
Typically, when walking or trotting, a wildtype mouse will walk in a straight line with 
alternate fore and hind paw steps, lifting the fore paw on one side and the hind paw on the 
other together, and swinging the hind paw through to the spot from which the forepaw on the 
same side had previously rested (Fig 4.9B.). Consequently, a powerful measure of precision 
and co-ordination of walking is provided by the degree to which the forepaw and hind paw 
prints overlap. The homozygote mice displayed a co-ordinated walking pattern except for the 
hind paws being placed well outside of the fore paw step pattern (Fig 4.9A.). Footprint 
analysis patterns were taken before onset of tremors or ataxia.
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5.3.4 Rotarod
The rotarod test was used to study motor performance/co-ordination and skill learning. From 
the first day of testing at 23 days of age there was a significant correlation between genotype 
and time spent on the accelerating rotarod. Analysis of the raw data (Fig 5.10.) showed 
improvements by all genotypes in time spent on the rotarod during the first few testing 
sessions. This either indicates their ability to learn the new skill or is an increase in muscle 
mass due to the immaturity of the mice at the beginning of testing. By comparing the rotarod 
performance of the mice at 28 and 33 days of age to their final rotarod performance at 87 days 
of age, the Opa3'' and Opa3+l showed no improvement in rotarod performance. Whereas, the 
Opa3+l+ did show an improvement over time with a significant difference in rotarod 
performance (P=0.031). This suggests a deficit in cerebellar-dependent motor learning in the 
Opa.31 and Opa3+/ mice. Rotarod performance is sensitive to body weight with mice of 
smaller strains having longer latencies to fall and mice of larger weight having shorter 
latencies [McFadyen et al, 2003]. This suggests that the Opa3~ performance maybe poorer 
than results would suggest.
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Figure 5.10. Accelerating rotarod performance. Data expressed as average latency to fall off 
rotarod in secs ± S.E.M. A cohort of 21 mice were tested from 23 days of age, every 5 days, until
87 days old (Opa3+l+ n=7, Opa3+" n=7, Opa3 " n=7).+/- > - / -
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The Opa3'' mice showed a decrease in latency to fall relative to the Opa3+l+ and Opa3+/ mice 
(Fig 5.11.) and were statistically significantly different to the Opa3+l and Opa3+/+ on all days 
tested (P< 0.005 at all time points). There was no statistical difference between the Opa3+/ 
and Opa3+l+ at any time points. In order to test if poor performance of Opa3 ' mice on the 
rotarod was due to abnormal muscle strength, they were assessed for grip strength on the wire 
hang.
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Figure 5.11. Box plot of final rotarod performance in 87 day old mice. The data are presented as 
a box plot (median, 25th and 75th percentile, whiskers with the highest and lowest values)
** P<0.01.
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5.3.5 Wire Hang
The wire hang task (the ability to hang upside down from a wire screen) measures 
neuromuscular function, grip strength, and motivation.
Analysis of neurological performance on the wire hang test showed the Opa3+l mice fell off 
the screen without any significant time difference from their wildtype controls (Fig 5.12.).
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Figure 5.12. Hanging wire test to measure balance and grip strength in a cohort of 21 mice 
tested from 23 days of age every 5 days until 87 days of age. Time on the wire was recorded up to 
a maximum of 10 mins. Data expressed as average latency to fall off the wire grid in secs ± 
S.E.M. (Opa3+,+ n=7, Opa3+l n=7, Opa3 ' n=7).
In the O p a 3 mice genotype effect was confirmed from 23 days of age through to 48 days of 
age where they were statistically significantly different. However, a global increase of 
performance was noted with progressive ageing in the Opa3 A mice and from 53 days of age 
onwards there was no difference in genotypes. Therefore, by 53 days of age no major 
abnormalities in muscle strength were observed when compared with Opa3+/+ mice.
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5.3.6 Open Field Testing
5 .3 .6 .1 iMtency to reach the periphery.
When placed in the open field wildtype mice moved quickly to the edges of the open field 
apparatus, whereas the homozygote mice took significantly longer to reach the periphery (Fig 
5.13.). Opa3+l+ took on average of 3.1 ± 0.8 secs, Opa3+l took 31.8 ± 13.5 secs and Opa3 ' 
took 69.6 ± 6.9 secs (P=0.000). A large variability was seen in time taken for the 
heterozygotes to reach the periphery and on average was less than half that of the wildtypes 
but it was not statistically significant (P= 0.166).
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Figure 5.13. Latency to reach perimeter squares of Opa3''' and Opa3+l' and Opa3+/+ mice in open 
field testing. Data expressed as mean ± S.E.M. (Opa3+l+ n = 9, Opa3+l' n =10, Opa3''' n =9) ***P < 
0 .001.
During initial exposure to the novel environment mice normally display ‘stretch attends’ 
which is a risk assessment behaviour. All of the OpaS1 displayed virtually no stretch attend 
movements suggesting a lack of anxiety and fear.
5.3.6.2 Total A ctivity
Study of the raw data (Fig 5.14.) which was broken into 30 sec intervals showed that total 
locomotor activity which included horizontal (squares entered) as well as vertical (rears) 
activity was significantly lower in Opa3' compared to the Opa3+l and Opa3+/+ mice. 
Comparisions were made of number of squares entered at each time point using a paired 
sample t test. The homozygotes showed a statistical significant increase in number of squares 
entered during the 5 mins. Comparisions of squares entered by the homozygotes during 0-30
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sec compared to 271-300 secs (P=0.008), 31-60 secs compared to 271-300sec (P=0.032) by 
61-90sec there was no significant difference (P=0.190). This suggests that the Opa3'/ mice 
failed to show within-session habituation. Wildtype and heterozygotes showed no statistical 
difference between any time points suggesting that they habituated to the open field.
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Figure 5.14. Graph showing total locomotor activity for each 30 sec period during the 5 min 
testing.
Analysis of total locomotor activity (Fig 5.15.) showed an effect of genotype. The Opa3' and 
Opa3+l~ mice showed clear evidence of decreased locomotor activity, with total locomotor 
activity in O p a 3 mice 3.6 fold less (62.77 ± 11.81, P= 0.000) and Opa3+l mice 1.8 fold less 
(119.5 ± 10.43, P= 0.000) when compared with wildtype (225 ± 18.84). There was also a 
significant difference when comparing locomotor activity in Opa3 A mice with Opa3+l mice 
(P=0.023).
159
300 
■f* 250
200  
2
g 150 
| 100
|  50
0
★ * *
w i l d t y p e  h e t e r o z y g o t e
G enotype
h o m o z y g o t e
Figure 5.15. Total locomotor activity of Opa3-/- and Opa3+/- and Opa3+/+ mice in open field 
testing. Locomotor activity is defined as number of squares entered plus number of rears. Data 
are expressed as mean ± S.E.M. (Opa3+/+ n = 9, Opa3+/- n =10, Opa3-/- n =9) ***P < 0.001.
5.3.6.3 Exploration an d  R earing
Number of rears is an indicator of exploratory behaviour. Reduced exploratory behaviour in 
Opa3 '~ mice was reflected as a decreased incidence of rearing activity against the wall in the 
open field (Fig 5.16.).
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Figure 5.16. The number of rears during 5 mins of Opa3 ' and Opa3+l' and Opa3+l+ mice in open 
field testing. Data expressed as mean ± S.E.M. (Opa3+l+ n = 9, Opa3+/' n =10, Opa3''' n =9). ***P < 
0.001, **P< 0.01, *P< 0.05.
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For the number of rears against the wall the Opa3'f and Opa3+l were statistically significantly 
different from their wildtype controls (Opa3''' P= 0.000; Opa3+l P=0.005). Without the wall 
only the Opa3+,~ were significantly different (P=0.04) and in the centre of the arena there was 
no difference observed between any of the genotypes.
The time spent in the centre of the arenas was also measured as very little time spent in the 
centre can be an indication of altered anxiety especially if animals remain thigmotaxic 
throughout the entire test period (Fig 5.17.).
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Figure 5.17. Percentage of time spent in various areas of the arena of OpaS'1' and Opa3+l' and 
Opa3+l+ mice in open field testing. Data expressed as mean ± S.E.M. (Opa3+l+ n = 9, Opa3+l n =10, 
Opa37 n =9). ***P < 0.001.
The Opa3 l mice are seen to spend considerably more time in the central squares than the 
heterozygotes and wildtypes. This difference was due to the long period of time taken to reach 
the periphery when initially placed in the open field arena Homozygotes were significantly 
different from wildtypes in central CP=0.000) and peripheral (P=0.001) but not comer 
(P=0.074). Difference in time spent in peripheral squares was due to reduced locomotor 
activity in the homozygotes. Heterozygotes were not different form wildtypes in any part of 
the arena. Homozygotes were only different from heterozygotes in the peripheral (P=0.032).
The Opa3 ‘ mice performed fewer complete grooming cycles than Opa3+l+ mice which is 
consistent with the general reduction in co-ordinated activity observed in Opa3'1' mice.
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5.3.7 Muscle COX-SDH
COX-SDH staining was analysed on the gastrocnemius muscle of 30 day old mice (Opa3+l+ 
n=3, Opa3' n=3). Previous H&E staining (Chapter IV, Fig 4.9B.) showed normal muscle 
fibre morphology. No SDH staining and no COX deficient fibres were identified in any of the 
homozygote sections (Fig 5.18A.).
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Figure 5.18. Dual COX-SDH staining in (A) homozygote and (B) wildtype muscle sections. (Opa3 
+/+ n=3, Opa3 A n=3). Magnification x20.
Muscle fibres were counted for any difference in light and dark stained fibres, no statistical 
difference was observed. The average sampling of 161 muscle fibres for each section, five 
section per mouse (Standard deviation = 6.88, range = 175-153).
5.3.8 Cerebellar MRI imaging
High resolution MRI allows precise measurement of volumes, and eliminates artefacts due to 
dehydration or paraffin embedding that can occur from histological preparation. Brains of one 
homozygote mouse and one control were measured with high contrast at high resolution (pixel 
resolution of 50 pm). The architecture of major brain regions (cortex, hippocampus, 
cerebellum) are clearly defined at this resolution (Fig 5.19A.) and poly microgyria can be seen 
in the homozygote.
Volumes of total brain, and cerebellum only were determined for each brain in the horizontal 
and saggital planes. Cerebellar volume had to be estimated as a proportion of the entire brain, 
as overall brain size between homozygote and wildtype is different due to homozygotes being 
significantly smaller than wildtypes. Therefore, the cerebellum of Opa3 homozygote mice is 
reduced in size and is proportionately smaller relative to the total brain size. Volumes were 
calculated by summing volumetric pixels (voxels) in every MRI slice. The volume of the
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Opa3 homozygote cerebellum can clearly be seen to be smaller (Fig 5.19C.) and as a 
proportion of the whole brain was 9.71% whereas the wildtype cerebellum was 16.08% of 
whole brain volume. Therefore homozygote cerebellum was ~ 40% smaller than that of the 
wildtype.
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Homozygote Wildtype
Figure 5.19. Cerebellar volume is reduced in Opa3 '- mice. (A) Representative 
MRI images of mouse brain in horizontal plane. (B) Manual outlining of 
cerebellum (green) and rest of brain (red) for volume analysis. (C) 3-D 
rendering of mouse brain showing cerebellum (green) and rest of brain (red). 
Cerebellum is visibly smaller in the homozygote.
5.4 Discussion
The present findings demonstrate that Opa3'/' mice display major changes in novelty-driven 
spontaneous activity characterised by hypoactivity, abnormal exploratory behaviour and 
impaired habituation to the test environment suggesting neuropsychiatric function maybe 
altered. In addition, Opa3'!' mice exhibit major impairments in motor coordination as 
observed in the rotarod and open field which cannot be explained by a deficit in muscle 
strength. This together with a splayed gait suggests cerebellar dysfunction. In rotarod testing 
they also exhibit poor motor learning skills which indicate deficits in cerebellum-dependent 
motor-learning tasks. Spinocerebellar function may also be impaired as indicated by limb 
grasping and splayed gait. These findings of impaired cerebellar function were strengthened 
by preliminary data on cerebellum volumetric analysis which showed a 40% reduction in 
cerebella brain mass in homozygotes.
In SHIRPA testing Opa3~l~ showed clenching of the hind limbs when held by the tail and this 
together with the tremors and lower body weight are all signs of a neurological disorder. The 
leg extension reflex test evaluates the presence or absence of clasping of the hind limbs when 
a mouse is suspended by the tail, this is a measure of motor neuron functionality [Bameoud 
and Curet, 1999]. Limb clasping/extension, splayed gait and general aberrant behaviour 
suggest dysfunction of the cerebellum.
The homozygotes also showed a large reflexive body flinch to the acoustic startle test. This 
phenotype is usually considered to be a deficit in sensorimotor gating. Sensorimotor gating 
refers to the state-dependent regulation of transmission of sensory information to a motor 
system. It has been known for decades that sensory information does not have unfettered 
access to its targets in the CNS, as has the fact that sensorimotor gating often occurs via 
presynaptic inhibition of the activated sensory neuron(s). Glutamate is ubiquitously expressed 
in the brain and is a primary excitatory neurotransmitter. Glutamate excitotoxicity would 
affect the neurotransmission across the synapse and cause the high acoustic startle response 
and would also account for the cognitive deficits observed in MGA-III patients. This 
phenotype is a defect of the brain stem and since other brain stem tests were normal i.e., ear 
reflex, it may be that the high startle response is due to a defect in the structure of the 
tympanic bone which is known to be abnormal in some Opa3~l~ mice (see Chapter IV). There
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were neurological tests in which the homozygotes exhibited normal behaviour, such as tactile 
stimulus and negative geotaxis, suggesting the disease is confined to certain parts of the CNS.
The impairments in the open field task appear to reflect a deficit in motor co-ordination and 
the acquisition of normal patterns of adult mouse behaviour. The Opa3A mice displayed a 
reduction in horizontal as well as vertical activity. This reduction in locomotor activity may 
be indicative of motor impairment or weakness in the Opa3'l~, particularly as little rearing 
behaviour was observed. As no muscle weakness was observed in the wire hang test it is more 
likely that lower locomotor activity was a result of motor impairment. However, it should be 
noted that the consistently smaller size of mutants may be masking any muscular strength 
deficiency on the wirehang test.
Alternatively, low activity can indicate increased anxiety or neophobia. Anxiety can be 
inferred by whether the majority of exploration occurs in close proximity to the walls 
(thigmotaxis) or in the centre of the test arena. The Opa3''' spent significantly more time in 
the centre of the arena compared to the Opa3+l+ and Opa3+l' mice suggesting a lack of fear. 
Also, when the apparatus is novel to the animals, more fear and anxiety related behaviours 
(such as stretch attends and activity in the comers and walls of the open field) would usually 
be displayed. The Opa3~/~ displayed extremely few stretch attends and did not spend 
significantly more time in the corners of the arena compared to the Opa3+l+ and Opa3+/~ mice 
again suggesting a lack of fear and anxiety at being exposed to a novel environment.
These results for the homozygotes are unusual as time in centre is highly correlated with total 
locomotion these being related measures of avoidance and exploratory behaviour. However, if 
the raw data of the number of central and peripheral squares entered during the 5 mins is 
examined (Appendix III, Fig 10.1.) it can be seen that the Opa3~l~ mice enter significantly less 
central squares than the Opa3+l+ which would suggest increased anxiety. Also, if their 
behaviour is examined after they reach the periphery (time zero being once they have reached 
the periphery not when they were dropped into the arena) see Appendix III, Fig 10.2. the 
results would also suggest increased anxiety as the homozygotes spend significantly longer in 
the comer squares and significantly less time in the centre squares.
A reduction in rearing counts during the open field test strongly suggests an increase in 
anxiety and a deficit in exploratory behaviour. However, this discrepancy could be related to a
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decrease in the balance and/or motor-coordination abilities of the Opa3' mice and not directly 
related to the exploratory behaviour or anxiety of the mice. The two legged stance used for 
rearing is less stable than the four legged stance used for horizontal movement. Control of 
body position involves the vestibular part of the inner ear, proprioreceptors in joints and 
muscles as well as vision. Gait abnormalities may affect the ability of animals to perform 
some of the tasks. Gait abnormalities can either be attributed to skeletal, muscular or 
neurological defects. In Costeff syndrome, patients suffer from extra-pyramidal dysfunction. 
The extra pyramidal system regulates posture and skeletal muscle tone. An inability to 
maintain posture and poor muscle tone may explain the footprint pattern of the homozygote 
mutant. Gait abnormalities together with limb grasping/limb extension are suggestive of 
defects in nerve function.
Overall, the lack of habituation in open field, no stretch attends when first placed in the arena, 
a considerably long time spent in centre of the arena when first dropped in, reduced rearing 
activity and reduced locomotor activity are not correlated behaviours and seem to reflect a 
generalized deficit in the acquisition of normal adult mouse behaviour in the homozygote 
mouse.
To investigate defects in motor coordination and balance an accelerating rotarod was used 
which requires enhanced motor coordination skills. This test is sensitive to cerebellar 
degeneration in mice with natural mutations [Lalonde and Strazielle, 1999] as well as 
transgenic mice with neurofilament [Lalonde et al, 1999 and 2003] and muscular anomalies 
[Taylor, 2001; Sugarman, 2002]. Motor impairment was present in the O p a 3 mice through 
the whole of testing and was statistically significantly different from the Opa3+,+ (P<0.005 at 
all time points), which suggests a baseline motor coordination impairment in the Opa3~'' mice. 
This would point to decreased cerebellar function, which is consistent with decreased stability 
in rearing. In addition, a reduction in the latency to fall off the rotating rod over repeated test 
sessions provides a measure of cerebellar motor-learning. Opa3~1' showed no improvement in 
rotarod performance indicating a deficit in cerebellar-dependent motor learning.
At the end of wirehang testing there was no statistically significant difference between all 
three genotypes suggesting that deficits in motor-co-ordination and splayed gait are not due to 
muscle weakness. Muscle histology and COX-SDH also suggest no muscular defects in the 
Opa3 homozygote mice. It is interesting however that during the first several testing ages the
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latency to fall was considerably lower in the homozygotes when compared to the wildtypes 
but over time showed a dramatic improvement. There maybe several possible reasons for this 
(i) The wirehang is based on fear of falling from a height, as the homozygote mice are blind 
this paradigm may not work as well, (ii) In the home cage environment food is suspended 
from a wire grid cage top. This wire grid can be used for exercise by the mice. Because the 
homozygotes are so small they cannot reach the wire grid and therefore unlike the wildtype 
and heterozygotes have no previous experience of hanging from a wire grid, (iii) Or, yet 
again, due to a generalised deficit in the acquisition of normal adult mouse behaviour, (iv) The 
dramatic improvement maybe due to the homozygotes weighing considerably less than the 
heterozygotes and wildtypes.
Each of these methods has limitations. There are several common confounders of the rotarod 
test. The first is that some animals may cling to the beam, and rotate with it, rather than fall 
when they lose balance. The second confound relates to individual animals that refuse the test 
and simply fall as soon as they are placed on the rod. This is especially relevant in 
longitudinal assessments, during which the animals can learn over repeated tests that the 
consequences of falling are innocuous. This behaviour was observed in several of our animals 
and they had to be excluded from the test cohort. A third confound relates to mouse weight: 
heavy mice perform worse than light mice. Thus, genetic or lesion-induced weight loss can 
offset motor disability and potentially skew results. Finally, and particularly with the 
accelerating version of the rotarod, speed is confounded by fatigue at progressively longer 
latencies. However, demonstration of differential deficits at higher rotation rates in a series of 
fixed-speed tests can be used to ensure that a more rapid fall is indeed attributable to problems 
with motor coordination rather than to greater susceptibility to fatigue. Despite these 
confounds, the rotarod remains one of the main tests of motor function in the mouse owing to 
its ease of use and sensitivity.
The wirehang test lacks sensitivity, and accurate assessment of grip strength is dependent on 
homogeneity of mouse weight across the cohorts. In addition, the mice tend to move around 
when the grid has been inverted, and consequently different muscle groups are being used or 
rested while the animal is moving. This contrasts with testing mice on the mechanical 
systems, where only forelimb muscles are being strained. Mouse movement can be difficult to 
overcome and tends to be strain dependent; agitating the grid before inverting it partially
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resolves the problem, as the animals increase their grip as the grid is shaken. The same weight 
problem applies to the wire hang test.
The Opa3''' mice show no gross outward abnormalities. However, they are considerably 
smaller than their wildtype littermates and exhibit deficits in both motor and cognitive 
behaviour. Despite the small size of the Opa3''~ the differences in motor function tests are 
unlikely to be attributed to body mass as apart from an initial improvement in performance 
(probably due to either initial learning of the task or increase in muscle mass due to the young 
age of the mice) the variation between the wildtype and mutant strain was essentially 
consistent throughout the experiment.
All the above neurological and behavioural tests suggest defects in the cerebellum which is 
known to play an important role in motor control. It is also involved in some cognitive 
functions such as attention and language, and probably in some emotional functions such as 
regulating fear and pleasure responses. The cerebellum also is necessary for several types of 
motor learning, most notably learning to adjust to changes in sensorimotor relationships. The 
cerebellum does not initiate movement, but it contributes to coordination, precision, and 
accurate timing. It receives input from sensory systems and from other parts of the brain and 
spinal cord and integrates these inputs to fine tune motor activity. Because of this fine-tuning 
function, damage to the cerebellum does not cause paralysis but instead produces disorders in 
fine movement, equilibrium, posture, and motor learning.
High resolution three-dimensional MRI revealed that the volume of the cerebellum was 
significantly reduced in the homozygote mouse. This anatomical phenotype was not readily 
apparent from previous H&E analysis [Davies et al, 2008]. Cerebellar dysfunction is present 
in MGA-III patients but usually of a mild degree and cognitive impairments are seen in some 
individuals ranging from IQ of 40 upwards. Any reduction in cerebellar volume in MGA-III 
patients is at present unknown.
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5.5 Conclusions
- The Opa3' mice exhibited major impairments in motor coordination as observed in the 
rotarod and open field which is not caused by a deficit in muscle strength as shown in the 
wirehang test. Therefore, the data supports the idea that absence of OPA3 contributes 
significantly to neurological impairment in diseases such as MGA-III.
- The wirehang test, COX-SDH staining and H&E muscle sections (Chapter IV) suggest that 
the Opa3u22p mutation does not affect muscle.
- The findings suggest that Opa3 plays a role in the mechanisms underlying complex 
behaviours in the adult mouse, in particular cognitive processes. The mice displayed abnormal 
exploratory behaviour and impaired habituation to the test environment suggesting 
neuropsychiatric function maybe altered. It is therefore likely to be important for normal 
function in the human brain. This concurs with MGA-III patients who are known to suffer 
from cognitive deficits.
- Cerebellum function is affected in the Opa3U22p mice. In rotarod testing, they also exhibited 
poor motor learning skills, which again indicate deficits in cerebellum-dependent motor- 
learning tasks. A splayed gait also suggests cerebellar dysfunction. These findings of impaired 
cerebellar function were strengthened by preliminary data on cerebellum volumetric analysis 
which showed a 40% reduction in cerebellar brain mass in homozygotes.
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CHAPTER 
VI
The Opa3Ll22P mouse model of MGA-III displays profound 
disturbance in lipid metabolism
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6.1 Introduction
Aims of chapter
- Plasma biochemistry for metabolic disturbances and analysis of 3-methylglutaconic acid to 
confirm our Opa3u22? mutant mouse as a model of MGA-III.
- Assessment of decreased body fat observed in MRI scans by quantification of subcutaneous 
and visceral fat pads.
- Analysis of disturbed energy homeostasis by quantification of increased fat deposition in 
liver and bone marrow.
Increased urinary excretion of 3-methylglutaconic acid and to a lesser extent 3-methylglutaric 
acid is a common feature of all the MGA syndromes and they are therefore considered 
metabolic disorders. It was not surprising then, that in the homozygote mouse, profound 
disturbances in metabolic homeostasis were observed. MRI scans showed a lack of white 
adipose tissue (WAT) [Davies et al, 2008], histological sections (Chapter IV) showed G3/4 
Opa3''' C57BL/6JCrl mice with large fat deposits in the liver, and homozygote mice whilst 
housed separately seemed unable to maintain their body temperature and quickly die. Bio­
informatics of TFBS for putative functional analysis also indicated a possible role for Opa3 in 
adipogenesis. This chapter attempts to characterize the disturbance in metabolic homeostasis 
in our mouse model.
All work in this chapter was done in collaboration with Dr Timothy Wells, School of 
Biological Sciences, Cardiff University, with plasma analysis undertaken by Dr Irina 
Guschina, School of Biological Sciences, Cardiff University.
6.1.1 Adipose tissue in mammals
The adipose tissue pool in mammals is composed of two different types of fat: WAT and 
BAT, which have different physiological roles and can be distinguished by their appearance 
and metabolic features [Cinti, 2005]. The quantity of body fat varies widely in mammals, 
ranging from 2 to > 50% of body mass, but is typically 10 to 25% in mice and humans. 
Adipose tissue is an important metabolic organ that is crucial for whole-body energy 
homeostasis {Rosen and Spiegelman, 2006].
172
WAT is the predominant type of fat in adult humans and mice and white adipocytes are the 
major cellular components of visceral and subcutaneous WAT depots [Cinti, 2005]. It is the 
major organ for regulated storage of triglycerides for use as metabolic energy and also helps 
control energy homeostasis including food intake, metabolic efficiency, and energy 
expenditure via secreted signalling molecules, termed adipokines. Thus WAT is involved in 
diverse range of physiological processes.
The principal function of BAT is heat production (non-shivering or adaptive thermogenesis) 
this phenomenon does not exist in the absence of functional brown adipose tissue. It is the 
primary thermogenic mechanism for newborns and rodents to prevent hypothermia 
[Klingenspor, 2003]. Brown adipocytes are very rich in mitochondria that uniquely express 
the UCP-1. When activated, this protein dissipates proton motive force in the form of heat. 
Recent data has shown the presence of this tissue in healthy, adult humans [Nedergaard et al, 
2007; Virtanen et al, 2009].
Mitochondria play a central role in adipose metabolism, as highlighted by mitochondrial 
impairment in metabolic diseases [Holloway et al, 2009] and neurodegenerative diseases, and 
in aging [Guarente, 2008 and Katie et al, 2007].
6.1.2 Energy homeostasis
Energy homeostasis is the process whereby bodyweight and fat mass are maintained at 
relatively stable levels over long periods despite day-to-day fluctuations in food intake and 
energy expenditure and depends on the ability of the CNS to sense and respond to changes in 
adiposity. A sophisticated lipoprotein transport system exists to meet the different energy 
demands from a variety of tissues (Fig 6.1.).
Most of the energy stored in adipose tissue comes from plasma triglycerols which are 
provided by dietary lipids. These dietary lipids are absorbed through the gastrointestinal tract 
in the form of circulating chylomicrons and very-low-density lipoprotein (VLDL), part of 
which is metabolized to provide energy and the rest of which enters the liver and adipose 
tissue for short and long term storage, respectively. As a gauge of the level of energy reserves, 
adipose tissues secrete several adipokines, such as leptin, which regulates energy homeostasis 
by signalling to the brain and peripheral tissues.
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To meet increasing energy demands, or during starvation, triacyl glycerol (TAG) stores are 
mobilised in adipose tissue, this hydrolysis of TAG into FAs and glycerol being known as 
lipolysis. Leaving the adipocytes, the FAs circulate in the plasma as free FAs bound to plasma 
albumin to be utilized principally by adipocytes (re-esterification into TAG), muscles 
(oxidation) and liver (oxidation and also for TAG synthesis and VLDL secretion).
Figure 6.1. Adipose tissue, which is the main energy storage site, is responsive to both central 
and peripheral metabolic signals by regulating lipid storage and mobilization. [Shi and Burn, 
2004]
The liver has an important role as a homeostat for transient energy fluctuation; it protects 
other tissues from postprandial triglyceridaemia by temporarily storing FAs from the 
circulation as a benign derivative, TAG, and secreting them as VLDL when the period of 
maximum lipid load has passed. The liver is also an important site for energy conversion, 
exchanging energy sources from one form to another, such as glycogen to glucose, FA to 
TAG and saturated FA to unsaturated FA. The potential sources of hepatic TAG include
CNS regulation
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peripheral fats stored in WAT that flow to the liver by way of the plasma free FAs pool, 
dietary FAs (mainly through the uptake of intestinally derived chylomicron remnants), and 
FAs newly made within the liver through de novo lipogenesis (Fig 6.2.). After the 
esterification step (conversion of FAs into TAG), TAG can then be stored as lipid droplets 
within hepatocytes or secreted into the blood as VLDL for storage in adipocytes and to 
cardiac and skeletal muscle for energy consumption. Lipoproteins are composed of 
triglycerides, cholesterol esters, phospholipids, and apolipoproteins, which modulate 
lipoprotein catabolism. Triglycerides can also be hydrolyzed and the FAs channelled towards 
the p-oxidation pathway.
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Figure 6.2. Model of lipid flux through the liver. De novo lipogenesis (DNL) indicates new fat 
synthesis from 2-carbon precursors (e.g., dietary carbohydrate); chylomicrons are lipoproteins 
made in the intestine that carry dietary fat. FA, cellular fatty acids (fatty acids not esterified to 
glycerol but bound to a carrier protein); LPL= lipoprotein lipase, NEFAs = nonesterified fatty. 
[Donnelly et al, 2005]
The synthesis of TAG in liver is nutritionally regulated, and its formation from simple 
carbohydrates requires multiple metabolic pathways, including glycolysis and pyruvate 
oxidation to generate acetyl-CoA for FA synthesis, NADPH generation to supply the 
reductive power, packaging of FAs into a glycerophosphate backbone, and finally, lipoprotein 
packaging to export TAG.
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6.1.3 Thermogenesis
BAT has developed as an essential thermoregulatory effector in cold defence in rodents and 
other small mammals [Golozoubova et al, 2006], including infant humans. Upon cold 
exposure, heat production in the animals is facilitated by the splanchnic nerve-stimulated 
release of catecholamines, which activates thermogenesis and dissipation of the generated 
heat through the circulation. Heat production is accomplished by the heat-generating capacity 
of a significant facilitated proton leak across the extensive mitochondrial membranes of the 
brown adipocytes, which occurs because of the high expression of UCP-1 in BAT 
mitochondria [Cannon and Nedergaard, 2004]. UCP-1 is exclusively expressed in brown 
adipocytes, and while analysis of WAT depots displays some low level of UCP-1, it is likely 
due to the sparse distribution of brown fat cells throughout the tissue.
The potential significance of BAT thermogenesis in adult humans and other large mammals 
has been controversial, at least in part, because evidence for its existence has been lacking. 
However, several recent observations using positron emission tomographic scanning to assess 
tissue glucose uptake [reviewed by Nedergaard et al, 2007] have demonstrated a remarkable 
amount of brown adipose tissue in adult humans, and the locations of BAT depots in adult 
humans bear a striking similarity to those in rodents: a large BAT pad in the vicinity of the 
scapulae and shoulders and individual pads atop each sympathetic ganglion and surrounding 
the adrenal glands and kidneys.
In addition to BAT, body temperature is also regulated by shivering thermogenesis in skeletal 
muscles. During the rapid, repeated skeletal muscle contractions of shivering and during 
increases in heart rate, thermogenesis arises primarily from the inefficiency of energy 
utilization in cross-bridge cycling and calcium ion sequestration and, to a lesser degree, from 
mitochondrial membrane proton leak in the course of ATP production from fuel substrate 
oxidation [Rail and Woledge, 1990; Jubrias et al, 2008]. The muscle contractions of shivering 
result from rhythmic bursts of activity in the a-motoneurons innervating skeletal muscle 
fibres.
There are no reports of unusual WAT distribution or hepatic steatosis in MGA-III patients, 
but microvesicular hepatic steatosis has been observed in MGA-V patients. This chapter 
attempts to characterize these phenomena in our mouse model. To determine the severity of 
lipodystrophy, fat deposition in abdominal and visceral fat pads was quantified. Liver and 
bone marrow adiposity were also assessed to give a better understanding of energy
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homeostasis. This together with serum chemistry quantification of metabolites and 3- 
methylglutaconic acid will assist in characterizing the disturbances in metabolic homeostasis 
in our mouse model.
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6.2 Materials and Methods
6.2.1 Mice used
A cohort of twelve male 30 day old mice were used (O p a 3 n=6, Opa3+l+ n=6).
6.2.2 Tissue collection
Mice were weighed and anesthetized with isofluorane prior to decapitation. Trunk blood was 
collected, centrifuged and separated plasma was stored at -20°C for subsequent plasma 
biochemistry. Visceral (epididymal and retroperitoneal) and subcutaneous (inguinal) fat pads 
were excised and weighed. The right tibiae were removed, the length measured with a hand­
held micro meter and treated for subsequent determination of epiphyseal plate width (EPW) 
and quantification of bone marrow adiposity. Liver samples excised stored at -70°C for 
subsequent analysis of lipid and TAG content.
6.2.3 Blood plasma biochemistry
It was not possible to obtain urine samples from the Opa3 homozygotes mice because they 
produced such extremely low amounts despite not being dehydrated. Blood was therefore 
analysed for 3-methylglutaconic acid to confirm the mouse as a model of MGA-III.
6.2.3.1 Measurement o f 3-methylglutaconic acid
50-100 pi of plasma was extracted with ethyl acetate (3x3ml) and diethyl ether (3x3ml). The 
combined extracts were dried under a stream of nitrogen, reconstituted in small volumes of 
hexane and transferred into gas chromatography vials. Pentadecanoic acid (C15:0) was added 
as an internal standard, the extracts were dried under nitrogen and derivatised with BSTFA 
(N,0-bis(trimethylsilyl)trifluoroacetamide) and pyridine (1:1, v/v) at 70°C for 30 mins. The 
solution was dried under nitrogen and re-dissolved into 30 pi of hexane.
Trimethylsilyl (TMS) derivatives of 3-methylglutaconic acid was analysed by GC-MS using 
an Agilent 6890N GC with 5973N MS and 7683 autosampler fitted with 30m X 0.25mm 
internal dimensions (i.d.) column (Agilent HP-5MS, phase thickness 0.25um). A 2pl sample 
was injected at 230°C using a 50:1 split ratio. The column was temperature programmed from 
80°C to 270°C 10°C/min, then held at 270°C for 20 min; carrier gas was helium at the 
constant pressure of 13.43 psi. MS scanning mass to charge ratio (m/z) from 50 - 700 after 2
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mins solvent delay. Characteristic ion for di-TMS of 3-methylglutaconic acid at m/z 288 was 
used to monitor the separation of 3-methylglutaconic acid. Quantification was made by 
reference to an internal standard of pentadecanoate (C l5: 0).
6.2.3.2 Liver triglycerides
Lipids were extracted (from plasma and liver) by the Folch method [Kates, 1986]. 
Triacylglycerols and total polar lipids were separated by thin-layer chromatography and 
quantified by their FA contents. FA methyl esters were separated using a Clarus 500 gas 
chromatograph (PerkinElmer, Norwalk, CT), identified by comparing retention times with FA 
standards (Nu-Chek Prep., Inc., Elysian, MN) and quantified against an internal 
pentadecanoate standard.
6.2.4 Bone histology
Dissected tibiae were fixed in 4% PFA for five days and decalcified in 20% EDTA for three 
weeks. After being embedded in paraffin wax, 7-pm-longitudinal/anterior-posterior sections 
were taken and alternate sections stained with Masson’s Trichrome [Masson, 1929] or 
toluidine blue (see Chapter II). EPW were measured on Masson’s Trichrome-stained sections 
under light microscopy using Leica QWin software, with three measurements taken per 
section and three sections measured per bone. Bone marrow adiposity was analysed on 
toluidine blue sections using Image J.
6.2.4.1 Analysis of bone marrow adiposity using Image J
Digital images of mid-diaphyseal marrow were taken with a Leica DFC300FX digital camera 
mounted on a Leica DMLB microscope. A scale bar was added for image size and the image 
was saved as a jpeg file.
6.2.4.2 Using Image J
The images were converted to black and white. Firstly, this was done by brightness/contrast 
so that the white of the adipocytes is truly white, and then the image was changed to black and 
white using Image-type 8 bit.
Adipocytes were identified in the picture by circling in grey then all the adipocytes were filled 
in black. This was then checked against the original section picture to make sure all the 
adipocytes were filled in. The rest of the image was then removed to leave just the adipocytes
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by selecting Image-Adjust-Threshold. The number of adipocytes and their area was then 
counted by selecting Analyze-Set Measurements and ticking Area. Then Analyze-Analyze 
particles were selected and range was set “from lOpm-Infmity”, “Include interior holes” and 
“Exclude particles touching the edge”. The data was then copied into an excel file and 
expressed as % adiposity, adipocyte number and adipocyte size. Three different sections from 
each bone were analysed.
6.2.5 Adiposity profiling of Liver
15pm cryostat sections of liver were stained with Oil red-O and counterstained with Mayer’s 
haematoxylin (see Chapter II). Digital images (one image per section, three sections per 
mouse) were obtained with a Leica DFC300FX digital camera and a Leica DMLB 
microscope. Hepatic lipid droplets were measured using Q-Win.
6.2.5.1 Analysis o f liver steatosis using QWin
The Leica QWin V3 software was used to analyse steatosis. The microscope was set to bright 
field and x 20 magnification. On the image preview page the ’ 16-Bit/Channel’ colour depth 
and ‘Colour’ image type were selected. The settings were then adjusted to:-
Exposure 2.03ms Gain x 4 Colour saturation x 2
The focus was then changed to x 40 and the zoom was used to focus the section. ‘Acquire’ 
was clicked then ‘lens select for x 40’ was clicked to change the pixel ratio to 0.205um 
The ‘colour detect’ setting was then adjusted depending on the tissue type.
For normal steatosed liver i.e., wildtype mice, the setting was:
Colour detect Red 255/130 Green 110/0 Blue 50-60/0
For heavily steatosed liver ie homozygotes the setting was:
Colour detect Red 255/160 Green 60/0 Blue 50/0
Then ‘measure feature’ was clicked to give the number of features and the total area of the 
features. Colour detect levels for the heavily steatosed livers had to be set a different levels 
otherwise the whole field of view was marked as being fat.
6.2.6 Thermal Imaging
Using a dynamic, non-contact infrared camera (Thermo-Tracer TH7102MX, NEC San-ei), 
thermal images were taken of a 30 day old female and a wildtype control mouse. As 
variations in surface and volume ratios in organisms lead to variations in heat loss or retention
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a 12 day old pup was also compared to the 30 days old homozygote female as a size matched 
control.
6.2.7 Statistics
Statistical analysis was carried out with SPSS 16. Results are expressed as mean ± S.E.M, 
differences between groups was compared using unpaired Student’s t test. Results with P < 
0.05 were considered statistically significantly different.
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6.3 Results
6.3.1 General Physiology and Plasma Biochemistry of Opa3 mutant mice
At 30 days of age the Opa3'' mice were considerably smaller than their wildtype controls 
which corresponded to a 60 % reduction in body weight, accompanied by a 22 % reduction in 
tibiae length (Table 6.1.). The EPW of the Opa3f mice was 86% of the wildtype controls (P= 
0.140). This would indicate that their lower body weight was due more to loss of body tissue 
than to a smaller skeleton.
Quantification of circulating 3-methylglutaconic acid showed a 16 fold increase confirming 
the Opa3 homozygote mouse as a suitable model of Costeff s Syndrome. Serum chemistry 
quantification of plasma lipid, free FAs, plasma esterase (ES) and plasma ES-ARA were not 
significantly different from wildtype controls. Plasma ES and plasma ES-ARA are diet 
derived fats and indicate that the lack of WAT was not due to starvation.
Wildtype Opa3 hom ozygote E-value
Body W eight (g) 16.24 ± 0 .4 7 6.46 ±  0 .50 P <  0.001
Tibial Length (mm) 15.18 ± 0 .1 4 11.79 ±  0 .46 P < 0.001
Tibial epiphyseal plate width (pm) 272 ± 8 234 ±  32 P  = 0.140
Plasma Biochemistry
Osmolality (mOsm/kg) 295.7 ± 2 .0 296.6  ±  3.4 P = 0.202
3-methylglutaconic acid (pg /  lOOpl) 0.377 ± 0 .0 5 8 6.150  ± 2 0 .3 2 5 P  = 0.000
Total plasma lipid (pg /  lOOmg) 221.716 ± 18.661 182.36 ± 2 1 .1 2 0 P = 0.097
Plasma free fatty acids (pg /  lOOmg) 11.917 ± 1.395 14.7 ± 1.665 P = 0.286
Plasma ES (pg /  lOOmg) 64.45 ± 9 .2 1 7 48.42 ±  4 .632 P  = 0.089
Plasma ES-ARA (pg /  lOOmg) 51.15 ± 9 .2 3 4 41.48 ± 10.482 P = 0.252
Table 6.1. G eneral physiology and plasm a biochem istry in  m ale Opa.3'1' m ice.
6.3.2 Opa.3'1' display profound leanness
To assess the loss of adipose tissue observed in previous MRI scans [Davies et al, 2008], fat 
depots were taken and weighed. Three fat pads were taken: one subcutaneous (inguinal) and 
two visceral (epididymal and retroperitoneal). Visceral adiposity was considerably decreased 
in the male Opa3~l~ mice with both visceral depots as a percentage of body weight less than 
one-half that in wildtype controls (Fig 6.3A&E.). No significant difference was observed in 
the weight of the inguinal fat pads. Therefore, only abdominal fat depots seem to be affected.
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Histological sections were taken of epididymal fat pads for adipocyte size measurements 
(Adipocyte size analysis by Dr Tim Wells) (Fig 6.3.)- Adipocytes were 70% smaller than the 
wildtype controls (PcO.OOl). White adipocytes are typically larger than brown adipocytes, 
contain fewer mitochondria, and have a single large lipid droplet, pushing the nucleus to the 
cell periphery. In contrast, brown adipocyes are polygonal in shape, mitochondria-rich with 
multiple lipid drops scattered throughout. The nucleus is round and although eccentrically 
located, it is not in the periphery of the cell. Micrographs show the homozygote adipocytes to 
be structurally different (Fig 6.3D.) to the wildtype controls. The adipocytes in the wildtype 
control are typical of WAT displaying a single large lipid droplet with the nucleus at the cell 
periphery as seen in Fig 6.3C (arrow). However, structurally the WAT in Opa3'f' more closely 
resembles BAT displaying smaller cells with larger eccentrically located nuclei as seen in Fig 
6.3D (arrow).
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Figure 6.3. Quantification of (A) epididymal, (E) retroperitoneal and (F) inguinal WAT 
depots from male 30 day old Opa3 '' and age-matched control mice. (B) Graph displaying 
decreased adipocyte size in epididymal WAT depots in Opa3'f' compared to age-matched 
control mice. Representative images of epididymal fat pad sections in (C) Opa3+l+ and (D) 
Opa3''' are also presented (scale bar, 50 pm). Values shown are mean ± S.E.M. (Opa3 /‘ 
n=6, Opa3+l+ n=6). BW, body weight. **P < 0.01; ***P < 0.001.
6.3.3 Bone Marrow adiposity
Despite a reduction in abdominal adiposity, bone marrow adiposity was considerably 
increased in Opa3' tibiae with large numbers of adipocytes filling the medullary canal (Fig 
6.4.) and marrow space in the secondary centre of ossification. Our interpretation that these 
cells were adipocytes was based on their location, morphology, and that they were devoid of 
toluidine blue stain. These structures were not fixed cells but fixed cell ghosts that appear 
white because lipophilic agents (acetone and ethanol) extract the lipid from the cells during 
sample preparation.
Adiposity in Opa3'~ male mice bone marrow was increased 8 fold (P= 0.014) (Fig 59.A.) 
with adipocyte number increased by over 5 fold (P=0.028) (Fig 6.4C.). The size of the 
adipocytes in the homozygote was 158% of the wildtype but this was not significant (P= 
0.087). The increase in adipocytes number suggests an increase in adipogenesis in the bone 
marrow.
6.3.4 Hepatic steatosis
Hepatic steatosis is common in lipodystrophic mouse models [Shimomura et al, 1998; Moitra 
et al, 1998]. The livers in the Opa3~'~ mice were enlarged, heavier (Fig 6.5A.) and were lighter 
in colour. To assess for altered triglyceride distribution in the Opa3~'~ mice, lipid content in 
liver sections was quantified. Total lipid area, visualized by Oil-red-O staining (Fig 
6.5B&C.), showed an ~ 9 fold increase in homozygote livers (P= 0.018) (Fig 60.D.), which 
was never observed in controls.
Serum chemistry quantification of hepatic TAG, hepatic phospholipid content and plasma 
TAG confirmed that the mice had increased lipid content with ~ 9 fold increase in stored 
triglycerides (P=0.015). Interestingly, hepatic phospholipids and circulating TAG were not 
significantly different. Normal levels of hepatic phospholipids indicate that the structural 
integrity of the hepatic cells is intact and normal levels of circulating TAG suggests that TAG 
is being stored in the liver and not released to other organs for energy consumption or storage 
in adipose tissue.
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m arrow adiposity in toluidine blue 
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Figure 6.5. The effect of the Opa3 mutation on hepatic TAG production and storage. (A) Liver weight. (B) Representative 
images of liver sections from O p a 3 mice as compared to age-matched littermate control (C). Increased hepatic lipid 
content shown on (D) together with increased hepatic TAG content (E). (F) and (G) show no significant difference in 
hepatic phospholipids and plasma TAG respectively. Values are shown as mean ± S.E.M. *P<0.05.
6.3.5 Thermal imaging
Body temperature was assessed in the homozygotes. When housed individually they seem 
unable to maintain their body temperature and die within a short time. Preliminary results of 
surface body temperature in a 30 day old female Opa3' mice in the latter stages of the disease 
state showed a reduction in body temperature of ~4°C (Fig 6.6A.). The lower temperature was 
not observed in homozygote mice in the early stages of the disease state. To assess if the 
lower body temperature was an effect of higher surface area to volume ratio, the homozygote 
was also compared to a 12 day old pup (Fig 6.6B.) as variations in surface and volume ratios 
in organisms can lead to variations in heat loss or retention. The image shows a lower 
temperature in the 30 day old homozygote compared to the 12 day old pup suggesting surface 
area/volume ratio is not an influencing factor.
This reduction in body temperature is of particular interest as BAT in the Opa.3' as a 
percentage of body weight was double that in controls (Fig 6.6C.) and BAT intrascapular 
adipocytes were more than three times larger than controls (Fig 6.6D.) suggesting that the 
reduced body temperature is due to perturbed metabolic processes rather than aberrant tissue 
development. However, the Opa3'/' mice were inactive compared to the control mice, which 
would suggest that the hypothermia maybe due in part to a lack of locomotor activity.
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Figure 6.6. The O p a 3 mice display defects in thermoregulation. Thermal imaging 
shows lower surface body temperature in a 30 day old homozygote compared to (A) age 
matched control and (B) 12 day old, size matched pup. (C) Quantification of 
intrascapular BAT depots from male 30 day old Opa3-l- and age-matched control mice. 
(D) Graph displaying increased adipocyte size in intrascapular BAT depots in Opa3'' 
compared to age-matched control mice. Values shown are mean ± S.E.M. (Opa3+l+ n=3, 
Opa3''' n=3). BW, body weight. *** P< 0.001.
6.4 Discussion
i i  2 2 PThe data presented here confirms that the Opa3 mice display elevated 3-methylglutaconic 
acidemia. In addition, there is a profound reduction in intra-abdominal WAT, and what little 
remains appeared histologically similar to BAT. This was accompanied by an elevation in 
marrow adiposity and severe hepatic steatosis. Despite this fact the circulating TAG was not 
significantly different. In the final stages of the disease state Opa3''~ mice exhibited an ~4°C 
reduction in surface body temperature.
One of the hallmarks of the Opa3 homozygote phenotype is a significant loss of adipose 
tissue which manifests as a reduction in abdominal fat depots but not in subcutaneous depots. 
This would be expected, as abdominal fat is linked to metabolic disorders more than 
subcutaneous fat. The difference may be due to subcutaneous and visceral adipocytes being in 
different anatomical sites, having differences in basal metabolic properties [Montague et al, 
1998] and higher rates of lipid turnover than subcutaneous adipose tissue [Marin et al, 1996]. 
The venous drainage of visceral adipose tissue is via the portal system, directly providing free 
FA as a substrate for hepatic lipoprotein metabolism and glucose production [Kissebah and 
Krakower, 1994; Montague et al, 1998; Niesler et al, 2001]
This reduction in fat mass may be due to one or more cellular processes a) decreased 
differentiation b) decreased lipid accumulation or c) increased apoptosis. To determine 
whether the lean phenotype is due to a reduction in energy intake (i.e., adipocytes depleted in 
triglycerides but otherwise normal), daily food intake measurements can be taken. 
Unfortunately, the mice could not be housed separately and neurological problems made it 
difficult for them to reach the food hopper, thus this test was not undertaken. Measurements 
of plasma ES and ES-ARA however showed no significant difference in dietary derived 
lipids, suggesting normal food intake in homozygotes compared to wildtypes. Normally, mice 
with depleted adipocytes are insulin sensitive, have normal sized livers, and have normal or 
low liver and circulating triglycerides. In contrast, mice with ablated or malfunctioning 
adipocytes have insulin resistance, enlarged fatty livers and elevated circulating triglyceride 
levels. The Opa3~l~ mice do not fall definitely into either category, as they display enlarged 
fatty liver but have normal circulating triglyceride levels. However, the enlarged liver, normal 
plasma ES and ES-ARA levels and WAT appearing histologically similar to BAT would 
suggest that the adipocytes are malfunctioning.
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The histological sectioning of the depleted epididymal fat depots showed that the adipoctyes 
look structurally like brown adipocytes. Previous descriptions of fat depots have implied that 
white and brown adipocytes are in separate depots in distinct sites around the body. However, 
a very recent theory suggests that white and brown adipocytes are intermingled in fat depots 
[Cinti, 2009] which has led to the new concept of the adipose organ. This hypothesis of 
reversible physiological transdifferentiation suggests that brown and white adipocytes co-exist 
in fat depots and are capable of transdifferentiating into one another, to meet different energy 
partitioning demands. This reversible transdifferentiation can be induced by physiological 
stimuli, such as exposure to cold (the organ’s phenotype switches from white to brown), 
warm exposure (the phenotype switches from brown to white), and pregnancy-lactation (part 
of the organ’s phenotype changes from WAT to milk secreting glands), which would stem 
from intrinsic biological properties of the adipocytes. Therefore the brown adipocytes 
phenotype observed in the epididymal WAT depot of the homozygote maybe a compensatory 
mechanism for the observed decrease in body temperature. An increase in brown adipoctes in 
WAT depots has been observed in 129Sv mice kept in cold conditions (6°C) for 10 days. 
These mice displayed a dramatic increase in brown adipocyte content in their fat depots 
compared to mice maintained in near thermoneutrality conditions (28°C) for 10 days [Cinti, 
2009]. It has been shown that these cold induced changes are not due to DNA replication in 
WAT as the total number of adipocytes does not differ from that of controls [Miller and 
Faust, 1982; Cousin et al, 1996]. There is no sign of white adipocyte degeneration or 
apoptosis it is therefore likely that most of the newly-formed brown adipocytes are derived 
from a direct transformation of white adipocytes into brown adipocytes [Murano et al, 2005] 
Emergence of brown adipocytes in WAT depots has been associated with a lean phenotype in 
several transgenic mouse models [Tsukiyama-Koharaer al, 2001; Cederberg et al, 2001].
Although brown and white adipocytes, in their extremes, possess opposite functional 
properties, mitochondrial content and lipid droplet morphology, apparent intermediate forms 
can exist under different conditions. In mature human adipocytes, forced expression of PGC- 
la  which is highly expressed in BAT but low in WAT [Lin et al, 2005] can induce a brown 
fat-like phenotype including induction of UCP-1 and other mitochondrial genes. However, the 
response of typical white adipocyte PPARy targets to PPARy agonists is not altered by PGC- 
la. While this reveals a high degree of plasticity in the mature white fat cell phenotype it also 
argues in favour of differences in early lineage specificity as the underlying mechanism in 
differentiation of bona fide brown adipocytes. Thus, white adipocytes can attain many typical
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BAT features but still maintain a white adipocyte phenotype. Interestingly a recent report by 
Timmons et al, [2007] suggest that BAT and WAT are not derived from a common 
preadipocyte pool as previously thought [Ailhaud et al, 1992] but may have different origins. 
BAT is apparently more closely related to muscle as brown preadipocytes appear to express 
myogenic specific proteins. Interestingly, differentiated WAT has been shown to acquire 
certain BAT-like properties and can be converted into an energy consumption organ under 
special conditions. It has been observed that cold-exposure or administration of p3-agonist 
could induce the emergence of multilocular brown adipocytes that contain high amounts of 
mitochondria and expresses UCP-1 in WAT depots [Bouillaud et al, 1984; Yoshida et al, 
1998]. Furthermore, ablation of p3-adrenoceptor diminishes the formation of BAT in white 
fat in cold exposed mice JJimenez et al, 2003}, suggesting the requirement of p-adrenoceptor 
signalling for the transdifferentiation of WAT to BAT.
Lipids are essential for reproductive physiology and a lack of adipose tissue can cause leptin 
deficiency which is required for sexual maturation and fertility which might explain why the 
Opa3''~ never get bigger than a ‘weaner’ size and are unsuccessful at mating. However, fat is 
also needed for reproductive function via leptin independent mechanisms.
6.4.1 Hepatic Steatosis
Lipid accumulation in the liver is characterized as macrovesicular hepatic steatosis and is the 
result of an imbalance between production and utilization of triglycerides. There are three 
sources that may increase the hepatic FA pool: circulating free FAs from various adipose 
compartments, de novo lipogenesis within the liver and dietary factors that promote 
lipogenesis (Fig 6.7.).
De novo lipogenesis is dependent on acetyl Co-enzyme A, an intermediate that enables 
proteins and carbohydrates to be driven towards lipogenic pathways. The two main effectors 
that drive hepatic de novo lipogenesis are acetyl-CoA carboxylase and FA synthase. Dietary 
factors that may promote hepatic lipogenesis include exogenous FAs as well as carbohydrates 
which can drive triglyceride formation by way of triose phosphate as a basis for glycerol 
formation and by way of FA formation by acetyl-CoA. A specific dietary factor that promotes 
hepatic lipogenesis is fructose, which is an unregulated substrate for liver triglyceride 
synthesis.
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Figure 6.7. Metabolic defects leading to the development of hepatic steatosis. Different sources of 
fatty acids contribute to the development of fatty liver. Under conditions of insulin resistance, 
insulin does not adequately inhibit HSL, and lipolysis in white adipose tissue is not suppressed. 
Therefore peripheral fats stored in adipose tissue flow to the liver by way of plasma NEFAs. 
Dietary fatty acids are also taken up by the liver through the uptake of intestinally derived 
chylomicron (CM). In addition, the combination of elevated plasma glucose (hyperglycemia) and 
insulin concentrations (hyperinsulinemia) promotes de novo fatty acid synthesis (lipogenesis) 
and impairs p-oxidation, thereby contributing to the development of hepatic steatosis. After the 
esterification step (conversion of FAs into TGs) TG can then be stored as lipid droplets within 
hepatocytes or secreted into the blood as VLDL. Although the hepatic accumulation of lipids is 
widely believed to result in insulin resistance, it remains uncertain whether a causal relationship 
exists. Several recent studies have even showed a clear dissociation between hepatic steatosis and 
insulin resistance. FA, fatty acid. [Postic and Girard, 2008]
Factors that decrease the hepatic FA pool are either synthesis of triglycerides and 
phospholipids or FA oxidation. VLDL and chylomicron remnants have also been shown to 
contribute to hepatic triglyceride synthesis and storage [Parks and Hellerstein, 2006]. The 
rate-limiting step of mitochondrial ft-oxidation is the transfer of FAs into the mitochondria, 
regulated by carnitine palmitoyl acyltranferase-1 which is inhibited by insulin. The balance 
between lipogenesis and lipolysis in the liver is mainly affected by the ratio of insulin and 
glucagon. In the case of insulin resistance, fatty acid flux to the liver is increased from 
increased lipolysis in adipose tissue leading to increased fatty acid uptake. This in turn 
increases hepatic glucose output and triggers increased insulin secretion in order to maintain
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euglycemia. Increased concentrations of insulin in the liver induce de novo lipogenesis thus 
creating a vicious cycle.
6.4.2 Bone Marrow Adiposity
A significant increase in bone marrow adipogenesis has been observed in the Opa3 
homozygote mice. Bone marrow adipogenesis is a normal physiologic process in all 
mammals and follows a defined pathway that begins with a common mesenchymal stem cell 
that is pluripotent [Rosen and Spiegelman, 2001]. Once adipogenesis begins, it is highly 
regulated and complex. The central components of this network are Cebpp and PPARy, two 
critical TFs that initiate a cascade of other factors that enhance differentiation of adipocytes. 
This generation of fat in the marrow is presumed to be identical to adipogenesis in other 
tissues. However, since the function of marrow fat is unknown, the type of fat tissue (i.e., 
white or brown adipose tissue) in the bone marrow has not been established. Since 
developmental phenotyping of marrow fat in inbred strains or mutant mice has not been 
accomplished to date, little is known apart from an inverse relationship exists between the 
amount of marrow fat, measured by spectroscopy, and bone mineral density measured by 
DXA or quantitative CT [Griffith et al, 2006].
6.4.3 Thermoregulation
The inability to maintain a normal body temperature was confirmed by thermal imaging, 
showing a surface body temperature around 4°C lower in the homozygote than the wildtype 
control. As Opa3''~ mice are leaner and have abnormal adipocytes the hypothermia seen in 
Opa3~'~ mice may be due to the reduced lipid storage, which translates into less fuel for 
muscle activity.
In mammals, alert consciousness and normally patterned motor activities only occur when 
the temperature of the CNS is approximately 36-39°C. A fall in cellular temperature reduces 
enzyme efficiency and diffusion capacity, reducing cellular energy availability and membrane 
ion fluxes. Below-normal brain temperatures are associated with reduced alertness and with 
behavioural and physiological disorganization, although without physical damage to the CNS 
or peripheral tissues. Therefore, it should be taken into account that the moribund state seen in 
the homozygotes is actually hypothermia, and this may be the cause of death.
An interesting mouse model which links mitochondrial dysfunction to the metabolic defects 
observed in our mouse model (i.e. defective thermogenesis and WAT that histologically
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resembles BAT ) is the Transgenic N171-82Q mice for Huntington’s disease [Weydt et al, 
2006]. The neurodegenerative disorder Huntingtons is thought to be caused by - 
mitochondrial dysfunction and impaired energy metabolism [Grunewald and Beal, 1999]. 
This mouse model displays profound hypothermia with body temperatures dropping to < 
27°C and metabolic defects. It is thought that impaired thermogenesis in these Huntingtons 
mice stems from PG C-la transcription interference in BAT which supports the idea that 
defective PG C-la activity links mitochondrial dysfunction in neurodegeneration to 
thermoregulatory and metabolic defects. Also, as mentioned earlier, forced expression of 
PGC-la can induce a brown fat-like phenotype. Therefore, PG C -la expression may be worth 
investigating in our mouse model.
Taken together, results suggest that Opa3 may play a role in metabolic regulation, 
mitochondrial activity and white adipocyte identity. Therefore, Opa3 could serve as a 
potential therapeutic target for the control of obesity and diabetes.
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6.5 Conclusions
- Quantification of circulating 3-methylglutaconic acid showed a 16 fold increase confirming 
the Opa3 homozygote mouse as a model of Costeff’s Syndrome.
- Opa3 homozygote mice display a significant decrease in abdominal fat depots with no 
difference in subcutaneous fat depots which is consistent with a metabolic disorder.
- Plasma ES and ES-ARA indicate that the lack of WAT was not due to starvation. This 
together with increased adipogenesis in the bone marrow and epididymal adipocytes which 
look structurally like brown adipocytes suggest that adipocytes are abnormal rather than 
normal but depleted of triglycerides.
- Opa3 homozygote mice suffer from defects in thermoregulation and their final moribund 
state highly resembles hypothermia. This may therefore be a contributing factor to cause of 
death.
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CHAPTER
vn
Pupillary and Visual function are dissociated in the
Opa3L122P mouse model
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7.1 Introduction
Aims of chapter
- To assess and compare visual acuity in G1 and G3/4 mice.
- To determine the effect of the Opa3u n p  mutation on image-forming and non-image forming 
pathways.
- Use of histology to analyse the effect of the Opa3ul2P mutation on retinal architecture in 
adult homozygote mice.
One of the common characteristics in both patients with MGA-III and ADOAC is the 
reduction of visual acuity. Mutations in OPA3 cause early-onset bilateral optic atrophy in 
MGA-III and optic atrophy and cataracts in ADOAC. In primary optic atrophies, the 
pathology largely affects the RGCs and loss of these cells leads to a reduction of optic nerve 
tissue and thinning of the nerve along its length. In this chapter our Opa3U22P mutant mouse 
was studied for any visual impairment.
Visual impairment does not generally adversely affect the fitness of laboratory mice and 
animals with eye mutations are widely used as models for vision research because they are 
easily studied. Mice are not typically considered as visual animals, they are nocturnal and rely 
primarily on olfaction, audition and the use of their whiskers for sensing their environment 
[Pinto and Enroth-Cugell, 2000]. Although the mouse eye has many similarities to the human 
eye, there are a number of differences. When comparing prenatal development the major 
difference is that the cilary body and the iris of the developing mouse eye begin to form during 
the last two prenatal stages (15-19 days), whereas in the human eye the formation begins at a 
much later date. The adult mouse retina is also slightly different, particularly with respect to 
the number and distribution of the photoreceptor cells. The mouse, as a nocturnal animal, has a 
retina dominated by rods. In contrast, the cones are small in size and represent only 3-5% of 
the photoreceptors. In addition, the mouse does not have a well-defined macula and instead of 
three cone opsin pigments present in the human retina mice express only two types of cone 
opsins: the ultra violet-sensitive short wavelength opsin and the green medium wavelength 
opsin. This means that mice cannot see the red part of the spectrum. However, this has not 
stopped the generation of numerous macular degeneration models since the mouse still 
represents an excellent model of macular and retinal degeneration.
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7.1.1 Image and non-image forming pathways
There are two visual pathways in the mammalian eye, the image forming (IF) pathway and 
the non-image forming (NIF) pathway. The traditional IF pathway involving the 
determination of the detailed form and colour of objects relies on rods and cones. This 
pathway is composed of photoreceptors (rods and cones) projecting to nonphotosensitive 
RGCs and then on to the lateral geniculate nuclei (LGN) of the thalamus. The NIF pathway 
(Fig 7.1.) is composed of photoreceptors projecting to melanopsin containing ipRGCs which 
project minimally to visual centres in the dorsal LGN, but primarily to nonvisual brain 
centres, including the suprachiasmatic nuclei (loci of the master circadian rhythm pacemaker) 
and the olivary pretectal nuclei (loci of the pupillary light response) [Hattar et al, 2002 and
2006].
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Figure 7.1. Diagram of the pathways taken by melanopsin ganglion cells to the brain. The 
pathway is to the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract (blue) and on 
to the pituitary to regulate melatonin release. This circuit drives the circadian oscillator. A 
second pathway is through the LGN to the olivary pretectal nucleus (OPN) and to the Edinger 
Westaphal (EW) nucleus for control of the PLR (light blue). [Berson, 2003]
The NIF pathway controls entrainment of circadian rhythms [Freedman et al, 1999], photic 
suppression of pineal melatonin [Lucas and Foster, 1999], behavioural masking to light-dark 
cycles [Mrosovsky et al, 2001], and the PLR [Lucas et al, 2001; Keeler et al, 1927].
7.1.2 Testing the mouse visual system
There are several widely used behavioural tests for mouse vision including maze based tests, 
visual cliff, cued fear conditioning, optokinetic nystagmus (OKN), circadian rhythm and PLR. 
Due to the physical limitations of our mouse model, the maze based tests could not be used, as 
they require the mouse to be trained to move or swim towards visual stimuli. Some tests, such 
as the cued fear conditioning, require the learning of visual cues. As MGA-III patients suffer
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from cognitive deficits and it is unknown as to whether our model suffers from such deficits 
we decided not to use any tests involving learning and memory. The running wheel for 
circadian entrainment was attempted but the homozygous mice never mounted the wheel. So, 
the most appropriate tests for our model were OKN for the IF pathway and pupillary light 
response for the NIF pathway.
7.1.2.1 Optokinetic Nystagmus
OKN is based on the fact that the eyes tend to follow or track the motion of one element at a 
time in a steadily moving display. As the tracked element moves out of sight, the eyes will 
‘snap back’ and fixate and follow another one. The eye movements form the characteristic 
OKN while the less well studied head movements are often called optomotor tracking. These 
are thought to be subcortically mediated functions which can be tested on an optokinetic drum 
that can display moving gratings of various contrast and fineness. The drum was originally 
designed for the rat by Coffey and co-workers [Coffey et al, 2002; Lawrence et al, 2000; Lund 
et al, 2001a, b]. The absence of an OKN response suggests that the mouse does not perceive 
the bars in the grating as separate elements. Therefore, by varying the characteristics of a 
display, such as its contrast and fineness of the gratings, the researcher can measure a mouse’s 
spatial vision e.g., contrast sensitivity or visual acuity.
7.1.2.2 Pupillary light reflex
The PLR controls the diameter of the pupil. Pupil constriction regulates the amount of light 
entering the eye and thus pupil diameter is negatively correlated with light intensity. At high 
light intensity the iris decreases the area of the pupil by 95% (full constriction) in comparison 
with dark-adapted conditions (fully dilated) (Fig 7.2.).
Dark adapted Bright light
Figure 7.2. Images of mouse pupils showing full dilation of pupil in dark adapted eye and full 
constriction of pupil in bright light.
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Light-induced pupillary constriction in mice is initiated by both outer and inner retinal 
photoreceptors [Lucas et al, 2001; Hattar et al, 2003]. At low light intensity in which the 
pupil constricts by 50% or less, rod-cone input is the main signal [Lucas et al, 2003; 
Mrosovsky and Hattar, 2003]. For full pupil constriction the protein melanopsin in ipRGCs is 
necessary [Lucas et al, 2001]. Melanopsin is a blue light sensitive protein expressed 
specifically in ipRGCs [Berson et al, 2002]. In mice this represents a subset of 2% of RGCs 
[Provencio et al, 2002; Hattar et al, 2002]. Therefore, rods and cones are responsible for 
responses at lower light levels, while ipRGCs underlie pupillary constriction in brighter light 
[Lucas et al, 2003].
Mice with outer retinal degeneration or dysfunction that also lack melanopsin cannot entrain 
their circadian rhythms to light-dark cycles, nor do such animals show pupillary light 
responses [Panda et al, 2002; Ruby et al, 2002]. This suggests that the axons of melanopsin- 
containing ipRGCs convey the signals from both the outer and inner retinal photoreceptors 
that initiate pupillary constriction to the pretectum [Bailes et al, 2009] thus, melanopsin is 
required for nonvisual photoreception.
To assess whether IF functions are affected in the Opa3 mice optokinetic responses were 
measured and for NIF function the PLR was assessed. Retinal thicknesses and RGC counts 
were also performed to assess any loss of retinal layering and/or cell types.
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7.2 Materials and Methods
7.2.1 Optokinetic Nystagmus
The optokinetic response of the mice was tested using a rotating optokinetic drum. The visual 
tracking drum consists of a motorised drum which rotates at 2 rev/min in a clockwise or anti­
clockwise direction (Fig 7.3.). The inner wall of the drum can be lined with black and white 
vertical stripped card of known frequency. The mouse is placed on a stationary wire platform 
in the centre of the drum and is not restrained. A digital video camera (JVC, GR-D250) linked 
to a monitor and a DVD recorder (Hitachi) was used to record any head tracking movements.
Setup: o k n
Camera
i Monitor
Video Recorder
M ouse
Rotating Drum Platform Mouse
Figure 7.3. Optokinetic drum set up for visual acuity testing.
Initially, a small cohort of 21 G1 mice (Opa3~7 n=8, Opa3+/~ n=8 and Opa3+l+ n=5) were 
tested at two months of age to validate the use of the protocol on the Opa3 mice. Briefly, mice 
were placed on the platform and allowed to settle for 2 mins. The drum was rotated for 1 min 
and the mice were observed for a head tracking response. After a 30 sec break, the drum was 
rotated in the opposite direction for 1 min. The mice were presented with a 1°, 2°, 4° and 8° 
grating (corresponding to 0.5 , 0.25, 0.125 and 0.0625 cycles/ degree respectively). Mice were 
tested on all gratings each day for three consecutive days, all at the same time of day. The 
visual acuity threshold of the C57BL/6J mouse has been measured by Schmucker et al. 
[2005] in an optomotor drum and was found to be around 0.3-0.4 cycles/degree. This 
corresponds to somewhere between the 1° (0.5 cycles/ degree) and 2° (0.25 cycles/ degree)
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grating on our optokinetic drum. Therefore, it would be expected that all mice with normal 
visual acuity would see the 2° grating.
For the second test a larger cohort of 38 G3 and G4 mice (Opa3+l+ n=l 1, Opa3+l n=22, OpcCi1 
n=5) were assessed. These mice were tested at 18, 21, 25, 28 and 31 days of age to look for 
onset in vision deterioration. On the first day of testing at 18 days of age the mice were 
presented with the 8° grating, if they could track this grating they were presented with the next 
smallest gratings until they reached a grating they could not see. At the next testing age the 
mice were presented with the lowest grating they could see on the previous test and then 
presented with the next grating down to see if their eyesight had improved (with visual 
maturation) or deteriorated (with pathology).
The heterozygotes and wildtypes were aged and tested again and the heterozygote ‘founders’ 
(Opa3+l' n=4, Opa3+l+ n=4) were also tested at two years of age. Both were assessed using the 
same protocol as that for the G1 mice.
7.2.2 Pupillometry
Pupillometry was performed by Dr Ron Douglas and Dr Marcela Votruba on G3/4 animals at 
six weeks of age (Opa3 '~ n=5, Opa3+l+ n=5), during the light phase of their light/dark cycle. 
The right eyes of unanaesthetised animals, restrained by hand, were filmed under infrared 
illumination by an infrared-sensitive camera (Cohu, San Diego, USA) fitted with a zoom lens 
(giving a field of view of 8.7x6.9 mm) positioned in a plane parallel to the plane of the pupil. 
Various intensities of white light, filtered by a heat glass and neutral density filters and 
controlled by a shutter, were delivered to the eye being filmed through a fibre optic from a 
Leica CLS lOOx light source.
The spectral irradiance at the animal’s cornea for each neutral density filter was measured in 
lnm steps (200-870nm) using an Ocean Optics USB2000 fibre optic spectrometer and CC3- 
UV cosine collector calibrated with an Ocean Optics DH-2000-Cal light source prior to 
measurements. Since the action spectrum of wildtype mouse pupil constriction is described 
by the mouse’s scotopic sensitivity [Lucas et al, 2001], measured spectral irradiances were 
weighted by the spectral absorbance of the murine rod visual pigment (Xmax 498nm).
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After at least 1 hr dark adaptation the eye was initially filmed in infrared illumination before a 
light stimulus was delivered for 20 secs. The animal was then released and returned to 
darkness for at least 2 mins before being exposed to a brighter light for another 20 secs. In this 
way animals were subjected to 14 different light intensities presented in ascending order of 
brightness.
VHS video images were digitised and the area of the pupil, both before light exposure and in 
the frame showing the greatest pupillary constriction following illumination, was determined 
using Image J software. Pupil areas, after illumination, were corrected for individual 
variations in dark-adapted pupil size by expressing them relative to the area of the pupil in 
darkness immediately preceding the light exposure.
Irradiance response curves were constructed for each animal by plotting the minimum relative 
pupil size attained during light exposure against the irradiance level. Average irradiance 
response curves were also constructed for each genotype. The average degree of constriction 
at each irradiance for the homozygotes and their wildtype siblings was compared using a 
student’s / test. Since multiple tests were being performed two points were only considered 
different if P<0.01. Irradiance response curves were also fitted by a four term sigmoid 
relationship (SigmaPlot, Systat Software Inc., San Jose, USA) of the form y=y0+a/(l+exp(- 
(x-x0)/b)).
7.2.3 Histology of the retina
Eyes from the mice used in the pupillometry testing (Opa3+l+ n= 4 and OpaS'1' n = 4 - one of 
the mice had an erratic response to low light levels in pupillometry testing so was omitted 
from pupillometry results and histology) were taken and embedded in wax. 7pm retinal 
sections were cut through the optic nerve to the ora serrata then stained with H&E (see 
chapter II for protocol). Images were taken of each section using a Leica DMR microscope 
and a Leica DC500 camera. Qwin software was used for retinal layer thicknesses and Image J 
for RGC counts.
7.2.3.1 Quantification o f thicknesses o f the retina and GCL counts
The vertical thickness of all the layers of the retina in Opa3~ a n d  control mice used in the 
pupillometry were measured. Briefly, H&E-stained retinal sections that included the ora 
serrata and the optic nerve were used. Two regions of each retinal section were selected for
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quantitative analysis, each one being 100 pm on either side of the optic nerve head. Individual 
retinal layer thickness was measured using the Qwin software. The thickness of the layers was 
determined by averaging data from four animals of each genotype. For the GCL counts, cells 
were counted on the whole section (ten sections per animal).
7.2.4 Statistics
Statistical analysis was carried out using SPSS 16. For the optokinetic drum testing results no 
statistical analysis was done due to the homozygotes showing no OKN responses. Student’s t 
test was carried out on the mice undergoing pupillometry. For pupillometry testing P values < 
0.01 were considered statistically significant. GCL counts and retinal layer thicknesses were 
analysed by the Mann Whitney U test. P values < 0.05 were considered statistically 
significant.
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7.3 Results
7.3.1 Loss of visual acuity in the Opa.3'1' mice
As cataracts are part of the ADOAC human phenotype the mice were checked for presence of 
cataract by a dilated examination on a slit lamp by Dr Marcela Votruba. No cataracts were 
observed in any homozygotes or heterozygotes. Heterozygote ‘founders’ aged to two years also 
did not appear to develop cataracts. Therefore, cataracts are not considered part of the disease 
phenotype in this animal model and any diminishment in visual acuity is not due to lens 
opacity.
7.3.1.1 Optokinetic drum testing on G1 cohort
The initial G 1 cohort of 21 Opa3 mice was tested at two months of age to validate the use of 
the optokinetic drum protocol. All mice were tested on each grating three times and at the 
same time on consecutive days. The mouse was said to be able to see the grating if it made at 
least one head tracking movement in at least one direction of drum rotation and was not able to 
see the grating if the mouse failed to make any head tracking movements.
The G1 Opa3+l+ and Opa3+l mice displayed good visual function with no statistical difference 
between them (Table 7.1.). All of the wildtypes and heterozygotes were able to track the 2° 
grating and all of the wildtypes and 75% of the heterozygotes were able to track the 1° grating. 
However, the homozygotes showed an impairment of visual acuity where none were able to 
track the 1° grating and only one out of the five (20%) was able to track the 2° grating. Three 
out of five (60%) could see the 4° and finally four out of five (80%) could see the 8° grating. 
Only one homozygote remained non-responsive to all of the gratings. There was a statistically 
significant difference between wildtype and homozygotes at 1° (P=0.001), 2° (P=0.001), 4° 
(P=0.034) but not 8°. When comparing the heterozygotes and homozygotes a statistically 
significant difference was only observed at 1° (P= 0.011) and 2° (P=0.003).
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Animal Sex Genotype 1 deg 2 deg 4 deg 8 deg
269 f +/+ Y Y Y Y
270 m +/+ Y Y Y Y
271 m +/+ Y Y Y Y
274 f +/+ Y Y Y Y
275 f +/+ Y Y Y Y
277 f +/+ Y Y Y Y
280 m +/+ Y Y Y Y
281 m +/+ Y Y Y Y
264 f +/- Y Y Y Y
265 f +/- Y Y Y Y
266 f +/- N Y Y Y
272 m +/- N Y Y Y
282 m +/- Y Y Y Y
283 m +/- Y Y Y Y
284 m +/- Y Y Y Y
304 m +/- Y Y Y Y
267 f -/- N N N Y
268 f -/- N N Y Y
278 m -/- N N Y Y
279 m -/- N N N N
302 m -/- N Y Y Y
Table 7.1. The visual acuity of G1 Opa3 wildtype, heterozygote and homozygote mice on the 1°, 
2°, 4° and 8° gratings at 2 months of age. A cohort of 21 mice were tested (Opa3+/+ n=8, Opa3+/~ 
n=8 and O p a 3 n=5). Y = mice made at least one head tracking movement at that grating. N= 
mice made no head tracking movements.
7.3.1.2 Optokinetic drum testing on aged ‘founders’
The colony heterozygote ‘founders’ and their wildtype littermates were assessed on the 
optokinetic drum at two years of age for any diminished visual acuity with age (Fig 7.4.). 
Homozygotes could not be aged and assessed as they do not survive past a few months old. 
Mann Whitney U showed no significant difference between heterozygous founders and their
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wildtype littermates at 1° or 2° gratings. Therefore, there was no late onset disease phenotype 
observed in the heterozygotes ‘founders’.
Founders +/■
Opa3+/+
Figure 7.4. Graph showing the visual acuity of heterozygous ‘founders’ and their wildtype 
controls on the 1° and 2° grating at two years of age. A cohort of eight mice were tested (Opa3+/+ 
n=4 and Opa3+l' ‘founders’ n=4).
Due to the variability seen in the visual acuity of the G 1 mice i.e. from normal visual acuity to 
functionally blind, further assessment of vision was undertaken on the G3/4 mice in the hope 
of less variability in the phenotype due to mice being more congenic. All experiments, here 
after, have been performed on G3/4 mice.
7.3.1.3 Optokinetic drum testing on the G3/4 cohort
Visual testing started when the mice opened their eyes at 14 days of age. However, some of 
the runts in the litters did not open their eyes until 15-16 days so could not be tested at 14 
days. Those mice that had opened their eyes and were tested had a tendency to fall asleep on 
the platform during the experiment. Therefore, the 14 days of age data was not included and 
results only show visual acuity from 18 days onwards (Fig 7.5.).
In the G3/4 OKN testing, 100% of the Opa3+,+ and Opa3+,~ could see the 2° grating by 25 
days of age. The ability of the Opa3+l+ and Opa3+l to see the 1 ° grating improved over time 
and by 31 days 82% of Opa3+/+ and 64% of Opa3+l could see it. This discrepancy between
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percentages maybe by chance as the visual threshold of mice on an optokinetic drum is 
between 1° and 2° or there may be some loss of vision or delayed visual maturation in the 
heterozygotes. Therefore, the wildtype and heterozygotes were aged and retested to look for 
any late onset of visual loss in the heterozygotes. Results showed no effect of age on the 
visual acuity of the heterozygotes (data not shown).
None of the homozygotes tracked any of the gratings at any time points and are therefore 
considered functionally blind. This indicates that the visual phenotype has become more 
severe on the more congenic C57BL/6JCrl backgound and/or the age of onset of blindness is 
earlier.
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Figure 7.5. Graphs showing the visual acuity of Opa3 
wildtypes, heterozygotes and homozygotes on the (A) 
1°, (B) 2° and (C) 4° grating from 18 days of age up to 
31 days of age. A cohort of 38 mice were tested 
(Opa3+>+ n = ll, Opa3*'-n=22 and Opa3 '- n=5).
7.3.2 Retention of the pupillary light reflex
The right eyes of (Opci3''' n=5 and Opa3+l+ n=5) mice were tested for their pupil response to 
light. Heterozygotes were omitted pupillometry testing and further investigation due to no 
significant difference in their visual acuity compared to wildtypes. After at least 1 hr dark 
adaptation they were exposed to a series of increasing light intensities for 20 secs with at least 
2 mins of darkness separating each exposure. Pupil size was determined as the pupil area >5 
secs after illumination and is expressed as a ratio of the size of the pupil after it has been 
exposed to light relative to the pupil area in darkness immediately before exposure.
Opa3+l+ and Opa3~'' mice showed a graded pupil response to illumination (Fig 7.6.). The 
average response intensity curve of the Opa3 homozygote mice was displaced towards higher 
light levels relative to that of wildtype controls. The difference between the two curves was 
most apparent at lower levels of illumination. At 50% constriction the Opa3''~ mice were 0.61 
log units less sensitive than their wildtype siblings. Student t tests, however, showed the 
Opa3'1' only differed from the wildtypes significantly at two irradiance levels (Fig 7.6.).
One of the five homozygotes had an erratic response to low light levels so was excluded from 
detailed irradiance response. Therefore the average response of the homozygotes was from 
three animals not four.
Scrutiny of the curves shows that all four remaining Opa3'!' (red) did not begin constricting 
their pupils until higher light levels than wildtypes (i.e. response/intensity curves are shifted to 
the left and are ‘higher’ for mutants). This is clearly seen when comparing averages for the 
four ‘good’ Opa3 and the five wildtypes.
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Figure 7.6. The average minimum pupii area expressed as a percentage of maximum dilation 
following illumination with various intensities of white light for mice homozygous for mutations 
of the Opa3 gene (n=5, +1 s.d.) (solid/black symbols), compared to wildtype siblings (open/red 
symbols, -1 s.d.). All data is fitted with four term sigmoidal functions (solid lines) of the form 
y=y0+a/(l+exp(-(x-x0)/b)). The goodness of fit of these sigmoids (R2) to the data of all four 
genotypes is very high (Opa3 mutants, 0.981; Opa3 wildtypes, 0.998). The degree of constriction 
at each irradiance for the mutants and their wildtype siblings was compared using a Student t 
test. The Opa3 mutants differed from their wildtype siblings at 2 irradiances (P<0.01) (indicated 
by *).
7.3.2.1 O ptokinetic drum  testing o f  the m ice used in pupillom etry
All of the G3/4 six week old mice used in the pupillometry were tested afterwards on the 
optokinetic drum using the protocol for the G1 mice. None of the homozygotes could track any 
of the gratings indicating that they were functionally blind (Fig 7.7.). This result is consistent 
with observations of the larger G3/4 cohort who were functionally blind from 18 days onwards.
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Figure 7.7. Graph showing the visual acuity of wildtypes and homozygotes used in the 
pupillometry testing on the optokinetic drum. Head tracking responses were recorded on the 1°, 
2°, 4° and 8° gratings at 6 weeks of age. A cohort of ten mice were tested (Opa3+l+ n=5, Opa.3'1' 
n=5).
7.3.3 GCL counts and retinal layer thicknesses for mice used in pupillometry testing
Histological sections of wildtype and homozygote mice were taken (Fig 7.8A&B.). Light 
microscope observations of retina from adult mice used in pupillometry testing (O p a 3 n=4 
Opa3+l+ n=4) revealed a statistically significant reduction in the thickness in virtually all cell 
layers of Opa3~'' mice (Fig 7.8D.). The whole retina, measured from retinal pigment 
epithelium (RPE) to NFL, was significantly thinner, with most marked differences in the 
combined RGC and NFL (P=0.005), inner plexiform layer (P=0.001), inner nuclear layer 
(P=0.04) and the outer nuclear layer (P=0.009) and the rods and cones (P=0.014). Layers 
that were not significantly affected were the outer plexiform layers (P=0.344) and RPE (P= 
0.093). GCL counts from H&E stained retinal sections were statistically different between 
Opa3'' and Opa3+l+ mice (P = 0.021) (Fig 7.8C.).
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Figure 7.8 Opa3-/- adult mice display panretinal degeneration. Representative photomicrographs of H&E stained 7-pm sections of 
six week old adult (A) Opa3+/+ and (B) Opa3 - / -  retinas displaying thinning of all layers. (C) Graph displaying mean number of 
cells in GCL per retinal section in 6 week old mice (10 sections were counted per mouse). (D) Graph showing the mean thickness 
(pm) of the retinal layers for six week old adult Opa3+/+ and Opa3-/- mice (Opa3-/~ n=4 and Opa3+/+ n=4). Values are shown as 
mean ± S.E.M.*P<0.05, **P<0.01, ***/><0.001. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; 
OPL, outer plexiform layer; ONL, outer nuclear layer; R&C, outer and inner segments of rods and cones; RPE, retinal pigment
p n ith p lin l  la v p r
7.4 Discussion
This chapter presents data showing that in the G3/4 OKN testing none of the homozygotes 
tracked any of the gratings at any time points indicating that they are all functionally blind. It 
has previously been reported that the G1 homozygote mice tested at two months old have a 
variable visual acuity ranging from normal to functionally blind [Davies et al, 2008]. These 
results show that as the background became more congenic C57BL/6JCrl the age of onset of 
blindness was earlier and variability of onset was decreased. Comparisons with G1 retinal 
histology indicate that the visual phenotype did not become more severe. This finding of 
functional blindness was reinforced with adult retinal histology showing the homozygote 
retinas were 30% thinner. This thinning was most apparent in the GCL and IPL. Cell 
counts showed a loss of 40% of the cells in GCL. In mice, RGCs and displaced amacrine 
cells each constitute about one-half of the cells in GCL [Perry, 1981; Barnstable and Drager, 
1984]. Therefore, the 40% loss of cells in GCL could account for an 80% loss of RGCs.
7.4.1 OKN
The visual acuity threshold of the C57BL/6J mouse has been measured by Schmucker et al, 
[2005] in an optomotor drum and was found to be around 0.3-0.4 cycles/degree. This 
corresponds to somewhere between the 1° (0.5 cycles/ degree) and 2° (0.25 cycles/ degree) 
grating on our optokinetic drum. Therefore, it would be expected that all mice with normal 
visual acuity would see the 2° grating.
Visual acuity is known to be more acute on other types of visual testing, such as the visual 
water task and the t-maze behavioural task. It is thought that there are at least two possible 
explanations for the discrepancy. Firstly, visual pathways subserving behavioural responses in 
optomotor and reinforcement-based tasks process different features of the retinal output, and 
therefore, reflect different measures of vision. Mouse grating acuity generated in the visual 
water tasks can be significantly reduced by cortical lesions [Douglas et al, 2005]. Cortical 
lesions however, have no effect on OKN eye movements [Hobbelen and Collewijn, 1971; 
Harvey et al, 1997], suggesting head-tracking thresholds measure the function of subcortical 
pathways whereas, the visual water task measures cortical vision. As optokinetic eye 
movements and head tracking in the optokinetic drum have clear parallels, it is thought that 
they are both driven by subcortical, low-frequency visual pathways. The second possibility is 
that differences in grating thresholds between optomotor and reinforcement-based tasks reflect
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differences in behavioural responses. Because the optomotor response is graded with less 
vigorous tracking near threshold, it is possible that a weak sensory signal is present without 
any apparent behavioural response. In either case, the differences in the measures show that 
discrimination-based tasks and optomotor tasks are complimentary and not interchangeable, 
and prudence should be exercised when comparing threshold values generated with the 
different methodologies.
The difference in the visual acuity of the homozygotes in the initial G1 cohort was probably 
in part due to the variability of onset of the disease phenotype. The mice that could see the 2° 
degree grating were not suffering from any noticeable neurological defects at the time of 
testing whereas the mouse that did not track any of the gratings was quite ill.
In the G3/4 OKN testing, visual acuity initially improved in the wildtype and heterozygotes. 
At 21 days of age all of the Opa3+,+ could see the 2° grating and by 25 days of age all of the 
Opa3+/ could see the 2° grating. This corresponds with maturity of the mouse eye around 21- 
25 days [Smith, 2002]. This initial improvement in visual acuity after eyes open at around 
P I5 concurs with observations by Prusky et al, [2004] who measured visual acuity on the day 
of eye opening ( P15: mean acuity, 0.031 cyc/deg) and reached a maximum (0.4 cyc/deg) by 
P24. This development of visual acuity suggests that although head-tracking is present on the 
day of eye opening, indicating that the visuomotor circuitry is already in place when high- 
quality visual information normally becomes available, the visuomotor circuitry requires 
experience to fully develop. Also development of visual thresholds could be influenced by 
changes in the visual system, the motor system, or both.
Only 72% of Opa3+l+ and 63% of Opa3+l~ could see the 1° degree grating. There are several 
possible reasons for this observation. 1) Their level of visual acuity on the optokinetic drum is 
between the 1° and 2° gratings, therefore even normal mice will have difficulty seeing the 1° 
grating. 2) The mice are not restrained on the platform; therefore depending where they are 
on the platform will alter the distance they are from the striped pattern. 3) At the smallest 
grating (1 °) the head tracking movements are so small and for such brief periods that they are 
very difficult to observe and can be missed (as mentioned above for lower visual acuity on 
optokinetic drum compared to other visual acuity tests). These disadvantages have been 
shown to be obviated by replacing the mechanical drum with a virtual-reality cylinder [Prusky 
et al, 2004]. Being computer generated, the spatial frequency, contrast, and velocity of the
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stimulus pattern can be changed instantaneously. Furthermore, by monitoring the position of a 
freely moving animal inside the system with a camera, the drum can be kept centred on the 
head so it is not necessary to restrain the animal.
7.4.2 Pupillometry
Although the Opa3' mice are functionally blind (Fig 7.5.) and show widespread retinal 
thinning (Fig 7.8D.), the pupil response is little affected (Fig 7.6.). Their pupillometry response 
was found to be diminished only slightly, i.e., at each light intensity the pupil of the 
homozygotes did not constrict as much as the pupils of the wildtype mice, but this was not 
statistically significant overall.
Non-visual ocular responses to light such as PLR and circadian rhythm are mediated by 
ipRGCs [Berson et al, 2002]. Induced ablation of melanopsin expressing ipRGCs causes 
complete loss of non-image forming visual responses. This suggests that axons of ipRGCs are 
the site of functional integration of the rod/cone and melanopsin phototransduction pathways 
and are the primary anatomical site for the divergence of the image and non-image forming
i j 22Pphotoresponses in mammals [Hatori et al, 2008]. Since Opa3 has little affect on
pupillary constriction but causes a large reduction in cells in the RGC layer (Fig 7.8C.) this 
would suggest that ipRGCs must be ‘spared’ while severely compromising other retinal 
ganglion cells projecting to the LGN.
Whereas outer retinal degenerate mice lacking melanopsin show no responses to light, mice 
lacking either outer retinal photoreceptors or melanopsin (but not both) show only subtle 
circadian entrainment phenotypes and demonstrate only partial loss of pupillary light response 
[Selby et al, 2000; Panda et al, 2002; Ruby et al, 2002; Lucas et al, 2003]. Melanopsin- 
deficient mice show behavioural masking defects primarily under bright light [Mrosovsky and 
Hattar, 2003]. Only when outer and inner retinal photoreceptor-specific mutations are 
combined do complete phenotypes emerge. Thus, there is a substantial overlap between 
signalling pathways from rods and/or cones and inner retinal photoreceptors to brain centres 
mediating nonvisual photically driven phenomena. While pupil response is affected to a lesser 
degree than visual acuity there is a small but significant loss of pupil sensitivity at lower light 
levels. As low light level pupil responses are mainly determined by rod and cone function 
[Lucas et al, 2003], this suggests that the Opa3 L122P mutation might also be affecting function 
and/or viability of the rods and cones. Measurements of retinal layer thicknesses did show a
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loss of cells from the rods/cones and their associated layers (Fig 7.8D.). However, pan-retinal 
degeneration has occurred and there was a significant thinning of the INL which might also be 
affecting this response at low light levels.
These findings mirror data from patients with dominant optic atrophy [Bremner et al, 2001] 
and Leber's hereditary optic neuropathy [Bremner et al, 1999], both degenerative diseases of 
RGCs linked to defective mitochondrial function which affect the pupil responses to a much 
lesser degree than perceptual visual function.
7.4.2.1 Why should ipRGCs be less susceptible to mitochondrial impairment than those 
ganglion cells going to the LGN?
It is likely that the cells least affected by loss of mitochondria are those in which energy 
demand is lowest. Melanopsin-containing ganglion cells are morphologically [Hattar et al, 
2002] and physiologically [Berson et al, 2002] different to other ganglion cells. For example, 
electrophysiologically they are very sluggish [Berson et al, 2002]. Whether they require less 
energy and might thus be less affected by mitochondrial defects, however, is unclear.
From an evolutionary perspective of opsins, mouse melanopsin is most closely related to 
invertebrate opsins [Provencio et al, 1998]. Melanopsin within this class of RGC may 
represent a marker for an evolu tionary  distinct class of RGC that is more injury-resistant (or 
in the case of Muller glia-derived support, more responsive) than RGCs that are not 
intrinsically photosensitive.
An alternative explanation for Opa3~' mice having affected image forming vision while 
sparing the pupil response, is that image quality may be affected by, for example, lenticular 
opacities which patients with ADOAC are known to have. This would decrease acuity while 
leaving the pupil response relatively unaffected. However, in agreement with previous reports 
on the Opa3 mice [Davies et al, 2008] we did not observe cataracts in any of the wildtype or 
mutant mice, thereby discounting this interpretation.
Pupil function seems far less affected than visual function in our mouse model of the disease. 
This dissociation between visual perception and pupillary function in both mouse and man 
implies that the RGCs subserving pupillary function are less susceptible to damage by 
mutations of Opa3 than the retinogeniculate fibres underlying visual perception and/or the
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melanopsin RGCs are less susceptible than non-melanopsin RGCs. At present this is being 
explored further by melanopsin qPCR for detection and quantification of melanopsin in Opa3 
homozygote retina compared to wildtype.
If the relationship between visual deficit and pupil deficit can vary in different diseases, then a 
study of pupil function in different optic neuropathies may have clinical diagnostic potential, 
particularly in the MGA syndromes where the detection of new clinical features would 
facilitate their difficult diagnosis. Therefore, the PLR could be assessed in MGA patients to 
confirm retention of the reflex as part of the MGA syndrome phenotype. At present the PLR 
is being assessed as a technique to detect asymmetric retinal damage in patients diagnosed 
with glaucoma [Wride et al, 2009] and interestingly as a possible new technique for the 
investigation of early cholinergic deficits, which generally lead to memory and cognitive 
disorders in Parkinsons and Alzheimers [Fotiou et al, 2009]. Moreover, the relative 
susceptibility of pupil afferent fibres compared with visual afferent fibres in different diseases 
has important implications regarding the underlying mechanisms of damage.
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7.5 Conclusions
- The Opa3 homozygous mice are functionally blind at P I8 onwards. Heterozygotes 
displayed normal vision. Aging the heterozygote ‘founders’ to two years showed no onset of 
disease phenotype with age.
LI 22P- Opa3 mutation causes pan-retinal degeneration which was most apparent in the GCL 
and IPL.
- Pupil function seems far less affected than visual function, suggesting that ipRGCs must be 
‘spared’ while severely compromising other RGCs projecting to the LGN.
- Homozygote visual phenotype does not become more severe as we move to a more congenic 
C57BL/6JCrl background. However, the age of onset of blindness is reduced and there is less 
variability in onset of disease phenotype.
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CHAPTER 
VIII
Retinal degeneration in Opa3Ll22p mouse is associated 
with increased postnatal apoptosis
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8.1 Introduction
Aims of chapter
- To assess the effect of the Opa3U22p mutation on retinal development, GCL and INL cell 
counts were taken at various time points during early postnatal retinal development through to 
adulthood.
- TUNEL stained retinal sections were assessed for timing and region(s) of apoptotic cell loss 
within the retina during postnatal development and adulthood.
Apoptosis is a mechanism of programmed cell death in which the cell plays an active role in 
its own demise. This carefully orchestrated series of intracellular events produces a quiet 
death that minimises injury to adjacent cells and is important in constructive physiological 
processes, such as embryogenesis, and tissue remodelling [Wyllie et al, 1980; Gerschenson 
and Rotello, 1992]. This mechanism is also of considerable interest given that it is implicated 
in both development and degeneration of the mammalian nervous system. Neuronal death is a 
normal component of retinal development [Young, 1984] and maturation [Penfold and Pro vis, 
1986], but excessive apoptosis during adult life is a pathological process that produces 
degeneration of the retina and causes blindness. Apoptosis is responsible for the removal of 
damaged cells in degenerative conditions of the retina such as retinitis pigmentosa [Li and 
Milam, 1995], glaucoma [Quigley et al, 1995], and age-related macular degeneration [Dunaief 
et al, 2002]. It has been suggested that the molecular mechanisms of apoptosis may be 
different under circumstances of development and degeneration, but the identity of the key 
regulators remains unknown [Hsu et al, 2004; Bahi et al, 2006; Donovan et al, 2006].
Work presented in previous chapters has shown a pan-retinal degeneration in the adult 
homozygous mice (Chapter VII) which supports observations in the optokinetic drum that 
these mice are functionally blind at P I8 and onwards (Chapter VII). Blindness from such an 
early age could be caused by the Opa3U22P mutation affecting retinal development or the 
retina develops normally and degeneration occurring afterwards. Both possibilities have been 
observed in other optic neuropathy mouse models. In the mouse model of Leber’s congenital 
amarousis in which the AIPL1 gene is mutated (as in at least 7% of Leber’s congenital 
amarousis patients [Sohocki et al, 2000]) there is severe early retinal degeneration. A central- 
to-peripheral degeneration begins around P I2 and leads to loss of almost all photoreceptors
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by postnatal week 8 in the homozygote null mouse [Dyer et al, 2004]. This phenotype is 
consistent with the human disease. At the other end of the scale, in terms of time of onset and 
duration of cell death is the ENU induced O palQ2S5X mouse model of ADOA [Davies et al,
2007]. This model has a 50% reduction in Opal protein expression in the O pal+l mice and 
shows a slow onset of degeneration with retinal histology still normal at 6 months of age. 
Humans with OPA1 mutations in ADOA are also heterozygous and thus have at least one 
functional allele.
Onset and duration of retinal degeneration in our Opa3 mouse model is unknown. Therefore, 
due to the large phenotypic variation observed in other models of retinal degeneration it 
seemed prudent to choose a wide range of time points to cover the possibilities of early or late 
retinal degeneration. Although mice were chosen from P0 to 6 weeks of age this time frame 
does cover a large proportion of the mutant mouse lifespan. P0 was the starting point due to 
ease of collection and processing of retinal material.
8.1.1 Development and degeneration of the mouse retina
Mouse retinal development begins midway through embryogenesis (E10), but it proceeds well 
into the postnatal period until eye opening around P14 [Cepko et al, 1996]. Development 
begins with the formation of bilateral evaginations from the prosencephalon leading to the 
formation of an inner and an outer layer [Kaufman, 1994]. The inner layer of the optic vesicle, 
the neuroblastic layer, differentiates into additional layers. From approximately E17, the 
neuroblastic layer consists of an inner neuroblastic layer, which later gives rise to the GCL 
and an outer neuroblastic layer. These two layers are separated by the IPL. The outer 
neuroblastic layer divides at around P6 to P8 to give the ONL, in which the photoreceptor 
cells differentiate, and the INL, which consists of horizontal, bipolar, Muller, and amacrine 
cells. The outer plexiform layer (OPL) forms between these two nuclear layers.
Neurogenesis occurs in the mouse retina between E13 and P10, with exit from the cell cycle 
reaching a maximum at E18-P0. During this time cells in the ventricular zone undergo 
successive periods of proliferation and differentiation to generate seven types of retinal cells in 
a highly ordered fashion (six types of neurons and one glial cell type) (Fig 8.1.). RGCs are first 
produced followed immediately by amacrine cells, horizontal cells and cone receptor cells, in 
highly overlapping waves of cell differentiation. Subsequent to the formation of these early
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neuronal cell types the later cell types form: bipolar cells, rod photoreceptor cells and Muller 
glia cells.
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Figure 8.1. Temporal and spatial heterogeneity of developing retinal progenitor cells. Retinal 
formation spans approximately 2 weeks in the developing mouse and several months in the 
developing human. During this time, retinal progenitor cells divide and generate post mitotic 
cells that commit to different cell fates and differentiate to form necessary synaptic connections 
for proper visual signal processing. There is considerable overlap of the birth dates of different 
cell types, and the peak periods are represented by individual overlapping curves. [Schweers 
and Dyer, 2005]
Cell degeneration is also an essential part of neuronal development, including that of the 
retina. In many regions of the developing nervous system, neurons and their connections are 
produced in excess of their adult number and then are partly eliminated [Buss and 
Oppenheim, 2004]. Dying cells can be recognised on the basis of morphological and 
biochemical criteria, the former being useful for preliminary or quantitative analyses, the 
latter being a very powerful tool to identify specific death pathways. At the light microscope 
level, neurons that are dying as part of the normal developmental process exhibit 
condensation and breakdown of chromatin into fragments, or apoptotic bodies [Wyllie et al, 
1980]. Cells displaying this morphology are called pyknotic.
In the developing retina two periods of cell death can be observed. Morphogenetic cell death, 
which takes place during early development, eliminates neuroepithelial cells and contributes 
to the formation of the optic vesicle, cup, fissure, and nerve. Later, histogenetic cell death 
removes some of the differentiated neurons.
In the postnatal (P0-P30) mouse retina pyknotic nuclei can be observed at different retinal 
locations [Young, 1984]. Cell death occurs primarily during the first 2 weeks after birth and is 
essentially complete by the end of the third week (Fig 8.2.).
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Figure 8.2. Apoptosis throughout the development of the C57BL/6J mouse retina. Each layer is 
shown in a different colour; each point corresponds to 1 day. Four peaks can be observed at 
stages embryonic day (E) 10.5, postnatal day (P) 2, P9, and P15. Error bars represent 95% 
confidence intervals of the percentage. NbL, neuroblastic layer; INbL, inner neuroblastic layer; 
ONbL, outer neuroblastic layer; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, 
ganglion cell layer. [Pequignot, 2003]
From birth through 4 days, an increasing incidence of cell death is observed among 
ventricular cells. Ganglion cell degeneration is present from P0 to P 11 in the GCL, with a 
numerical peak at P2-P4. At P9 most of the dying cells are observed in the INL and at P I5 
there is a peak in the loss of cells from the ONL.
This chapter represents the first in-depth histological examination of retinal tissue in the B6; 
C3-Opa3U22? homozygote mouse during degeneration of the early postnatal retina.
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8.2 Materials and Methods
8.2.1 Histology of the retina
The distribution of RGCs across the retina is not even. Near the optic nerve, ganglion cells are 
closely spaced, forming a layer two to four cells thick. A short distance from the optic nerve 
this becomes a single layer of cells that remains closely packed. Anterior to the equator the 
nuclei become more widely spaced. This can make cell counting highly inaccurate if different 
regions of retina are used. To over come this, only whole sections which passed through the 
centre of the cornea and through the optic nerve were evaluated.
Eyes from PO, P8, P12 and P26 mice (Opa3+/+ n = 3 and O pa3f n = 3) and the six week old 
mice, used in the pupillometry testing (Chapter VII) (Opa3+/+ n = 4 and Opa3~'' n = 4), were 
enucleated and embedded in wax. 7pm retinal sections were cut through the optic nerve to the 
ora serrata then stained with H&E (as per protocol Chapter II). Images were taken of each 
section using a Leica DMR microscope and a Leica DC500 camera. For the GCL and INL 
counts, cells were counted on the whole section (ten sections per animal) from optic nerve to 
ora serrata. Images were analysed using Image J.
8.2.2 Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labelling (TUNEL) 
Technique.
TUNEL is the most common technique used to study apoptosis on histolological sections. 
The technique is based on the detection of DNA fragments typical of apoptosis. TUNEL only 
indicates that a cell is apoptotic, as apposed to necrotic. It does not indicate whether the 
apoptosis was mediated by intrinsic (mitochondrial) or extrinsic (death receptors) pathways.
Labelling of fragmented DNA in retinal sections was carried out using ApopTag Plus 
Fluorescein In Situ Apoptosis Detection Kit (Chemicon) as follows.
8.2.2.1 Preparation and permeabilization o f wax embedded retinas
Before commencement of TUNEL labelling, wax sections need to be deparraffinised and 
permeabilised. Slides were immersed three times for 5 mins each in 100% xylene. After the 
third wash the samples were rehydrated using a decreasing gradient of ethanol solutions. 
Samples were washed twice in 100% ethanol for 5 mins, then 3 mins in 95% ethanol and 3
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mins in 70% ethanol. Finally, the samples were soaked in PBS for 5 mins. After the 
preparation steps, the slides were permeabilized by incubating for 15 mins with lOOpl of 
20pg/ml of Proteinase K to each slide. After incubation slides were washed twice in PBS, 2 
mins for each wash.
8.2.22 TUNEL Assay
Subsequent to the permeabilisation step the samples were equilibrated for 2-3 mins (minimum 
10 secs) with the equilibrium buffer using 75pl/5cm . Excess buffer was removed and the 
slides were incubated with working strength TdT enzyme (77pl reaction buffer plus 33pl TdT 
enzyme using 55pl/5cm3) in a humid chamber for 1 hr at 37°C. Slides were then washed in 
stop/wash buffer (1ml stop/wash buffer and 34ml of dt^O) for 10 mins at room temperature, 
then in three changes of PBS for 1 min each. Excess liquid was removed and warmed anti- 
digoxigenin conjugate (68pl blocking solution plus 62pl anti-digoxigenin conjugate) was 
added to each slide using 65pl/5cm2. Slides were then covered in aluminium foil to protect 
them from direct light and incubated in a humid chamber for 30 mins. After incubation the 
reaction was stopped by using four washes of PBS for 2 mins each. The samples were 
counterstained with 0.2pg/ml Hoechst 33258 (Invitrogen) and then mounted using 
Hydromount (National Diagnostics).
82.2.3 Positive Control
Rat mammary gland reference slides (Millipore) were used as a positive control. Rat 
mammary gland undergoes programmed cell death processes during the tissue regression that 
follows lactation. The same procedure was used for the control slides.
The TUNEL method was used in order to analyse the loss of retinal cells during postnatal 
development and adulthood. The number of TUNEL-positive nuclei in the RGC and INL, 
from optic nerve head to ora serrata were counted by microscopy (five sections per animal) 
and data from three animals in each group, at each stage, were averaged.
8.2.3 Statistics
Statistical analysis was carried out using SPSS 16. GCL and INL counts were analysed by 
the Mann Whitney U test. TUNEL-positive cell counts were analysed by unpaired Student's 
Mest. P values < 0.05 were considered statistically significant.
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8.3 Results
8.3.1 Postnatal and adult changes in retinal morphology
To determine onset of retinal degeneration in O pa3f mice, histological sections of retinal 
tissues from O pa3f and Opa3+l+ controls were examined at several postnatal developmental 
stages (PO, P8, P I2, P26 and adult), at the light microscope level (Fig 8.3A.). GCL and INL 
cells were counted on H&E stained sections which included the optic nerve head and ora 
serrata. INL cell counts were not performed on PO retinas as the outer neuroblastic layer does 
not divide into the INL and ONL until around P6 to P8.
For GCL counts the homozygote mice showed no statistically significant difference compared 
to age-matched controls at PO (846.1 ±11.7 (S.E.M.) cells per section, P = 0.707). However, 
by P8 the homozygotes showed a 16% reduction in the number of nuclei compared with 
controls (460.6 ± 7.7 cells per section, P = 0.002). This gradual loss of cells continued with a 
significant loss at P12 (448.7 ± 19.3 cells per section, P -  0.002), and P26 (404.1 ± 7.3 cells 
per section P = 0.000). By six weeks of age the Opa3'f' showed a 40% loss of GCL cells 
(326.6 ±51.4 cells per section, P  = 0.013) compared to wildtypes (Fig 8.3B.).
Cell loss was also observed in the INL of the homozygotes with a 15% loss observed at P8 
(3722.5 ± 73.1 cells per section, Z^O.005). This increased loss continued and by six weeks of 
age there was a 28% loss of cells (2456.8 ± 168.6 cells per section, P -  0.021) in the 
homozygote compared to the wildtype (Fig 8.3C.).
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Figure 8.3. Morphological demonstrations of retinal degeneration in Opa3-J- mice during postnatal development. (A) 
Representative photomicrographs of H&E stained 7-pm sections of Opa3-l- and Opa3+/+ retinas at P0, P8, P12, P26 and adult 
(6 weeks old). Scale bar = 100 pm. Graphs displaying the average number of nuclei per section (ten sections per animal) in GCL 
(B) and INL (C) of mice retinas at P0, P8, P I2, P26 and adult (6 weeks old) respectively (Opa3-/~ n=3 and Opa3+/+ n=3). Values 
are shown as mean ± S.E.M.*P<0.05, **P<0.01, ***P<0.001.
Adult
One of the adult Opa3 ' mice showed a prominent loss of cells in the GCL layer of -70% 
compared with a 32% and 36% loss in the other Opa31 mice when compared to wildtype 
controls (Fig 8.4.). This mouse was in the late stages of the disease and was moribund at the 
time the eyes were taken, indicating a dramatic escalation in loss of GCL cells in the final 
stages of the disease state.
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Figure 8.4. Graph displays individual GCL counts o f three adult hom ozygote m ice. Graph 
displays mean num ber o f cells in GCL per retinal section in 6 week old m ice (10 sections were 
counted per m ouse). O ne hom ozygote (yellow line) was m oribund at the tim e eyes were taken.
8.3.2 Retinal degeneration in Opa3'/m mouse associated with increased apoptosis in GCL 
and INL
Developmental apoptosis in mouse retina is well documented and occurs from approximately 
E10 through to P30. Pyknotic nuclei are present from PO to PI 1 in the GCL, with a numerical 
peak at P2-P4, and in the INL degenerating nuclei can be observed from PO to P I8. Thus, 
apoptosis is an established mechanism of cell loss in the postnatal retina.
The pathologic cell death underlying the degeneration of the Opa3~'~ mouse retina was 
examined using TUNEL which detects DNA fragmentation that is indicative of cell death. 
Cell death in the Opa3/' mouse retina was investigated in comparison to wild type retina
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increase in cell death and in the INL there was a 62% increase in cell death.
At adulthood, no TUNEL-reactive cells were observed in the Opa3+/+ retina (F 
the Opdi'1' retina there was an average 1.6 TUNEL-reactive cells in the G 
apoptotic cells in the INL per section. The number of TUNEL-reactive cells was 
significant in the INL at P8 (Fig 8.5D.) and in the GCL in the adult retina (Fig 8.5
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Figure 8.5. TUNEL staining in the O p a 3 and Opa3+,+ P8 and adult retina. Fluorescence photomicrographs of TUNEL positive 
cells in (A) P8 Opa3-l- and Opa3+/+ retina and (B) adult Opa3-l- and Opa3+l+ retina. (C) Graph displaying percentage of 
TUNEL positive cells per section in GCL of Opa3~'~ and Opa3+l+ P8 and adult retina. (D) Graph displaying percentage of 
TUNEL positive cells per section in INL of Opa3~'~ and Opa3+l+ P8 and adult retina. Apoptotic cells counts are average of five 
retinal sections around the optic nerve per animal. No TUNEL positive cells were observed in any of the other retinal layers. 
(For P8 and adult retina Opa3-/~ n=3 and Opa3+/+ n=3). Values are shown as mean ± S.E.M. *P<0.05, ***/><0.001.
8.4 Discussion
Results showed no increased loss of cells from the GCL in the homozygote mice compared to 
wildtype controls at PO, but by P8 there was a significant loss of cells from both the GCL and 
the INL. This loss was accompanied by increased TUNEL staining observed in these layers. 
Loss of these cells occurs during early postnatal development and seems to continue as a 
gradual loss throughout life. However, a dramatic escalation in cell loss was also observed in 
one mouse in the final stages of the disease state.
Opa3 is expressed in the developing lens and retina and in other ocular structures, such as the 
extra-ocular muscles and cornea. Opa3 expression is high in the developing RGCs of the optic 
nerve at 14.5dpc [Powell et al, submitted] which is approximately the peak time for RGC 
neurogenesis. Cell counts in the GCL in homozygous mutants, on H&E retinal sections at PO, 
show no significant loss of cells compared to the wildtype controls. With RGC neurogenesis 
ending at approximately 18.5 dpc (around birth) this suggests that the Opa3U22P mutation has 
no effect on the neurogenesis of the RGCs but appears to have an effect on their survival.
The greatest percentage cell loss from the GCL and the INL occurs by P8, where both layers 
have lost -15% more cells than their wildtype controls (Fig 8.6.).
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Figure 8.6. Percentage of cells in GCL and INL of homozygote mice as a proportion of the 
wildtype.
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While increased RGC death has been well documented in optic neuropathies, the significance 
of increased apoptosis in the INL layer is unclear. One possible explanation for apoptosis in 
both layers, based on observations in ferrets [Cusato et al, 2001; Williams et al, 2001], is that 
elimination of the ganglion cell population by optic nerve transection, in the early postnatal 
period, increases apoptosis in NBL/INL. This suggests developing neuroblasts and 
differentiating neurons of the NBL/ENL are normally dependent on the RGCs for their 
survival. GABAergic and glycinergic amacrine cell distribution was altered by unilateral 
removal at birth of the superior colliculus, pretectum, and optic tract in rats [Yamasaki et al. 
1997]. However, no delay was observed between GCL cell death and INL cell death with both 
layers having lost -15%  more cells than their wildtypes by P8. This suggests that transynaptic 
degeneration or defects in synaptogenesis are unlikely to be the causes of retinal degeneration. 
It is more likely that Opa3 is expressed in the GCL and INL and diminished metabolic 
capabilities of cells in these layers causes the pan retinal degeneration.
Increased cell death was also observed in these layers at P8 suggesting an increased 
sensitivity in the Opa3Ll22p mutant mice. This increase in cell death was observed prior to the 
high energy demand incurred by visually evoked potentials after eye opening, suggesting that 
even basal metabolic requirements of these cells are not being met.
Mitochondria play a role in promoting and regulating the apoptotic death of a cell and in 
energy production. The IMM is the site of apoptogenic proteins such as cytochrome c or the 
apoptosis-inducing factor and of the electron transport chain for ATP production.
Fibroblasts of ADOAC patients showed a reduction in COX activity and significantly 
enhanced complex V activity without modification of protein expression. Despite this the 
mitochondrial ATP production was normal but with reduced efficiency of ATP synthesis. In 
the routine respiratory state, the affected fibroblasts use a greater proportion of their 
respiratory capacity than controls (80% vs 60%), thus retaining a low ’reserve’ capacity to 
face greater energy requirements [Chevrollier et al, 2008].
Consequences of OXPHOS dysfunction are decreased ATP production and increased ROS 
production, both of which have multiple simultaneous consequences at the cellular level. 
Compensatory mechanisms for diminished ATP production have been observed in the Opa3 
homozygote mice i.e., increased COX has been observed in the post-laminar myelinated
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region of the optic nerve [Davies et al, 2008]. The proportion of opaque mitochondria was 
also significantly higher. Respiratory impairment may produce some compensatory 
mitochondrial proliferation in specific tissues. However, there was no increase in 
mitochondrial number density. ‘Dark’ degeneration of axons was also observed in our Opa3 '~ 
mice, consistent with the consequences of increased mitochondrial activity. This type of 
degeneration is when the myelin sheath remains the same but the axons contain a dense 
axoplasm [Marques et al, 2003].
Alternatively, inefficient respiratory chain activity might increase production of ROS which 
can ultimately lead to apoptosis. ROS production by mitochondria can lead to oxidative 
damage to mitochondrial proteins, membranes and DNA, impairing the ability of 
mitochondria to synthesize ATP and to carry out their wide range of metabolic functions. This 
includes the tricarboxylic acid cycle, FA oxidation, the urea cycle, aa metabolism, haem 
synthesis and FeS centre assembly that are central to the normal operation of most cells. 
Mitochondrial oxidative damage can also increase the tendency of mitochondria to release 
intermembrane space proteins, such as cytochrome c to the cytosol by mitochondrial outer 
membrane permeabilization and thereby activate the cells apoptotic machinery. In addition, 
mitochondrial ROS production leads to induction of the mitochondrial permeability transition 
pore, which renders the inner membrane permeable to small molecules in situations such as 
ischaemia/reperfusion injury.
The small amount of apoptosis observed in the adult retina and the slope of the graph for GCL 
and INL cell loss (Fig 8.6.) indicates that the disease causes a gradual postnatal cell loss that 
continues into adulthood. The increase in cell loss observed in one mouse in the final stages 
of the disease state (Fig 8.6.) may be attributed, over time, to the system becoming less able to 
compensate for the mitochondrial energetic deficiency.
TUNEL however does not indicate which apoptotic pathway is involved. Caspases are 
cysteine proteases that mediate apoptotic death in a variety of cellular systems, including 
neurons. Caspases are activated through the extrinsic (death receptor) pathway or the intrinsic 
(mitochondrial) pathway. The latter is used by most neurons in most situations. However, 
mitochondria can also induce apoptosis in both a caspase-independent manner. Apoptogenic 
factors residing in the mitochondrial intermembrane space, such as apoptosis inducing factor 
and endonuclease G, can be released into the cytosol, translocate to the nucleus resulting in
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chromatin condensation and DNA fragmentation independent of caspase activation. The 
caspase-independent pathway has been shown to be involved in RGC death induced by TNF-<* 
or hypoxia [Tezel and Yang, 2004]. Apoptosis by the caspase- independent pathway has also 
been observed in LHON cybrids which suffered a profound ATP depletion [Zanna et al, 
2005]. Now it is known that apoptosis is increased in Opa3Ll22p mice it would be prudent to 
assess the type of apoptosis involved as therapeutic strategies may need to take into account 
both caspase-dependent and -independent pathways.
Which apoptotic pathway is activated in the Opa3u22p mouse model could be explored by 
immunohistochemistry on retinal sections with antibodies for caspase 8 (for an initiator in the 
death receptor pathway) and caspase 9 in the mitochondrial apoptotic pathway. Caspase 3 
could also be performed alongside TUNEL as a confirmation of apoptosis.
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8.5 Conclusions
LI 22P- Retinal degeneration in the Opa3 mouse begins during early postnatal development and 
continues as a gradual loss of cells throughout life. This loss is increased as the disease 
severity progresses which may be attributed, over time, to the system becoming less able to 
compensate for the mitochondrial energetic deficiency.
LI 22P- Cell counts at PO in the GCL of the Opa3 mouse retina showed no significant 
difference to wildtype controls suggesting Opa3 does not play a role in GCL neurogenesis.
- Increased cell death occurs in both the GCL and INL during early postnatal development 
and adulthood suggesting an increased susceptibility in these layers. This susceptibility may 
be due to the basal metabolic requirements of these cells not being met.
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Final discussion, future 
work and conclusions
The scientist, by the very nature of their commitment, creates more and more 
questions, never fewer. Indeed the measure of our intellectual maturity, one 
philosopher suggests, is our capacity to feel less and less satisfied with our 
answers to better problems. ~G.W. Allport, Becoming, 1955
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9. Final discussion
9.1 Summary of results - Overview of mouse phenotype
This thesis investigates the outcome of introducing an ENU induced point mutation of the 
Opa3 gene into the mouse germline and compares the findings with those from clinical 
studies of patients with the MGA-III syndrome. The Opa3 homozygous mouse displays a 
disease phenotype that can be separated into three stages as it progresses (Table 9.1.).
Early Stage Growth retardation (smaller)
Blindness
Splayed gait
Middle Stage Lower activity 
Tremor (mild)
Higher acoustic startle response 
Pathological limb grasping 
Blanched skin colour
Late stages Weight loss 
Tremor 
Ataxia 
Hunched
Drop in body temperature 
Moribund
Table 9.1. Classification by phenotype of disease progression in the Opa3 homozygote mouse.
In the early stages, the mice are smaller and blind, but show no neurological or behavioural 
deficits at this point. As the disease progresses they start to show mild neurological defects 
that slow their co-ordination and activity, although the mice do not seem perturbed. Time of 
death is variable, but certain phenotypic traits are associated with the final stage of the disease 
such as: a drop in body weight, lack of movement even when provoked, blanched skin colour 
and ataxia. Death is usually then within a couple of days. Vocalisation is sometimes present 
and is a sign of distress.
From the use of a range of visual, neurological, behavioural and metabolic tests it is known 
that in the homozygous mutant state these mice manifest a multi-systemic disease that 
displays variable onset. Disease characteristics include decreased weight, pan-retinal
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degeneration, dilated cardiomyopathy, extra-pyramidal dysfunction, neuro-muscular defects, 
motor-learning deficits and severe metabolic defects including elevated blood plasma levels 
of 3-methylglutaconic acid and hepatic and bone marrow steatosis.
9.1.1 The Opa3L122P mouse as a model ofMGA- III
The Table below compares the mouse phenotype with the clinical description of human 
MGA-III patients, to illustrate the similarities and disparities (Table 9.2.).
Human clinical description Mouse phenotype Severity of mouse 
phenotype
ABNORMAL
Bilateral Optic atrophy, 
sometimes associated with 
horizontal nystagmus
Bilateral optic atrophy 3
Chorea No Chorea 0
Spastic paraplegia Abnormal movement of 
back legs
1
Unstable spastic gait Splayed gait 1
Increased tendon reflexes Normal 0
Positive Babinski sign may be 
seen
Cannot be tested /
Mild ataxia Ataxia 2
Dysarthria Cannot be tested /
Cerebellar dysfunction Cerebellar dysfunction 2
Cognitive impairment Deficits in cerebellum- 
dependent learning tasks. 
Learning and memory 
were not tested.
1
Increased urinary and blood 3- 
methylglutaconic and 3- 
methylglutaric acid
Increased blood 3- 
methylglutaconic
3
Normal lifespan Reduced lifespan 4
NORMAL
Electroretinogram Not tested /
Sensation Normal 0
Muscle tone Normal muscle tone 0
No cardiac abnormalities Cardiomyopathy 3
No structural brain 
abnormalities
Decreased cerebellum 
volume
2
Normal adiposity Low adiposity 3
Table 9.2. Human MGA-III syndrome and the Opa3Ll22P mouse model: diagnosis and phenotypic 
comparisons. Severity of mouse phenotype indicated by 0= normal, 1= mild, 2= moderate, 3= 
severe, 4= very severe.
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A tabulated comparison of mice and humans that are deficient in Opa3 activity indicates 
significant conservation of function. Affected mice and human patients show a similar and 
variable course of disease. Both show early optic atrophy, late-onset extrapyramidal 
dysfunction and motor-learning deficit with increase urinary excretion of 3-methylglutaconic 
acid. However, the mouse does display phenotypic characteristics not observed in MGA-III 
patients, such as craniofacial anomalies and hepatic and bone marrow steatosis. This however 
is not unexpected or necessarily unwanted. Due to the low number of human Opa3 mutations 
found so far no genotype/phenotype correlations can be made and variations in Opa3 
phenotypes have already been observed with the clinical descriptions of MGA-III versus 
ADOAC. Differences observed in disease physical signs between humans and mice with 
Opa3 deficiency may indeed reflect species-specific functions of the Opa3 protein. However, 
disease signs not reported in human MGA-III patients but present in Opa3'/~ mice may 
indicate that humans most severely affected may die in gestation or in early postnatal life, 
whereas those least affected may reach maturity with a variable subset of disease signs. 
Unfortunately, exact parallels with MGA-III patients cannot be made due to the small number 
of human patients assessed and to the fact that no human tissues have ever been analysed.
9.2 Possible mechanisms and causes of MGA-III
9.2.1 Possible origin and effect o f  3-methylglutaconic aciduria
Organic acid disorders are caused by an absence or a deficiency of one or more of the 
enzymes needed to complete the breakdown of dietary protein. Because the protein cannot be 
broken down, the body is unable to use it for growth and repair, and there is a build up of 
harmful substances, usually acids in the blood and urine. The increased excretion of 3- 
methlyglutaconic and 3-methylglutaric acid is a hall mark of the MG A syndromes and their 
excretion is indicative of a metabolic disturbance that impairs the body's ability to make 
energy in the mitochondria. The branched-chain organic acid, 3-methylglutaconic acid, is an 
intermediate (as the CoA thioester) in the leucine degradative pathway as well as the 
mevalonate shunt pathway which links isoprenoid metabolism with mitochondrial acetyl-CoA 
metabolism (Fig 9.1.).
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Figure 9.1. Metabolic pathway diagram showing branched-chain organic acid 3>MGC as an 
intermediate of leucine degradation and the mevalonate shunt pathway that links sterol 
synthesis with mitochondria] acetyl-CoA. 
[www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=gene.chapter.mga3]
The majority of patients with abnormal 3-methylglutaconic aciduria or acidemia appear to 
have normal leucine metabolism. This has also been seen in fibroblasts from MGA-III 
patients, which showed normal activity of 3-methylglutaconyl-CoA hydratase [Elpeleg, 
1994]. As leucine metabolism is normal, the link between MGA and mitochondrial 
respiratory-chain defects likely involves the mevalonate shunt; this pathway produces 3- 
methylglutaconyl-CoA from mevalonate via dimethylallyl pyrophosphate [Edmond and 
Popjak, 1974], an intermediate in the synthesis of cholesterol and polyisoprenoids (such as 
ubiquinone). It has been speculated that defective ubiquinone biosynthesis could lead to 
increased levels of precursors (e.g. mevalonate) in the pathway, thereby increasing synthesis 
of 3-methylglutaconic acid [Kelley and Kratz, 1995]. However Costeff et al, [1989] showed 
no beneficial effect, on administration of an active form of ubiquinone, coenzyme Qio, to 
three patients with MGA-III. Interestingly, a zebrafish model of MGA-III which has an 
antisense-based depletion of Opa3 has shown that zebrafish Opa3 interacts with both the 
leucine and mevalonate pathways [Pei et al, 2008]. Not all MGA-III patients have normal 
leucine metabolism and the zebra fish model shows Opa3 involved in leucine metabolism.
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Therefore, any therapeutic strategies for MGA-III will likely have to include the leucine 
degradation and mevalonate shunt pathways.
The mevalonate pathway or HMG-CoA reductase pathway or mevalonate-dependent route, is 
an important cellular metabolic pathway present in all higher eukaryotes and many bacteria. It 
is important for the production of dimethylallyl pyrophosphate and isopentenyl pyrophosphate 
that serve as the basis for the molecules used in processes as diverse as protein prenylation, 
cell membrane maintenance, protein anchoring and A-glycosylation. Two pathways of 
mevalonate metabolism are known: the major (sterol) pathway leads to cholesterol synthesis, 
whereas the second shunts mevalonate away from sterol production and ultimately results in 
its oxidation to CO2 . Edmond and Popjak [1974] found that this shunt pathway operates 
significantly only in tissues of ectodermal origin, such as the CNS and retina.
The shunt pathway of mevalonate metabolism is thought to begin in the cytoplasm and ends 
in the mitochondria. Alcohol dehydrogenase, which catalyses the oxidation of dimethylallyl 
alcohol to B-methylcrotonaldehyde is a cystolic enzyme. But, the steps B-methylcrotonyl- 
CoA to HMG-CoA, common with the leucine catabolism pathway are mitochondrial. 
Therefore, the shunt pathway crosses the mitochondrial membrane at the level of either B- 
methylcrotonaldehyde or B-methylcrotonate. It has been shown [Havre et al, 1977] that 
ethanol is converted to acetaldehyde in liver cytosol, while acetaldyhyde is oxidized to acetate 
mostly in the mitochondria. It is therefore likely that 3-methylcrotonaldehyde is the 
intermediate of the shunt pathway that crosses the mitochondrial membrane.
How this systemic metabolic disease contributes to ocular defects remains to be elucidated in 
MG A syndromes. Individuals affected by MG A predominantly accumulate 3- 
methylglutaconic acid and 3-methylglutaric acid in their tissues and body fluids, whereas 3- 
hydroxyisovaleric acid is also accumulated in MGA-I. Although MGA patients commonly 
present neurological manifestations, the pathophysiology of their symptoms is poorly 
established. However, it could be presumed that the increased tissue concentrations of these 
organic acids are associated with their neurologic symptoms, since they become worse during 
episodes of metabolic decompensation, in which there is a dramatic increase of the 
concentrations of these organic acids. Therefore, neurological defects could be due to direct 
toxic mechanisms of abnormal metabolic products or to accumulation of normal metabolites 
by errors of synthetic pathways or by deficient energy metabolism.
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OP A3 may localise to the OMM [Ryu et al, 2010], with a C-terminus exposed to the cytosol 
and an N-terminal mitochondrial targeting domain. OPA3 residues 83-102 are a hydrophobic 
region that is predicted to be a membrane spanning segment. Deletion of these residues 
showed a mitochondrial localisation but no morphological changes to the mitochondria. A 
plausible explanation is missorting of OPA3 with deleted 83-102 residues to the 
mitochondrial matrix. One might hypothesis, therefore, that if OP A3 is involved in the 
mevalonate shunt pathway by transport of metabolites from the cytosol into the mitochondria, 
then the etiology of MGA-III maybe the missorting of OPA3 to the matrix causing 
accumulation of abnormal metabolic products or normal metabolites within the mitochondria.
9.2.2 OP A3 and mitochondria
A variety of degenerative diseases have now been shown to be caused by mutations in 
mitochondrial genes encoded by mtDNA or nuclear DNA (nDNA) (Fig 78.). And the 
maintenance of a finely tuned balance between mitochondrial fusion and fission processes and 
the generation of energy in the mitochondria via OXPHOS can now be regarded as playing 
important pathogenic roles in neurodegeneration. Experimental evidence has shown that the 
syndromes of OP A3 can be added to the list of optic neuropathies that have a detrimental 
effect on both of these processes and comparisons made between these optic neuropathies 
reveals common themes (Fig 9.2.).
Comparisons between LHON, ADOA, ADO AC and MGA-III shows:- Firstly, in all four 
diseases, optic atrophy can be associated with more complex neurological signs such as 
dystonia or the Leigh-like syndrome in LHON, [Jun et al, 1994, Funalot et al, 2002] deafness 
in ADOA [Amita-Bonneau et al, 2003] and mild extrapyramidal signs in ADO AC and MGA- 
III. Second, all four diseases are caused by mutations in genes encoding proteins located in 
the mitochondria. LHON is mainly caused by mutation of mitochondrial DNA genes 
encoding respiratory chain complex I subunits; the OPA1 gene encodes a protein anchored to 
the IMM facing the intermembrane space [Olichon et al, 2002]; and OP A3 is known to be a 
mitochondrial protein although its exact location remains debatable.
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Figure 9.2. Schematic summary of the common themes linking mitochondrial optic 
neuropathies. [Carelli et al, 2009]
Third, LHON, ADOA, ADOAC and MGA-III are all associated with painless optic atrophy 
without inflammation, consistent with an apoptotic mechanism, which could be common to 
the four disorders causing RGC death culminating in optic atrophy. Indeed, it has been shown 
that complex I plays a key role in the permeability of transition pores [Chauvin et al, 2001] 
and that cells bearing mutations causing LHON are predisposed to apoptosis, [Danielson et al, 
2001; Ghelli et al, 2002] possibly because of increased production of reactive oxygen species 
[Li, 2003]. Similarly, it has been shown that the silencing of OPA1 by RNA interference in 
HeLa cells leads to cytochrome c release and commits cells to apoptosis [Olichon et al, 2003]. 
Reynier et al, in [2004] showed that fibroblast of ADOAC patients carrying the OPA3 
mutation (G93S) also has an increased susceptibility to the induction of apoptosis. Ryu et al, 
in [2010] also showed that mutant OPA3 (G93S) increased cell death and mitochondrial 
fragmentation in the absence of apoptotic stimuli. The further presence of cataract in ADOAC 
could also be explained by an apoptotic mechanism since there are several lines of evidence 
implicating apoptosis in cataractogenesis [Tempestini et al, 2003]. Experiments also revealed 
that overexpression of wildtype OPA3 did not induce cytochrome c release, caspase 3 
activation, or Bax translocation, although OPA3-overexpressing cells were sensitised to
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apoptotic stimuli. Therefore OPA3 has no pro-apoptotic effect, but rather potentiated cell 
death, via mitochondrial fragmentation, after apoptotic stimulation.
Some MGA patients have elevated lactic acid or citric acid cycle intermediates, as well as 
abnormalities of the mitochondrial electron transport chain [Ibel et al, 1993; Besley et al, 
1995; Ruesch et al, 1996], including deficiency of the activities of respiratory chain 
complexes I, II, III, IV and V [Gibson et al, 1993; Sweetman and Williams, 2001; Gunay- 
Aygun, 2005; Wortmann et al, 2006], strongly indicating mitochondrial dysfunction.
There is also a clear link between optic neuropathies and genes of the IMM and OMM 
involved in fission and fusion (Fig 9.2.). The clinical relevance of maintaining a balance 
between mitochondrial fusion and fission processes is underscored by the fact that the 
pathogenesis of certain hereditary neurodegenerative disorders such as ADOA and Charcot- 
Marie-Tooth neuropathy type 2A (CMT2A) can now be linked to mutations in genes 
encoding mediators of mitochondrial fusion. Recent experimental evidence has implicated 
OPA3 in these fusion/fission processes. The ring-like mitochondrial fragmentation phenotype 
observed in OPA3 overexpression has also been observed in overexpression of major fission 
mediators DRP1 and FIS1. Mitochondrial morphology significantly changes in mammalian 
cells overexpressing wildtype or mutant (G93S) OPA3 causing ring-like mitochondrial 
fragmentation and cells depleted of OP A3 via RNA interference, which induced an elongated 
mitochondrial morphology, suggesting a role for OP A3 as a mitochondrial fission factor or an 
inhibitor of fusion. OPA3 was also shown to induce mitochondrial fragmentation even in the 
absence, via RNA interference, of DRP1 and FIS1 suggesting OPA3 might be a fission factor 
independent of DRP1 and FIS 1.
Although overexpression of OP A3 does not itself induce spontaneous apoptotic cell death, the 
OPA3 induced alteration in mitochondrial morphology increased sensitivity to apoptotic 
stimuli. Thus, supporting a close connection between mitochondrial fragmentation and 
apoptotic processes. These findings substantiate the participation of OPA3 in mitochondrial 
dynamics and the pathogenesis of optic atrophy. It is however, still questionable as to whether 
syndromes of Opa3 are primary or secondary mitochondrial diseases although the consensus 
seems to be more towards secondary.
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9.3 Conclusions
The cascade of events leading to neuronal death are very complex and many players will need 
to be considered as each taken individually e.g. axoplasmic flow or energy depletion do not 
give a satisfactory answer. Because of the multiplicity of mitochondrial functions, ranging 
from intermediate metabolism, to energy production, to apoptosis, there are many, non- 
mutually exclusive, potential avenues whereby damaged mitochondria can sabotage the 
survival of a neuronal cell. In the case of Opa3 it is likely that mitochondrial dysfunction is 
the cause of neuronal death but the mitochondrial dysfunction itself maybe a downstream 
event of some other defect.
We should recognize that our understanding of Opa3 function is limited and therefore be 
wary of making assumptions and simplifications. For example, Wolfram syndrome 1, which 
is another syndromic recessive optic atrophy, is associated with multiple organ abnormalities, 
optic nerve atrophy and diabetes. It was initially suspected as a mitochondrial disorder, but 
subsequent studies showed that wolframin is an integral, endoglycosidase H-sensitive 
membrane glycoprotein that localises to the endoplasmic reticulum [Takeda et al, 2001; 
Hofmann et al, 2003; Osman et al, 2003].
In order to help understand the function of Opa3, comparisons with other optic neuropathies 
such as LHON and ADOA are useful as they show an intriguing degree of clinical overlap. 
But should we expect a mechanistic overlap? LHON is caused by defects in complex I and 
ADOA (OPA1) is caused by defects in mitochondrial fusion and fission. They are therefore 
considered primary mitochondrial diseases. However, MGA-III is a metabolic disease, and, 
unlike LHON and ADOA, has a massive build up of organic acid in the tissues. The 
Opa3Ll22P mouse model also displays phenotypic aspects that cannot be explained by 
mitochondrial dysfunction, such as craniofacial anomalies and bone marrow steatosis.
The most likely breakthrough now will come from animal models. Unfortunately, to date the 
only two published models of Opa3 are, our B6; C3-Opa3Ll22P mouse model and a zebrafish 
model [Pie et al. 2010]. This is probably due to the rarity of MGA-III/ADOAC in the human 
population. Overall, this thesis shows that our mouse model faithfully mimics many aspects 
of MGA-III and therefore is an extremely valuable tool in the study of OP A3. The further 
characterization of this model and future genetic and functional studies will eventually help
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elucidate the steps that must occur from defective gene to defective mitochondria, from 
abnormal biochemistry to the disease state and hopefully reveal important pathophysiological 
pathways amenable to therapeutic interventions.
9.4 Future Work
At present the analysis of EM sections of retina, optic nerve and muscle is being undertaken 
to assess for any alterations in mitochondrial morphology and number. Quantitative PCR is 
also being undertaken to confirm that melanopsin RGCs are being preferentially spared 
compared to the non-photosensitive RGCs.
Future work might entail:
1) Structural description of the protein by use of small angle x-ray scattering and circular 
dichroism for protein tertiary structure modelling would allow for a more detailed bio- 
informatic analysis of structure/function correlations.
i i oop
2) Increased apoptosis was observed in the retina of the Opa3 mouse. Increased apoptosis 
can occur by caspase dependent and independent pathways. In order to be in a position to 
modulate retinal apoptosis therapeutically, the apoptotic pathways must be carefully defined 
in our mouse model.
3) Histological sections of depleted epididymal fat depots showed that the adipocytes looked 
structurally like brown adipocytes. To determine if these cells are brown adipocytes 
immunohistochemistry could be undertaken for UCP-1 which is a protein unique to brown 
adipocytes.
4) Assessment of putative TFBS suggested a role for Opa3 in adipogenesis. Lipodystrophy 
was observed in the Opa3 homozygote mice. The reduction of adipocytes may occur via 
decreased growth and differentiation, increased apoptosis, or enhanced destruction as may 
occur in autoimmune destruction and metabolic disturbances. This suggests that 
transcriptional levels of PPARy, C-EBPa+b and PG C -la maybe altered. This could be 
analysed by quantitative real-time PCR.
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Appendix I
1) Chemicals and enzymes
3,3 diaminobenzidine tetrachloride (Sigma-Aldrich) 
Acetic acid (Fisher Solutions, UK)
Agarose molecular biology grade (Sigma-Aldrich) 
Alcian blue 8GX (Sigma-Aldrich)
Alizarin red S (Sigma-Aldrich)
Biomix red (Bioline)
Buffered formal saline 
Catalase (Sigma-Aldrich)
Cytochrome c (Sigma-Aldrich)
DirectPCR Lysis Reagent (Viagen)
DNA Hyperladder IV (Bioline) 
dNTPs (Bioline)
DPX permanent medium (BDH, England)
Ethanol (Fisher Solutions, UK)
Ethidium Bromide (Fisher Solutions, UK)
Eosin (Surgipath)
Formaldehyde (Sigma-Aldrich)
Glycerol (Merck)
Hydrochloric acid (Fisher Solutions, UK)
Hoechst (Invitrogen)
Isopentane (Fisher Solutions, UK)
Isopropanol (Merck)
Mayer haematoxylin (BDH, England)
Neutral buffered formalin 
Newborn calf serum (Sigma-Aldrich)
Nitroblue tetrazolium (Sigma-Aldrich)
OCT (ralamb.com)
Oil-red-O (Sigma-Aldrich)
Paraformaldehyde (Sigma-Aldrich)
Phenazine methosulphate (Sigma-Aldrich) 
Phosphate buffered saline (PBS) (Sigma-Aldrich) 
Proteinase K (Sigma-Aldrich)
Restriction enzyme Pstl (Promega)
RNAlater (Sigma-Aldrich)
Sodium acetate (Sigma-Aldrich)
Sodium azide (Sigma-Aldrich)
Sodium barbitone (Sigma-Aldrich)
Sodium hydroxide (Sigma-Aldrich)
Sodium succinate (Sigma-Aldrich)
Quick clean (Bioline)
Taq polymerase mastermix (Bioline)
TBE buffer (Sigma-Aldrich)
Toluidine blue powder (Sigma-Aldrich)
Xylene (Fisher Solutions, UK)
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2) Kits
ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit TUNEL (Chemicon) 
Quantitect Reverse Transcription Kit (Qiagen)
Wizard SV Genomic DNA purification System (Promega)
RNeasy mini kit (Qiagen)
3) Solutions, buffers and media
3, 3 Diaminobenzidine tetrahydrochloride 5mM
Inject 27.77 ml of distilled water into the container of 3,3 Diaminobenzidine 
tetrahydrochloride. Mix until dissolved. Add 27.77 ml of 0.2M phosphate buffer pH 7.4. 
Adjust pH to 7.0 with 0.1M hydrochloric acid or 0 .1M sodium hydroxide solution. Decant 
800pl into 1.5 ml microtubes and make a small hole in the lid. Snap freeze in liquid nitrogen 
and store at -20°C.
Cytochrome c 500pM
Disolve 62mg of Cytochrome c in 10 ml of 0.1M phosphate buffer. Adjust to pH 7.0.
Nitroblue tetrazolium 1.875mM
Disolve 49mg of Nitorblue tetrazolium in 32 ml of 0.1M phosphate buffer. Adjust to pH 7.0. 
Decant 800pl into 1.5ml microtubes and store at -20°C.
Oil red-O solution
Stock solution
Dissolve 0.5g of Oil red-O in 200 ml of isopropyl alcohol. Warm the solution in a 56°C water 
bath for 1 hr and allow to cool.
Working solution
Prepare on day of use. Add 12 ml stock solution and 8 ml of distilled water. Mix and allow to 
stand for 10 mins. Filter through a filter cartridge (0.2/0.45um) or a fine filter paper (no 45 
Whatman) before use.
Sodium succinate 1.3M
Disolve 3.5g of sodium succinate in 10 ml of 0.1M phosphate buffer. Adjust to pH 7.0. 
Decant 250pl into 0.5 ml microtubes and store at -20°C.
PBS
Dissolve 1 tablet of phosphate buffered saline (Sigma P4417) in 200 ml of distilled water. 
This yields a 0 .01M phosphate buffer, 0.0027M potassium chloride and 0.137M sodium 
chloride, PH 7.4 solution
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4% PFA
Measure 4g of parafolmaldehyde into a glass bottle in the fume hood. Add 100 ml of 
phosphate buffered saline (PBS) into the bottle and mix vigorously. Place in water bath at 
65oC for 3-4 hours. Allow the solution to warm up it will turn from cloudy to clear when it is 
ready. When cooled it can be transferred into smaller vials and placed in the freezer for long 
term storage.
Phenazine methosulphate 2.0mM
Disolve 3.0634g of phenazine methosulphate in 1L of 0.1M phosphate buffer which gives 
lOmM phenazine methosulphate. Adjust to pH 7.0. To make 2.0mM phenazine 
methosulphate take 2ml of lOmM phenazine methosulphate and add to 8ml of 0.1M 
phosphate buffer.
0.2 M Phosphate buffer pH7.4
Add 21.8g dibasic sodium phosphate (Na2HP0 4 ) and 6.4g monobasic sodium phosphate 
(NaH2P0 4 ) to 1000 ml of distilled water. Adjust pH to 7.4.
Perfusion Fix Buffer
Perfusion fix buffer is 4% PFA in 0.1M phosphate buffer which is made up as follows:-Firstly 
to make up 0.2M phosphate buffer pH 7.4. Add 21.8g dibasic sodium phosphate (Na2HPC>4 ) 
and 6.4g monobasic sodium phosphate (NaH2P 0 4) to 1000 ml of distilled water. In a separate 
bottle add 40g of paraformaldehyde to 500ml of distilled water. Heat to 60-65°C, solution will 
turn clear when ready. Then add 500ml of 0.2M phosphate buffer from the first bottle. Allow 
solution to cool and then filter. Adjust pH to 7.4.
Sodium azide lOOmM
Disolve 3.2505g of sodium azide in 500ml of 0.1M phosphate buffer which gives lOOmM 
phenazine methosulphate. Adjust to pH 7.0.
Toluidine Blue Solution
Sodium acetate 1.0 g
Sodium barbitone 1.5 g
Toluidine blue powder 1.5 g
Cone. Hydrochloric acid 1.0 ml
Distilled water 250 ml
Dissolve the sodium acetate and the sodium barbitone in the distilled water. Add the 
hydrochloric acid and adjust the pH to 5.0 using 10% HCL. Dissolve the Toluidine blue 
powder in this solution, filter and bottle.
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4) Software
Clustal W- www.ebi.ac.uk/clustalw/
DisEmbI- www.dis.embl.de/
Ensembl- www.ensembl.org/
Globplot- www.globplot.embl.de/
Matlnspector- http://genomatix.gsf.de/mat_fam;
Mulan- http://mulan.dcode.org/
NCBI- www.ncbi.nlm.nih.gov/
OMIM- www.ncbi.nlm.nih.gov/omim/
PONDR- http://www.pondr.com
PreMod- http://genomequebec.mcgill.ca/PReMod
Primer3input- http://frodo.wi.mit.edu/
Pmut- http://mmb .pcb .ub.es:8080/PMut/
PolyPhen- www.genetics.bwh.harvard.edu/pph/
SCpred- www.enzim.hu/scpred/pred.html 
SNP3D- www.snps3d.org/
TANGO- www.tango.crg.es/
TFsearch- http://www.cbrc.jp/research/db/TFSEARCH.html
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Appendix II
Sequencing results of murine Opa3 exons and transcripts 
la) Mouse transcript 1-2A Foward
> 1 5 1 0 0  8 _ 6  6 94 8 _ t r a n s l - 2 A _ t  r a n s 1 -  2 F
TGGTGGGCGCGTTCCCCATGGCGAAGCTGTTCTACTTGGGCATCCGGCAG
GTTAGCAAGCCGCTGGCCAACCGTATCAAGGATGCTGCCCGCCGCAGCGA
GTTCTTCAAGACCTACATCTGCCTACCGCCAGCCCAGCTGTACCACTGGG
TGGGAGATGCGGACGAAGATGCGCATAATGGGTTTCCGGGGCACTACCAT
CAAGCCACTGAATGAGGAGGCAGCAGCAGAGCTGGGTGCTGAGCTGCTGG
GCGAGGCCACCATCTTCATTGTGGGCGGAGGCTGCCTGGTCCTGGAGTAC
TGGCGCCACCAGACTCAGCAGCGCAATAAGGAGGAGGAACAGCGGGCAGC
CTGGAACGCTCTGCAGGATGAGGTGGGCCGCCTGGCACTGGCCTTAGAGG
CGCTGCAGGCTCAGGCACAAGCGATGCCCTCCTTGAGTGCCCTGGAGGAG
CTGCGGGAGGAGCTGCAGGAGGTGCGTGGTCAGGTCTGCAATGCTCACTG
TACTTCCAAGTGCCAGGCAGCATCTTCCAAGAAATAGCCAGCTGCTAAGG
CCTGGACTTGTTTGTGACCATGTGGCCTCCAATAGAGCCTTCTCCTCACA
CCTCCTGGCCCGGGATGCTCTGGCCTAGCAGAAACCACGAGGACCTTGAT
GTAGCTGTGACATGTGGTCACCCCTTACTGACAGGTTCTGGGCATTTCCC
CAGGGAGCACTCAGCAGAAGCCTTCAGAGCC
lb) Mouse transcript 1-2A reverse
> 1 5 1 0 0 8 _ 6 6  9 5 8 _ t r a n s l - 2 A _ t r a n s l - 2 R
CCTGTCAGTAAGGGGTGACCACATGTCACAGCTACATCAAGGTCCTCGTG
GTTTCTGCTAGGCCAGAGCATCCCGGGCCAGGAGGTGTGAGGAGAAGGCT
CTATTGGAGGCCACATGGTCACAAACAAGTCCAGGCCTTAGCAGCTGGCT
ATTTCTTGGAAGATGCTGCCTGGCACTTGGAAGTACAGTGAGCATTGCAG
ACCTGACCACGCACCTCCTGCAGCTCCTCCCGCAGCTCCTCCAGGGCACT
CAAGGAGGGCATCGCTTGTGCCTGAGCCTGCAGCGCCTCTAAGGCCAGTG
CCAGGCGGCCCACCTCATCCTGCAGAGCGTTCCAGGCTGCCCGCTGTTCC
TCCTCCTTATTGCGCTGCTGAGTCTGGTGGCGCCAGTACTCCAGGACCAG
GCAGCCTCCGCCCACAATGAAGATGGTGGCCTCGCCCAGCAGCTCAGCAC
CCAGCTCTGCTGCTGCCTCCTCATTCAGTGGCTTGATGGTAGTGCCCCGG
AAACCCATTATGCGCATCTTCGTCCGCATCTCCACCCAGTGGTACAGCTG
GGCTGGCGGTAGGCAGATGTAGGTCTTGAAGAACTCGCTGCGGCGGGCAG
CATCCTTGATACGGTTGGCCAGCGGCTTGCTAACCTGCCGGATGCCCAAG
TAGAACAGCTTCGCCATGGGGAACGCGCCCACCACCATCTCGGCGGCCGC
CCTGGGGCACGCGCAACCTTGC
2a) mouse transcript 1-2C Foward
> 1 5 1 0 0 8 _ 6 6 9 4 9 _ t r a n s l - 2 C _ t r a n s l - 2 F
TGGTGGGCGCGTTCCCCATGGCGAAGCTGTTCTACTTGGGCATCCGGCAG
GTTAGCAAGCCGCTGGCCAACCGTATCAAGGATGCTGCCCGCCGCAGCGA
GTTCTTCAAGACCTACATCTGCCTACCGCCAGCCCAGCTGTACCACTGGG
TGGGAGATGCGGACGAAGATGCGCATAATGGGTTTCCGGGGCACTACCAT
CAAGCCACTGAATGAGGAGGCAGCAGCAGAGCTGGGTGCTGAGCTGCTGG
GCGAGGCCACCATCTTCATTGTGGGCGGAGGCTGCCTGGTCCTGGAGTAC
TGGCGCCACCAGACTCAGCAGCGCAATAAGGAGGAGGAACAGCGGGCAGC
CTGGAACGCTCTGCAGGATGAGGTGGGCCGCCTGGCACTGGCCTTAGAGG
CGCTGCAGGCTCAGGCACAAGCGATGCCCTCCTTGAGTGCCCTGGAGGAG
CTGCGGGAGGAGCTGCAGGAGGTGCGTGGTCAGGTCTGCAATGCTCACTG
TACTTCCAAGTGCCAGGCAGCATCTTCCAAGAAATAGCCAGCTGCTAAGG
CCTGGACTTGTTTGTGACCATGTGGCCTCCAATAGAGCCTTCTCCTCACA
CCTCCTGGCCCGGGATGCTCTGGCCTAGCAGAAACCACGAGGACCTTGAT
GTAGCTGTGACATGTGGTCACCCCTTACTGACAGGTTCTGGGCATTTCCC
CAGGGAGCACTCAGCAGAAGCCTTCAGAG
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2b) Mouse transcript 1-2C reverse
> 1 5 1 0 0 8 _ 6 6  9 5  9 _ t r a n s l - 2 C _ t r a n s l - 2 R
ACCTGACCACGCACCTCCTGCAGCTCCTCCCGCAGCTCCTCCAGGGCACT
CAAGGAGGGCATCGCTTGTGCCTGAGCCTGCAGCGCCTCTAAGGCCAGTG
CCAGGCGGCCCACCTCATCCTGCAGAGCGTTCCAGGCTGCCCGCTGTTCC
TCCTCCTTATTGCGCTGCTGAGTCTGGTGGCGCCAGTACTCCAGGACCAG
GCAGCCTCCGCCCACAATGAAGATGGTGGCCTCGCCCAGCAGCTCAGCAC
CCAGCTCTGCTGCTGCCTCCTCATTCAGTGGCTTGATGGTAGTGCCCCGG
AAACCCATTATGCGCATCTTCGTCCGCATCTCCACCCAGTGGGTACAGCT
GGGCTGGCGGTAGGCAGATGTAGGTCTTGAAGAACTCGCTGCGGCGGGCA
GCATCCTTGATACGGTTGGCCAGCGGCTTGCTAACCTGCCGGATGCCCAA
GTAGAACAGCTTCGCCATGGGGAACGCGCCCACCACCATCTCGGCGGCCG
CCCTGGGGCACGCGCAA
3) Mouse exonl dna sample 1002 foward
> 0 3 1 0 0  8 a _ 6 6  3 8 3 _ 1 0 0 2 e x o n l _ e x o n l F
GGGGGAGGACGGCGAGGTCGGCGGCGCCCCGCCCAGTCAGCAAGGTTGCG
CGTGCCCCAGGGCGGCCGCCGAGATGGTGGTGGGCGCGTTCCCCATGGCG
AAGCTGTTCTACTTGGGCATCCGGCAGGTTAGCAAGCCGCTGGCCAACCG
TATCAAGGATGCTGCCCGCCGCAGCGAGTTCTTCAAGACCTACATCTGCC
TACCGCCAGCCCAGCGTGAGTCTCACCCCAAGGCCTCTAGCCCTTCCATT
CCCGATCTTTCTAGTTCAGGGGAACGGA
4a) Mouse exon2 dna sample 1002 foward
> 0 3 1 0 0 8  a _ 6  6 3 8 7 _ 1 0 0 2  e x o n 2 _ e x o n 2  F
AGATGCGCATAATGGGTTTCCGGGGCACTACCATCAAGCCACTGAATGAG
GAGGCAGCAGCAGAGCTGGGTGCTGAGCTGCTGGGCGAGGCCACCATCTT
CATTGTGGGCGGAGGCTGCCTGGTCCTGGAGTACTGGCGCCACCAGACTC
AGCAGCGCAATAAGGAGGAGGAACAGCGGGCAGCCTGGAACGCTCTGCAG
GATGAGGTGGGCCGCCTGGCACTGGCCTTAGAGGCGCTGCAGGCTCAGGC
ACAAGCGATGCCCTCCTTGAGTGCCCTGGAGGAGCTGCGGGAGGAGCTGC
AGGAGGTGCGTGGTCAGGTCTGCAATGCTCACTGTACTTCCAAGTGCCAG
GCAGCATCTTCCAAGAAATAGCCAGCTGCTAAGGCCTGGACTTGTTTGTG
ACCATGTG
4b) Mouse exon2 dna sample 1002 reverse
> 0 3 1 0 0 8 a _ 6 6 3  8 8 _ 1 0 0 2 e x o n 2 _ e x o n 2 R
CCTGACCACGCACCTCCTGCAGCTCCTCCCGCAGCTCCTCCAGGGCACTC
AAGGAGGGCATCGCTTGTGCCTGAGCCTGCAGCGCCTCTAAGGCCAGTGC
CAGGCGGCCCACCTCATCCTGCAGAGCGTTCCAGGCTGCCCGCTGTTCCT
CCTCCTTATTGCGCTGCTGAGTCTGGTGGCGCCAGTACTCCAGGACCAGG
CAGCCTCCGCCCACAATGAAGATGGTGGCCTCGCCCAGCAGCTCAGCACC
CAGCTCTGCTGCTGCCTCCTCATTCAGTGGCTTGATGGTAGTGCCCCGGA
AACCCATTATGCGCATCTTCGTCCGCATCTCCACCCAGTGGGTACACTGC
AGGGGAGAAAGAGGTCAGGTGTGTTCCGAAGCTCCACCCCCAATACTT
5a) Mouse exon3 dna sample 1002 foward
> 0 3 1 0  0 8 a _ 6 6 3  9 1 _ 1 0  0 2 e x o n 3 _ e x o n 3 F
TGTAGTCTGGGCTTGTAATGCAGACCAAGATGCGCATCATGGGCTTCCAT
GCTGAGGCCATCAAGCCACTGAATGAGGATGCAGCGACTGAGCTGGGTGC
GAACCTGCTGGGTGAAGCCATCATCTTTGCTGCTGCGGGCAGCTGTCTGC
TGCTGGAGTTCTGGCGCCAGAAGTCATCGAAACACCGCAGGGAAGTGGCG
CAGGTGGCCACGGTGCTGTCGCTGCGGGAGGATGTGGAATACCTGGAGAA
CATGCTGGACGAGGTGCAGGTGCAGGTGCAGGCAGCATTGCCCAGGAACT
CACTGGATGAGCTGCGGGCAGAGCTGCGGGCAGAGCTGCGGGCGGAGCTG
CGGACAGAGTTGCAAGCAGAGTTGCGGGCAGAGCTTCAAGATGAGCTACA
GAAGTTCAGAACCCAGATCTGTAAAGATTGCTATGAGCCAGAGCTTAAGC
CTGAACTCCAGTGTCCTGAGGCCCCCAAGGAGTAGAGGCCGCAGGACTCT
GGCCTTGGACGTGGACTGTTGTCTGGGCTTGT
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5b) Mouse exon3 dna sample 1002 reverse
> 0 3 1 0 0 8 a _ 6 6  3 9 2 _ 1 0  0 2 e x o n 3 _ e x o n 3 R
AAGCTCTGGCTCATAGCAATCTTTACAGATCTGGGTTCTGAACTTCTGTA
GCTCATCTTGAAGCTCTGCCCGCAACTCTGCTTGCAACTCTGTCCGCAGC
TCCGCCCGCAGCTCTGCCCGCAGCTCTGCCCGCAGCTCATCCAGTGAGTT
CCTGGGCAATGCTGCCTGCACCTGCACCTGCACCTCGTCCAGCATGGTTC
TCCAGGTATTCCACATCCTCCCGCAGCGACAGCACCGTGGCCACCTGCGC
CACTTCCCTGCGGTGTTTCGATGACTTCTGGCGCCAGAACTCCAGCAGCA
GACAGCTGCCCGCAGCAGCAAAGATGATGGCTTCACCCAGCAGGTTCGCA
CCCAGCTCAGCCGCTGCATCCTCATTCAGTGGCTTGATGGCCTCAGCATG
GAAGCCCATGATGCGCATCTTGGTCCGCATCTCTAGCCAGTGGTACACTA
CAGGGAAGAAGAGAGGAGTCGGAGTTTGCTTTGGCCAGGGACGCTCCTCA
CCCCACTGCAAACAC
5c) Reverse compliment of 1002exon3_exon3R
GTGTTTGCAGTGGGGTGAGGAGCGTCCCTGGCCAAAGCAAACTCCGACTC
CTCTCTTCTTCCCTGTAGTGTACCACTGGCTAGAGATGCGGACCAAGATG
CGCATCATGGGCTTCCATGCTGAGGCCATCAAGCCACTGAATGAGGATGC
AGCGGCTGAGCTGGGTGCGAACCTGCTGGGTGAAGCCATCATCTTTGCTG
CTGCGGGCAGCTGTCTGCTGCTGGAGTTCTGGCGCCAGAAGTCATCGAAA
CACCGCAGGGAAGTGGCGCAGGTGGCCACGGTGCTGTCGCTGCGGGAGGA
TGTGGAATACCTGGAGAACCATGCTGGACGAGGTGCAGGTGCAGGTGCAG
GCAGCATTGCCCAGGAACTCACTGGATGAGCTGCGGGCAGAGCTGCGGGC
AGAGCTGCGGGCGGAGCTGCGGACAGAGTTGCAAGCAGAGTTGCGGGCAG
AGCTTCAAGATGAGCTACAGAAGTTCAGAACCCAGATCTGTAAAGATTGC
TATGAGCCAGAGCTT
6a) Mouse exon2 dna sample 1003 foward
> 0 3 1 0 0 8 a _ 6 6 3  8 9 _ 1 0 0 3 e x o n 2 _ e x o n 2 F
GGGGCACTACCATCAAGCCACTGAATGAGGAGGCAGCAGCAGAGCTGGGT
GCTGAGCTGCTGGGCGAGGCCACCATCTTCATTGTGGGCGGAGGCTGCCT
GGTCCTGGAGTACTGGCGCCACCAGACTCAGCAGCGCAATAAGGAGGAGG
AACAGCGGGCAGCCTGGAACGCTCTGCAGGATGAGGTGGGCCGCCTGGCA
CTGGCCTTAGAGGCGCTGCAGGCTCAGGCACAAGCGATGCCCTCCTTGAG
TGCCCTGGAGGAGCTGCGGGAGGAGCTGCAGGAGGTGCGTGGTCAGGTCT
GCAATGCTCACTGTACTTCCAAGTGCCAGGCAGCATCTTCCAAGAAATAG
CCAGCTGCTAAGGCCTGGACTTGTTTGTGACCATGTG
6b) Mouse exon2 dna sample 1003 reverse
> 0 3 1 0 0 8 a _ 6 6 3  9 0 _ 1 0 0 3 e x o n 2 _ e x o n 2 R
CCGCAGCTCCTCCAGGGCACTCAAGGAGGGCATCGCTTGTGCCTGAGCCT
GCAGCGCCTCTAAGGCCAGTGCCAGGCGGCCCACCTCATCCTGCAGAGCG
TTCCAGGCTGCCCGCTGTTCCTCCTCCTTATTGCGCTGCTGAGTCTGGTG
GCGCCAGTACTCCAGGACCAGGCAGCCTCCGCCCACAATGAAGATGGTGG
CCTCGCCCAGCAGCTCAGCACCCAGCTCTGCTGGCTGCCTCCTCATTCAG
TGGCTTGATGGTAGTGCCCCGGAAACCCATTATGCGCATCTTCGTCCGCA
TCTCCACCCAGTGGGTACACTGGCAGGGGAGAAAGAGGTCAGGTGTGTTC
CGAAGCTCCACCCCCAATACTT
7a) Mouse exon3 dna sample 1003 foward
> 0 3 1 0 0  8 a _ 6 6 3  9 3 _ 1 0 0 3 e x o n 3 _ e x o n 3 F
TCGCTGCGGGAGGATGTGGAATACCTGGAGAACATGCTGGACGAGGTGCA
GGTGCAGGTGCAGGCAGCATTGCCCAGGAACTCACTGGATGAGCTGCGGG
CAGAGCTGCGGGCAGAGCTGCGGGCGGAGCTGCGGACAGAGTTGCAAGCA
GAGTTGCGGGCAGAGCTTCAAGATGAGCTACAGAAGTTCAGAACCCAGAT
CTGTAAAGATTGCTATGAGCCAGAGCTTAAGCCTGAACTCCAGTGTCCTG
AGGCCCCCAAGGAGTAGAGGCCGCAGGACTCTGGCCTTGGACGTGGACTG
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7b)Mouse exon3 dna sample 1003 reverse
> 0 3 1 0 0 8 a _ 6 6  3 9 2 _ 1 0 0 2 e x o n 3 _ e x o n 3 R
AAGCTCTGGCTCATAGCAATCTTTACAGATCTGGGTTCTGAACTTCTGTA
GCTCATCTTGAAGCTCTGCCCGCAACTCTGCTTGCAACTCTGTCCGCAGC
TCCGCCCGCAGCTCTGCCCGCAGCTCTGCCCGCAGCTCATCCAGTGAGTT
CCTGGGCAATGCTGCCTGCACCTGCACCTGCACCTCGTCCAGCATGGTTC
TCCAGGTATTCCACATCCTCCCGCAGCGACAGCACCGTGGCCACCTGCGC
CACTTCCCTGCGGTGTTTCGATGACTTCTGGCGCCAGAACTCCAGCAGCA
GACAGCTGCCCGCAGCAGCAAAGATGATGGCTTCACCCAGCAGGTTCGCA
CCCAGCTCAGCCGCTGCATCCTCATTCAGTGGCTTGATGGCCTCAGCATG
GAAGCCCATGATGCGCATCTTGGTCCGCATCTCTAGCCAGTGGTACACTA
CAGGGAAGAAGAGAGGAGTCGGAGTTTGCTTTGGCCAGGGACGCTCCTCA
CCCCACTGCAAACAC
7c) Reverse compliment of 1002exon3_exon3R
GTGTTTGCAGTGGGGTGAGGAGCGTCCCTGGCCAAAGCAAACTCCGACTCC
TCTCTTCTTCCCTGTAGTGTACCACTGGCTAGAGATGCGGACCAAGATGCG
CATCATGGGCTTCCATGCTGAGGCCATCAAGCCACTGAATGAGGATGCAGC
GGCTGAGCTGGGTGCGAACCTGCTGGGTGAAGCCATCATCTTTGCTGCTGC
GGGCAGCTGTCTGCTGCTGGAGTTCTGGCGCCAGAAGTCATCGAAACACCG
CAGGGAAGTGGCGCAGGTGGCCACGGTGCTGTCGCTGCGGGAGGATGTGGA
ATACCTGGAGAACCATGCTGGACGAGGTGCAGGTGCAGGTGCAGGCAGCAT
TGCCCAGGAACTCACTGGATGAGCTGCGGGCAGAGCTGCGGGCAGAGCTGC
GGGCGGAGCTGCGGACAGAGTTGCAAGCAGAGTTGCGGGCAGAGCTTCAAG
ATGAGCTACAGAAGTTCAGAACCCAGATCTGTAAAGATTGCTATGAGCCAG
AGCTT
8a) Mouse exon3 dna sample 1003 reverse
> 0 6 1 0 0 8 _ 6 6  52  8 _ 1 0 0 3 e x o n 3 _ e x o n 3 R
AAGCTCTGGCTCATAGCAATCTTTACAGATCTGGGTTCTGAACTTCTGTA
GCTCATCTTGAAGCTCTGCCCGCAACTCTGCTTGCAACTCTGTCCGCAGC
TCCGCCCGCAGCTCTGCCCGCAGCTCTGCCCGCAGCTCATCCAGTGAGTT
CCTGGGCAATGCTGCCTGCACCTGCACCTGCACCTCGTCCAGCATGGTTC
TCCAGGTATTCCACATCCTCCCGCAGCGACAGCACCGTGGCCACCTGCGC
CACTTCCCTGCGGTGTTTCGATGACTTCTGGCGCCAGAACTCCAGCAGCA
GACAGCTGCCCGCAGCAGCAAAGATGATGGCTTCACCCAGCAGGTTCGCA
CCCAGCTCAGCCGCTGCATCCTCATTCAGTGGCTTGATGGCCTCAGCATG
GAAGCCCATGATGCGCATCTTGGTCCGCATCTCTAGCCAGTGGTACACTA
CAGGGAAGAAGAGAGGAGTCGGAGTTTGCTTTGGCCAGGGACGCTCCTCA
CCCCACTGGCAAAC
8b)Reverse compliment of 1003exon3_exon3R
GTTTGCCAGTGGGGTGAGGAGCGTCCCTGGCCAAAGCAAACTCCGACTCCT
CTCTTCTTCCCTGTAGTGTACCACTGGCTAGAGATGCGGACCAAGATGCGC
ATCATGGGCTTCCATGCTGAGGCCATCAAGCCACTGAATGAGGATGCAGCG
GCTGAGCTGGGTGCGAACCTGCTGGGTGAAGCCATCATCTTTGCTGCTGCG
GGCAGCTGTCTGCTGCTGGAGTTCTGGCGCCAGAAGTCATCGAAACACCGC
AGGGAAGTGGCGCAGGTGGCCACGGTGCTGTCGCTGCGGGAGGATGTGGAA
TACCTGGAGAACCATGCTGGACGAGGTGCAGGTGCAGGTGCAGGCAGCATT
GCCCAGGAACTCACTGGATGAGCTGCGGGCAGAGCTGCGGGCAGAGCTGCG
GGCGGAGCTGCGGACAGAGTTGCAAGCAGAGTTGCGGGCAGAGCTTCAAGA
TGAGCTACAGAAGTTCAGAACCCAGATCTGTAAAGATTGCTATGAGCCAGA
GCTT
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9) Mouse transcriptl-3 foward
> 1 5 1 0 0 8 _ 6 6  9 5 1 _ t r a n s l - 3 A _ t r a n s l - 3 F
GCAGGTTAGCAAGCCGCTGGCCAACCGTATCAAGGATGCTGCCCGCCGCA
GCGAGTTCTTCAAGACCTACATCTGCCTACCGCCAGCCCAGCTGTACCAC
TGGGCTTGTAATGCAGACCAAGATGCGCATCATGGGCTTCCATGCTGAGG
CCATCAAGCCACTGAATGAGGATGCAGCGACTGAGCTGGGTGCGAACCTG
CTGGGTGAAGCCATCATCTTTGCTGCTGCGGGCAGCTGTCTGCTGCTGGA
GTTCTGGCGCCAGAAGTCATCGAAACACCGCAGGGAAGTGGCGCAGGTGG
CCACGGTGCTGTCGCTGCGGGAGGATGTGGAATACCTGGAGAACATGCTG
GACGAGGTGCAGGTGCAGGTGCAGGCAGCATTGCCCAGGAACTCACTGGA
TGAGCTGCGGGCAGAGCTGCGGGCAGAGCTGCGGGCGGAGCTGCGGACAG
A
10a) Human exon3 dna sample 486 foward
> 1 5 1 0 0  8 _ 6  6 95  0_ h u m a n E  3 4 8 6 _ h u m a n E  3 F
GGTTTCAATGCCGCTGCCATCAAGCCGCTGAACGAGGGTGCAGCCGCCGA
GCTGGGCGCGGAGCTGCTGGGCGAGGGCATCATCTTCATCACCGCCTGCA
GCTGCCTGATGCTGGAGTATTGGCGCCACCAGTTGCAGCAGCGCCGCAAG
GAAAAGGAGCGACGTGTTGCCAGGGAGGCGCTGCGGGGCGAGGTGGGCCA
CTTGGGGCTGGCGCTCGAGGAGTTGCAGGCGCAGGTGCAGGCGACGTCGA
CGCAGCTCGCCCTGGAGGAGCTGCGCGCTCAGCTGCAGGAGGTGCGAGCC
CACCTCTGCCTCCGAGACCCGCCGCCTGCACCCCCAGTTGCGCCGGCGTC
CGAGAAATAGGAGGTCTCGGGGCCCTGGTCTTG
10b) Human exon3 dna sample 486 reverse
> 1 5 1 0 0  8 _ 6  6 96  0_ h u m a n E 3  4 8 6 _ h u m a n E  3 R
GGGTGCAGGCGGCGGGTCTCGGAGGCAGAGGTGGGCTCGCACCTCCTGCA
GCTGAGCGCGCAGCTCCTCCAGGGCGAGCTGCGTCGACGTCGCCTGCACC
TGCGCCTGCAACTCCTCGAGCGCCAGCCCCAAGTGGCCCACCTCGCCCCG
CAGCGCCTCCCTGGCAACACGTCGCTCCTTTTCCTTGCGGCGCTGCTGCA
ACTGGTGGCGCCAATACTCCAGCATCAGGCAGCTGCAGGCGGTGATGAAG
ATGATGCCCTCGCCCAGCAGCTCCGCGCCCAGCTCGGCGGCTGCACCCTC
GTTCAGCGGCTTGATGGCAGCGGCATTGAAACCCATGATGCGCATTTTGG
TCCGCATCTCCAGCCAGTGGTACACTGGCAGGAAAAGACAGGAGT
11a) Human exon3 dna sample 487 foward
> 1 5 1 0 0 8 _ 6 6 9 5 l_ h u m a n E  3 4  8 7 _ h u m a n E  3 F
AAAATGCGCATCATGGGTTTCAATGCCGCTGCCATCAAGCCGCTGAACGA
GGGTGCAGCCGCCGAGCTGGGCGCGGAGCTGCTGGGCGAGGGCATCATCT
TCATCACCGCCTGCAGCTGCCTGATGCTGGAGTATTGGCGCCACCAGTTG
CAGCAGCGCCGCAAGGAAAAGGAGCGACGTGTTGCCAGGGAGGCGCTGCG
GGGCGAGGTGGGCCACTTGGGGCTGGCGCTCGAGGAGTTGCAGGCGCAGG
TGCAGGCGACGTCGACGCAGCTCGCCCTGGAGGAGCTGCGCGCTCAGCTG
CAGGAGGTGCGAGCCCACCTCTGCCTCCGAGACCCGCCGCCTGCACCCCC
AGTTGCGCCGGCGTCCGAGAAATAGGAGGTCTCGGGGCCCTGGTCTTG
lib ) Human exon3 dna sample 487 reverse
> 1 5 1 0 0 8 _ 6 6 9 6 l_ h u m a n E  3 4  8 7 _ h u m a n E 3 R
GGTGCAGGCGGCGGGTCTCGGAGGCAGAGGTGGGCTCGCACCTCCTGCAG
CTGAGCGCGCAGCTCCTCCAGGGCGAGCTGCGTCGACGTCGCCTGCACCT
GCGCCTGCAACTCCTCGAGCGCCAGCCCCAAGTGGCCCACCTCGCCCCGC
AGCGCCTCCCTGGCAACACGTCGCTCCTTTTCCTTGCGGCGCTGCTGCAA
CTGGTGGCGCCAATACTCCAGCATCAGGCAGCTGCAGGCGGTGATGAAGA
TGATGCCCTCGCCCAGCAGCTCCGCGCCCAGCTCGGCGGCTGCACCCTCG
TTCAGCGGCTTGATGGCAGCGGCATTGAAACCCATGATGCGCATTTTGGT
CCGCATCTCCAGCCAGTGGTACACTGGCAGGAAAAGACAGG
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Figure 10.1. Total number of central and squares entered during 5 mins of Opa3''~ and Opa3>+/-
and Opa3+,+ mice in open field testing. Data expressed as mean ± S.E.M. (Opa3+,+ n = 9, Opa3+'~ n+/+ >+/-
=10, O p a 3 n =9). ***P < 0.001.
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Figure 10.2. Percentage of time spent in various areas of the arena (after the mice had reached 
the periphery) of Opa3''' and Opa3+l' and Opa3+,+ mice in open field testing. Data expressed as
mean ± S.E.M. (Opa3+,+ n = 9, Opa3+l' n =10, Opa3 " n =9). ***P < 0.001.
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A. Homozygote
GCL IPL INL OPL ONL R&C RPE
um um um um um um um
618 15.8 25.6 28.7 8.5 38.8 9 13.2
618 11.4 26.4 31.5 10.5 44.1 11.4 15.8
654 6.9 9.6 24 9.6 34.2 9.8 11.4
654 6.4 9.1 23.6 9.1 35.7 7.9 10
628 11.3 18.9 25.7 9.3 32.75 9.2 11
628 9.6 19.8 22.5 9.5 33.14 8.6 12.1
637 10.7 27.3 23.7 9 37.8 9.4 14.3
637 9.2 19 17.7 7.7 29.9 7.1 11.2
average 10.1625 19.4625 24.675 9.15 35.79875 9.05 12.375
S.D 2.950514 7.0964654 4.1365099 0.82114902 4.4020789 1.28507921 1.92928558
S.E.M 1.043164 2.5089794 1.4624771 0.29032002 1.5563699 0.45434411 0.68210546
B. Wildtype
GCL IPL INL OPL ONL R&C RPE
um um um um um um um
636 25 52 35 16.3 41.1 9.3 15.6
636 31.1 48.4 33.3 16.3 39.1 10.8 13.1
1108 14.9 38.9 23.2 7.9 40.9 11.5 12.7
1108 14.4 35.2 28.7 10.9 40.7 9.4 11.1
1124 13.9 30.6 23.8 6.2 40.5 11 13.3
1124 12.9 33.3 28.8 7.1 38.7 10.4 15.2
1083 17.7 48 38.2 16.1 61.1 16 17.3
1083 14.5 41.2 35.3 16.6 51.9 12.9 17.1
average 18.05 40.95 30.7875 12.175 44.25 11.4125 14.425
S.D 6.528181 7.8401895 5.5300316 4.63488326 7.9962491 2.18268347 2.21859029
S.E.M 2.30806 2.7719256 1.9551614 1.63867869 2.827101 0.77169514 0.78439012
Table 10.1 Quantification of retinal thickness in adult homozygote and wildtype mice used in 
pupillometry testing. Vertical thickness of each retinal layer was measure in pm. Two 
measurements were taken for each mouse, each one 100pm from the optic nerve.
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A. Homozygote
GCL
%
IPL
%
INL
%
OPL
%
ONL
%
R&C
%
RPE
%
618 11.3 18.34 20.56 6.08 27.8 6.45 9.45
618 7.45 17.47 20.95 6.95 29.19 7.54 10.45
654 6.54 9.1 22.75 9.1 32.42 9.29 10.8
654 6.29 8.94 23.2 8.94 35.06 7.75 9.82
628 8.9 14.88 20.24 7.33 32.75 7.24 8.66
628 7.81 16.12 18.32 7.74 33.14 7.01 9.86
637 8.09 20.65 17.93 6.81 28.6 7.11 10.81
637 9.04 18.67 17.38 7.56 29.37 6.98 11
average
S.D
S.E.M
8.1775 15.52125 20.16625 7.56375 31.04125 7.42125 10.10625 
1.600533 4.3634306 2.1655348 1.03414475 2.6202914 0.84947778 0.80696853 
0.565874 1.5427057 0.7656322 0.36562538 0.9264129 0.30033575 0.28530646
B. Wildtype
GCL IPL INL OPL ONL R&C RPE
% % % % % % %
636 12.87 26.77 18.02 8.38 21.15 4.78 8.03
636 16.19 25.2 17.34 8.48 20.35 5.62 6.82
1108 9.93 25.93 15.46 5.27 27.27 7.67 8.47
1108 9.57 23.41 19.08 7.25 27.06 6.25 7.38
1124 9.98 21.97 17.08 4.45 29.07 7.9 9.55
1124 9.46 24.42 13.78 5.21 28.37 7.62 11.14
1083 8.3 22.38 17.81 7.5 28.5 7.45 8.06
1083 7.65 21.74 18.63 8.76 27.39 6.81 9.02
average 10.49375 23.9775 17.15 6.9125 26.145 6.7625 8.55875
S.D 2.764494 1.8977863 1.7469075 1.69634692 3.4066573 1.12287577 1.35262113
S.E.M 0.977396 0.6709688 0.6176251 0.5997492 1.2044353 0.39699654 0.47822379
Table 10.2 Percentage thickness of retina in adult homozygote and wildtype mice used in 
pupillometry testing. Each measurement was taken as a percentage of the whole retina. Two 
measurements were taken for each mouse, each one 100pm from the optic nerve.
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